Virus und Virusinfektionen, eine Einführung in die Grundlagen

  • Gerd Poetschke
  • Olaf Klamerth
Part of the Handbuch der Allgemeinen Pathologie book series (PATHOLOGIE, volume 11 / 2)

Zusammenfassung

Die Virologie entstand als eine angewandte Wissenschaft. Sie entwickelte sich in den letzten 25 Jahren zu einem eigenständigen und geschlossenen Wissensgebiet. Im Gegensatz zur Zoologie, Botanik oder Bakteriologie kann man von der Virologie jedoch nicht behaupten, daß ihr Gegenstand, die Viren, von einheitlicher Natur sei. Damit kann auch über eine phylogenetische Verwandtschaft und das taxonomische System der gesamten Gruppe nichts Sicheres ausgesagt werden. Es ist nach unserem heutigen Wissen sogar höchst unwahrscheinlich, daß eine entwicklungsgeschichtliche, innere Verwandtschaft aller Viren untereinander besteht.

Literatur

  1. Abercrombie, M.: Contact-dependent behavior of normal cells and the possible significance of surface changes in virus-induced transformation. In: Basic mechanisms in animal virology. Cold Spr. Harb. Symp. quant. Biol. 27 (1962).Google Scholar
  2. Ackermann, W. W.: Concerning the relation of the Krebs cycle to virus propagation. J. biol. Chem. 189, 421–428 (1951).PubMedGoogle Scholar
  3. Ackermann, W. W.: The relation of the Krebs cycle to viral synthesis. II. The effect of sodium fluoracetate on the propagation of influenza virus in mice. J. exp. Med. 93, 635–642 (1951).PubMedGoogle Scholar
  4. Ackermann, W. W.: Certain factors governing the persistence of poliovirus in tissue culture. In: Latency and masking in viral and rickettsial infections. Minneapolis: Burgess Publishing Company 1958.Google Scholar
  5. Ackermann, W. W., and T. Francis: Some biochemical aspects of herpes infection. Proc. Soc. exp. Biol. (N.Y.) 74, 123–126 (1950).Google Scholar
  6. Ackermann, W. W., and T. Francis: Characteristics of viral development in isolated animal tissues. Advanc. Virus Res. 2, 81–168 (1954).Google Scholar
  7. Ackermann, W.W., and R. B. Johnson: Some energy relations in a host-virus system. J. exp. Med. 97, 315–322 (1953).PubMedGoogle Scholar
  8. Ackermann, W. W., and H. Kurtz: The relation of herpes virus to host cell mitochondria. J. exp. Med. 96, 151–157 (1952).PubMedGoogle Scholar
  9. Ackermann, W.W., and H. Kurtz: Observations concerning a persisting infection of HeLa cells with poliomyelitis virus. J. exp. Med. 102, 555 (1955).PubMedGoogle Scholar
  10. Ackermann, W.W., F. E. Payneand H. Kurtz: Concerning the cytopathogenic effect of poliovirus; evidence for an extraviral toxin. J. Immunol. 81, 1–6 (1958).PubMedGoogle Scholar
  11. Ackermann, W.W., A. Rabsonand H. Kurtz: Growth characteristics of poliomyelitis virus in HeLa cell cultures. Lack of parallelism in cellular injury and virus increase. J. exp. Med. 100, 437 (1954).PubMedGoogle Scholar
  12. Ada, G. L., P. E. Lind, L. Larkinand F. M. Burnet: Failure to recover infective „ribonucleic acid“ from myxovirus preparations. Nature (Lond.)184, 360–361 (1959).Google Scholar
  13. Ada, G. L., and B. T. Perry: The nucleic-acid content of influenza virus. Aust. J. exp. Biol. med. Sci. 32, 453–468 (1954).PubMedGoogle Scholar
  14. Ada, G. L., and B. T. Perry: Influenza virus nucleic acid: relationship between biological characteristics of the virus particle and properties of the nucleic acid. J. gen. Microbiol. 14, 623 (1956).PubMedGoogle Scholar
  15. Ada, G. L., and J. D. Stone: Electrophoretic studies of virus-red cell interaction: nobility gradient of cells treated with viruses of the influenza group and the receptor-destroying enzyme of V. cholerae. Brit. J. exp. Path. 31, 263 (1950).Google Scholar
  16. Albrecht, W.: Die Phosphatasen der Darmschleimhaut. II. Die Aktivität der Darmphosphatase der Maus nach Virusinfektion. Z. Kinderheilk. 79, 270–275 (1957).PubMedGoogle Scholar
  17. Albrecht, W., H. K. Mittelstrassu. R. Sauthoef: Das Verhalten der alkalischen und sauren Phosphatase in Zellkulturen aus Affennieren nach Infektion mit Echo-Virus Serotyp 9 und Poliovirus hominis Typ 1. Z. Naturforsch. 13b, 71–74 (1958).Google Scholar
  18. Albrecht, W., u. R. Sauthoff: Über das Verhalten der alkalischen Phosphatase am Muskel der mit Coxsackie infizierten Säuglingsmaus. Z. Naturforsch. 9b, 340–342 (1954).Google Scholar
  19. Alexander, H.E., G.Koch, I. M. Mountain and O. van Dm/ME: Infectivity of ribonucleic acid from poliovirus in human cell monolayers. J. exp. Med. 108, 493 bis 506 (1958).Google Scholar
  20. Allison, A. C., and H. R. Perkins: Presence of cell walls like those of bacteria in rickettsiae. Nature (Lond.) 188, 796–798 (1960).Google Scholar
  21. Amoss, H. L., and E. Taylor: Neutralization of the virus of poliomyelitis by nasal washings. J. exp. Med. 25, 507 (1917).PubMedGoogle Scholar
  22. Anderer, F. A., E. Weber u. H. Uilig: Die Reihenfolge der Aminosäuren im Protein aus Tabakmosaik-virus. I. Die N-terminale Aminosäurefolge von Position 1–41. Z. Naturforsch. 15b, 79–85 (1960).Google Scholar
  23. Anderson, E. S., J. A. Armstrongand J. S. F. Niven: Fluorescence microscopy: Observation of virus growth with aminoacridines. In: Virus growth and variation. Cambridge: Cambridge University Pressl959.Google Scholar
  24. Anderson, G.W., G. Anderson, A. Skaar and F. Sandler: Poliomyelitis in pregnancy. Amer. J. Hyg. 55, 127 (1952).PubMedGoogle Scholar
  25. Anderson, G. W., and A. E. Skaar: Poliomyelitis occurring after antigen injections. Bull. Univ. Hosp. Minnesota 22, 359 (1951).Google Scholar
  26. Andervont, H. B.: Relation of milk influence to mammary tumors of hybrid mice. J. nat. Cancer Inst. 5, 391–395 (1945).Google Scholar
  27. Andervont, H. B.: Mammary tumor agent and its implication in cancer research. Yale J. Biol. Med. 18, 333–334 (1946). In: Roscoe B. Jackson Memorial Laboratory Twentieth Commemoration, p. 33. Bar Harbor, Maine: Bar Harbor Times 1949 a.Google Scholar
  28. Andervont, H. B.: Biological studies on the mammary tumor inciter in mice. Ann. N.Y. Acad. Sci. 54, 1004 (1952).PubMedGoogle Scholar
  29. Andervont, H. B.: In: Proc.Can. Cancer Research Conf. 1st Conf. Honey Harbor Ontario, p. 2, 1954 (1955).Google Scholar
  30. Andervont, H. B.: Genetic, hormonal and age factors in susceptibility and resistance to tumor-inducing viruses. Tex. Rep. Biol. Med. 15, 462–476 (1957).PubMedGoogle Scholar
  31. Andervont, H. B.: Unveröffentlichte Ergebnisse 1958. Zit. nach Andervont 1959.Google Scholar
  32. Andervont, H. B.: Problems concerning the tumor viruses. In: The Viruses. Edit. by Burnet and Stanley. London and New York: Academic Press 1959.Google Scholar
  33. Andervont, H. B., and T. B. Dunn: Mammary tumors in mice presumably free of mammary-tumor agent. J. nat. Cancer Inst. 8, 227–230 (1948 a).Google Scholar
  34. Andervont, H. B., and T. B. Dunn: Further studies on the relation of the mammary-tumor agent to mammary tumors of hybrid mice. J. nat. Cancer Inst. 9, 89–104 (1948b).PubMedGoogle Scholar
  35. Andervont, H. B., and T. B. Dunn: Reponse of mammary-tumor-agent-free strain DBA female mice to percutaneous application of methylcholanthrene. J. nat. Cancer Inst. 10, 895–925 (1950).PubMedGoogle Scholar
  36. Andervont, H. B., and T. B. Dunn: Studies of the mammary tumor agent carried by wild house mice. Acta Un. int. Caner. 12, 530–541 (1956).Google Scholar
  37. Andrewes, C. H.: Virus III in tissue cultures. Brit. J. exp. Path. 10, 273 (1929).Google Scholar
  38. Andrewes, C. H.: A change in rabbit fibroma virus suggesting mutation. I. Experiments on domestic rabbits. J. exp.Med. 63, 157 (1936).PubMedGoogle Scholar
  39. Andrewes, C. H.: Occurrence of neutralising antibodies for Rous sarcoma virus in sera of young „normal“ chicks. J. Path. Bact. 48, 225–227 (1939).Google Scholar
  40. Andrewes, C. H.: Interference by one virus with the growth of another in tissue culture. Brit. J. exp. Path. 23, 214–220 (1942).Google Scholar
  41. Andrewes, C. H.: The place of viruses in nature. Proc. roy. Soc. B 139, 313–326 (1952).Google Scholar
  42. Andrewes, C. H.: Nomenklatur der Viren. Zbl. Bakt., I. Abt. Orig. 161, 354 (1954).Google Scholar
  43. Andrewes, C. H.: Classification of viruses of vertebrales.In: Advanc. Virus Res. 9, 271–296 (1962).Google Scholar
  44. Andrewes, C. H., F. M. Burnet, J. F. Enders, S. Gard, G. K. Hirst, M. M. Kaplanand V. M. Zhdanov: Taxonomy of viruses infecting vertebrates: Present knowledge and ignorance. Virology 15, 52–55 (1961).PubMedGoogle Scholar
  45. Armbruster, O., u. U. Beiss: Die Untersuchungen der Phosphatidkomponenten von Viren der Influenzagruppe. Z. Naturforsch. 13 b, 75–79 (1958).Google Scholar
  46. Armstrong, C.: Seasonal distribution in the use of vaccines. Brit. med. J. 1948íI, 1007.Google Scholar
  47. Armstrong, C.: Seasonal distribution of poliomyelitis. Amer. J. pubi. 111th 40, 1296 (1950).Google Scholar
  48. Aronson, ST. M., and G. Shwartzman: Patho-logy of muscles changes in experimental poliomyelitis enhanced with aid of cortisone. Arch. Path. 50, 557 (1953 a).Google Scholar
  49. Aronson, ST. M., and G. Shwartzman: Histopathogenesis of cortisone altered experimental poliomyelitis. Observations on the Syrian hamster inoculated intracerebrally with strain MEF 1. Amer. J. Path. 29, 381 (1953b).PubMedGoogle Scholar
  50. Aschoff, L.: Über den Krankheitsbegriff und verwandte Begriffe. Dtsch. med. Wschr. 1909, 1417.Google Scholar
  51. Avery, O. T., C. M. Macleodand M. Mccarty: Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J. exp. Med. 79, 137–158 (1944).PubMedGoogle Scholar
  52. Aycock, W. L.: Alterations in autarceologic susceptibility to experimental poliomyelitis. Proc. Soc. exp. Biol. (N.Y.) 34, 573–574 (1936).Google Scholar
  53. Babes, V.: Traité de la rage. Paris: Baillière, et fils 1912.Google Scholar
  54. Baker, A. B., and S. Corn-Well: Poliomyelitis X: The cerebellum. Arch. Neurol. (Chic.) 71, 455 (1954).Google Scholar
  55. Baker, A.B.,S. Cornwelland I. A. Brown: Poliomyelitis: VI. The Hypothalamus. Arch. Neurol. (Chic.) 68, 16 (1952).Google Scholar
  56. Baker, A. B., S. Cornwelland F. Tichy: Poliomyelitis IX: Cerebral hemispheres. Arch. Neurol. (Chic.) 71, 435 (1954).Google Scholar
  57. Baker, R. F., F. Ratp, E. A. Groganand I. Gordon: Visualization of measles virus in human cells. Bact. Proc. 76 (1957).Google Scholar
  58. Baluda, M.: Properites of cells transformed by avian myeloblastosis virus. In: Basic mechanisms in animal virology. Cold. Spr. Harb. Symp. quant. Biol. 27 (1962).Google Scholar
  59. Bang, F. B., M. Foardand D. T. Karzon: Determination and significance of substances neutralizing Newcastle virus in human serum. Bull. Johns Hopk. Hosp. 87, 130 (1950).Google Scholar
  60. Bang, F. B., and C. N. Luttrell: Factors in the pathogenesis of virus diseases. In: Advances in virus research. New York and London: Academic Press 1961.Google Scholar
  61. Bang, G. B., and A. Warwick: 1960 (zit. nach Bang u. Luttrell 1961 ).Google Scholar
  62. Baniecki, H.: Plazentabefunde bei Viruserkrankungen. Verh. Dtsch. Ges. f. Path. 38. Tagg S. 135 (1955).Google Scholar
  63. Barksdale, W. L., and A. M. Pappenheimer: Phage-host relationships in nontoxigenic and toxigenic diphtheria bacilli. J. Bact. 67, 220–232 (1954).Google Scholar
  64. Baron, S.: Mechanism of recovery from viral infection. In: Advanc. Virus Res. 10, 39–60 (1963).Google Scholar
  65. Bauer, D. J.: Xanthine oxydase and virus growth. Nature (Lond.) 159, 438–439 (1947a).Google Scholar
  66. Bauer, D. J.: Dehydrogenase activity in virus infection. Brit. J. exp. Path. 28, 440 (1947 b).Google Scholar
  67. Bauer, D. J.: Association of xanthine oxydase with virus multiplication. Nature (Lond.) 161, 852 (1948).Google Scholar
  68. Bauer, D. J.: Nucleic acid metabolism in virus infections. Brit. J. exp. Path. 32, 7 (1951).PubMedGoogle Scholar
  69. Bauer, D. J.: Metabolic aspects of virus multiplication. In: The nature of virus multiplication, p. 46–84. Cambridge: Cambridge Univ. Press 1953.Google Scholar
  70. Bauer, K. H.: Mutationstheorie der Geschwulstentstehung. Berlin: Springer 1928. Das Krebsproblem. Berlin- Göttingen-Heidelberg: Springer 1949.Google Scholar
  71. Bawden, F. C., and N. W. Pirie: Virus multiplication considered as a form of protein synthesis. In: The nature of virus multiplication. Symp. Soc. gen. Microbiol. 2, 21 (1951).Google Scholar
  72. Baylin, G. J., I. N. Dubinand W. G. Gobbeljr.: The effect of roentgen therapy on experimental virus pneumonia. I. In feline virus pneumonia. Amer. J. Roentgenol. 55, 473–477 (1946).Google Scholar
  73. Beard, J. W.: Virus of avian myeloblastic leukosis. Poultry Sci. 35, 203–223 (1956).Google Scholar
  74. Beard, J. W.: Etiology of avian leukosis. Ann. N.Y. Acad. Sci. 68, 473–486 (1957).PubMedGoogle Scholar
  75. Beard, J W, R A Bonar, G. S. Beaudreau, C. Beckerand D. Beard: Biochemistry of the avian leukemia viruses. In: Biochemistry of virus, vol. VII, p. 99–118.Google Scholar
  76. Beard, J W, R A Bonar, G. S. Beaudreau, C. Beckerand D. Beard: Symposium of the Fourth Internat. Congr. of Biochemistry, Vienna, 1958. London: Pergamon Press 1959.Google Scholar
  77. Becker, Y., N. Grossowicz and H. Bernkopp: Metabolism of human amnion cell cultures infected with poliomyelitis virus. I. Glucose metabolism during virus synthesis. Proc. Soc. exp. Biol. (N.Y.) 97, 77–82 (1958).Google Scholar
  78. Behrend, R. CH.: Über infektionsfördernde und pathogenetische Faktoren bei der Hamburger Poliomyelitisepidemie 1947. Nervenarzt 20, 404 (1949).Google Scholar
  79. Beijerinck, M. W.: Über ein Contagium vivum fluidum als Ursache der Fleckenkrankheit der Tabaksblätter. Zbl. Bakt., II. Abt. 5, 27–33 (1899).Google Scholar
  80. Bell, E. J.: Experimental studies of variables in neutralization tests with Lansing poliomyelitis virus. Amer. J. Hyg. 48, 381 (1948 a).Google Scholar
  81. Bell, E. J.: The relationship between the antipoliomyelitic properties of human nasopharyngeal secretions and blood serums. Amer. J. Hyg. 47, 351 (1948b).PubMedGoogle Scholar
  82. Benjamin, B., and S. M. Ward: Leucocytic response to measles. Amer. J. Dis. Child. 44, 921 (1932).Google Scholar
  83. Benzer, S., M. Delbrück, R. Dulbecco, W. Hudson, G. S. Stent, J. D. Watson, W. Weidel, J. J. Weigle and E. L. Wollman: A syllabus of procedures, facts, and interpretations in phage. In: DELBRÜCK, Viruses 1950, Pasadena, Cal. Inst. Technol. Bookstore.Google Scholar
  84. Berenblum, I.: Carcinogenesis in relation to skin cancer. Med. J. Aust. 1960, 721–726.Google Scholar
  85. Bergolts, V. M.: The leukemia-producing activity of cell-free filtrates of human leukemic tissues. Bull. exp. Biol. Med. 45, 731–734 (1958).Google Scholar
  86. Bergolts, V. M.: An experimental study of the etiology of human leukemias. II. The effect of treatment with formalin and glycerol of high temperatures and radiant energy on the activity of human leukemic factor. Probl. Hemat. 4, 19–28 (1959a).Google Scholar
  87. Bergolts, V. M.: Experimental research on the etiology of leukemias in man. III. The importance of the lipid and liponucleoprotein component in the activity of the leukemic factor in man. Probi. Hemat. 4, 27–32 (1959b).Google Scholar
  88. Bergolts, V. M.: The virus etiology of the leukemias. Probl. Virol. (N. Y.) 4, 1–13 (1959 c).Google Scholar
  89. Bergolts, V. M., and L. V. Shershulskaia: The antigenic properties of „human leukemia acftor“ cultivated on the chorioallantoic membrane of the chick embryo. Bull. exp. Biol. Med. 45, 604–608 (1958).Google Scholar
  90. Bergs, V. V., G. Henle, F. Deinhardtand W. Henle: Studies on persistent infections of tissue cultures. II. Nature of the resistance to vesicular stomatitis virus. J. exp. Med. 108, 561–572 (1958).PubMedGoogle Scholar
  91. Bernal, J. D., and I. Fankuchen: X-Ray crystallographic studies of plant virus preparations. J. gen. Physiol. 25, 111, 165 (1941).Google Scholar
  92. Bernhard, W., H. L. Fevbre and R. Cramer: Cancérologie.Mise en évidence au microscope électronique d’un virus dans des cellules infectées in vitro par l’agent du polyome. C. R Acad. Sci. (Paris) 249, 483–485 (1959).Google Scholar
  93. Bernhard, W., and N. Granboulan: Morphology of oncogenic and non-oncogenic mouse viruses. In: A Ciba Foundation Symposium on tumour viruses of murine origin. London: J. and A. Churchill 1962.Google Scholar
  94. Bernhard, W., and L. Gross: Présence de particules d’aspect virusal dans les tissus tumoraux de souris atteintes de leucémies induites. C. R. Acad. Sci. (Paris) 248, 160–163 (1959).Google Scholar
  95. Bernkopf, H., M. Nishmi and A. Rosin: Effect of active and inactive vaccinia virus preparations on human amnion cell cultures. J. Immunol. 83, 635–639 (1959).PubMedGoogle Scholar
  96. Berry, G. P., and H. M. Dedrick: A method for changing the virus of rabbit fibroma (Shope) into that of infectious myxomatosis (Sanarelli). J. Bact. 31, 50–51 (1936).Google Scholar
  97. Berry, G. P., J. A. Lichtyjr. and H. M. Dedrick: Studies on the relationship of the viruses of rabbit fibroma (Shope) and infectious myxomatosis (Sanarelli). J. Bact. 31, 105 (1936).Google Scholar
  98. Bertarelli, E.: Wege auf denen das Wutvirus zu den Speicheldriisen des Hundes gelangt. Zbl. Bakt., I. Abt. Orig. 37, 213 (1904).Google Scholar
  99. BiegeleisenJ. Z., L. V. Scott and V. Lewisjr.: Rapid diagnosis of Herpes simplex virus infections with fluorescent antibody. Science 129, 640–641 (1959).PubMedGoogle Scholar
  100. Bieling, R.: Resistenz und Immunität In: Handbuch der allgemeinen Pathologie, Bd. VII/1, S. 601–673. Berlin- Göttingen-Heidelberg: Springer 1956.Google Scholar
  101. Bieling, R., u. G. Poetschke: Allgemeine Pathogenese der Virus-Krankheiten des Zentralnervensystems. In: Handbuch der speziellen pathologischen Anatomie und Histologie, Bd. 13/IV, S. 101–161. Berlin-Göttingen-Heidelberg: Springer 1958.Google Scholar
  102. Bielka, H., u. A. Graffi: Untersuchungen über die leukämogene Wirkung von Nucleinsäuren aus virusinduziertem Leukämiegewebe. Acta biol. med. germ. 3, 515–517 (1959).PubMedGoogle Scholar
  103. Bittner, J. J.: Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 84, 162 (1936).PubMedGoogle Scholar
  104. Bittner, J. J.: Mammary cancer in fostered and unfostered 0311 breeding females and their hybrids. Cancer Res. 3, 44 (1943).Google Scholar
  105. Bittner, J. J.: Some enigmas associated with genesis of mammary cancer in mice. Cancer Res. 8, 625–639 (1948).PubMedGoogle Scholar
  106. Bittner, J. J.: In: Breast Cancer and its diagnosis and treatment (E. F. Lewinson, ed.), chap. 4. Baltimore, Maryland: Williams und Wilkins Company 1955.Google Scholar
  107. Bittner, J. J.: Bertner foundation lecture: Studies on mammary cancer in mice and their implications of the human problem. Tex. Rep. Biol. Med. 15, 659–673 (1957 a).Google Scholar
  108. Bittner, J. J., and A. Kirschbaum: Assay of methylcholanthrene-induced mammary tumors of mice for mammary tumor milk agent. Proc. Soc. exp. Biol. (N.Y.) 74, 191 (1950).Google Scholar
  109. Blanc, G., and J. BrunEAU: De l’infection inapparente à l’infection apparente avec le virus de la pneumopathie du cobaye. Ann. Inst. Pasteur 75, 566 (1948).Google Scholar
  110. Blanc, G., Caminopetros et Manoussakis: Quelque recherches expérimentales sur la dengue. Arch. Inst. Pasteur hellén. 2, 162 (1928).Google Scholar
  111. Blanc, G., et L. A. Martin: Réceptivité du lapin aux virus de la poliomyélite épidémique. C. R. Acad. Sci. (Paris) 227, 242 (1948).Google Scholar
  112. Blanc, G., et L. A. Martin: Récéptivité du lapin aux virus poliomyélitiques. C.R. Soc. Biol. (Paris) 144, 48 (1950a).Google Scholar
  113. Blanc, G., et L. A. Martin: Conservation du virus poliomyélitique chez le Mérion (Meriones Shawi). C.R. Acad. Sci. (Paris) 230, 1545 (1950b).Google Scholar
  114. Blanc, G., et L. A. Martin: Premiers essais de prophylaxie de la poliomyélite par virus vivant fixé au lapin. Innocuité de la méthode. Bull. Acad. nat. Méd. (Paris) Sér. I II 137, 230 (1953).Google Scholar
  115. Boak, R. A., C. M. Carpenterand S. L. Warren: Symptomatic herpetic manifestations following artificially induced fevers. J. Bact. 27, 83 (1934).Google Scholar
  116. Boand, A. V., J. E. Kempfand R. J. Hanson: Phagocytosis of influenza virus. Fed. Proc. 12, 436 (1953).Google Scholar
  117. Boandjr., A. V, J E Kempf and R. J. Hanson: Phagocytosis of influenza virus. I. In vitro observations. J. Immunol. 79,416–421 (1957).Google Scholar
  118. Bodian, D.: Poliomyelitic changes in multinucleated neurons, with special reference to the site of action of virus in cell. Bull. Johns Hopk. Hosp. 77, 49–59 (1945).Google Scholar
  119. Bodian, D.: Poliomyelitis: Pathologic anatomy. First Internat. Poliomyelitis Conferencepp. 62–84.Google Scholar
  120. Bodian, D.: Philadelphia and Montreal: J. B. Lippincott Company 1948.Google Scholar
  121. Bodian, D.: Neutralization of three immunological types of poliomyelitis virus by human gammaglobulin. Proc. Soc exp. Biol. (N.Y.) 72, 259 (1949).Google Scholar
  122. Bodian, D.: Experimental studies on passive and active immunization against poliomyelitis. II. The prophylactic effect of human gamma globulin in paralytic poliomyelitis in cynomolgus monkey after virus feeding. Amer. J. Hyp. 56, 78 (1952 a).Google Scholar
  123. Bodian, D.: Pathogenesis of poliomyelitis. Amer. J. publ. Hlth 42, 1388 (1952b).Google Scholar
  124. Bodian, D.: Experimental studies on passive immunization against poliomyelitis. Amer. J. Hyg. 58, 81 (1953).PubMedGoogle Scholar
  125. Bodian, D.: Viraemia in experimental poliomyelitis. II. Viraemia and the mechanism of „provoking“ effect of injections or trauma. Amer. J. Hyg. 60, 358 (1954).PubMedGoogle Scholar
  126. Bodian, D.: The enhancement of susceptibility of monkeys to polioviruses of high and of low virulence. Amer. J. Hyg. 64, 92–103 (1956).PubMedGoogle Scholar
  127. Bodian, D.: Poliomyelitis: Pathogenesis and histopathology. In: Viral and rickettsial infections of man. Philadelphia, Montreal: J. B. Lippincott Company 1959.Google Scholar
  128. Bodian, D., and H. A. Howe: The rate of progression of poliomyelitis virus in nerves. Bull. Johns Hopk. Hosp. 69, 79 (1941).Google Scholar
  129. Boring, W. D., D. M. Angevineand D. L. Walker: Factors influencing host-virus interactions. I. A comparision of viral multiplication and histopathology in infant, adult, and cortisone treated adult mice infected with the Conn.-5 strain of Coxsackie virus. J. exp. Med. 102, 753 (1955).Google Scholar
  130. Borrel, A.: Epithélioses infectieuses et épithéliomas. Ann Inst. Pasteur 17, 81–84 (1903).Google Scholar
  131. Bourquin, J. B.: Les malformations du nouveau-né causées par des viroses de la grossesse, et plus particulièrement par la rubéole (Embryopathie rubéoleuse). Thèse de Genève 1948.Google Scholar
  132. Boyer, G. S., F. W. Dennyjr. and H. S. Ginsberg: Intracellular localization of Type 4 adenovirus. II. Cytological and fluorescein-labeled antibody studies. J. exp. Med. 109, 85–96 (1959a).PubMedGoogle Scholar
  133. Boyer, G. S., F. W. Dennyjr. and H. S. Ginsberg: Sequential cellular changes produced by types 5 and 7 adenoviruses in HeLa cells and in human amniotic cells. J. exp. Med. 110, 827–844 (1959b).PubMedGoogle Scholar
  134. Boyer, G. S., E. Leuchtenberger, and H. S. Ginsberg: Cytological and cytochemical studies of HeLa-cells infected with adenovirus. J. exp. Med. 105, 192–216 (1957).Google Scholar
  135. Bradish, C. J., W.M. Henderson, and J. B. Kirkham: Concentration and elec-tron microscopy of the characteristic particle of foot and mouth disease. J. gen. Microbiol. 22, 379–391 (1960).PubMedGoogle Scholar
  136. Bradlay, D., and D. KAY: The fine structure of bacteriophages. J. gen. Microbiol. 23, 553–563 (1960).Google Scholar
  137. Braganca, B. M., and J. H. Quastel: Enzyme inhibitions by snake venoms. Biochem. J. 53, 88 (1953).PubMedGoogle Scholar
  138. Brandis, H.: Die Anwendung von Phagen in der bakteriologischen Diagnostik mit besonderer Berücksichtigung der Typisierung von Typhus -und Paratyphus B-Bakterien sowie Staphylokokken. Ergebn Mikrobiol. 30, 96–159 (1957).Google Scholar
  139. Braunstein, A. E.: Transamination and the integrative function of the dicarboxylic acids in nitrogen metabolism. In: Advances in protein chemistry, vol. 3, p. 1–52. New York: Academic Press 1947.Google Scholar
  140. Braunsteiner, H., K Fellinger, and F. Pakesch: On the occurrence of virus-like bodies in human leukemia. Blood 15, 476–479 (1960).PubMedGoogle Scholar
  141. Breitenfeld, P. M., and W. Schäfer: The formation of fowl plague virus antigens in infected cells, as studied with fluorescent antibodies. Virology 4, 328–345 (1957).PubMedGoogle Scholar
  142. Brenner, S., and R. W. Horne: A negative staining method for high resolution electron microscopy of viruses. Biochim. biophys. Acta (Amst.) 34, 103–110 (1959).Google Scholar
  143. Brenner, S., G. Streisinger, R. W. Horne, S. P. Champs,. L. Barnett, S. Benzerand M. W. Rees: Structural components of bacteriophage. J. moles. Biol. 1, 281–282 (1959).Google Scholar
  144. Briody, B. A., W. A. Casseland M. A. Medill: Adaption of influenza virus to mice. III. Development of resistance to ß-inhibitors. J. Immunol. 74, 41 (1955).PubMedGoogle Scholar
  145. Briody, B. A., and D. Stannard: Studies on vaccinia virus. I. The development of hemagglutinating and infective particles in the chorioallantois of the chick embryo. J. Immunol. 67, 403–411 (1951).PubMedGoogle Scholar
  146. Brown, A., S. A. Mayyasiand J. E. Officer: The „toxic“ activity of vaccinia virus in tissue culture. J. infect. Dis. 104 193–202 (1959 a).Google Scholar
  147. Brown, A., S. A. Mayyasiand J. E. Officer: The agglutination of L cells by vaccinia virus. II. The cells virus interaction related to the agglutination reaction. J. Immunol. 83, 521–528 (1959b).Google Scholar
  148. Brown, D. D., and L. M. Kozloff: Morphological localization of the bacteriophage tail enzyme. J. biol. Chem. 225, 1–11 (1957).PubMedGoogle Scholar
  149. Brown, F., R. F. Sellers, and D. L. Stewart: Infectivity of ribonucleic acid from mice and tissue culture infected with the virus of foot and mouth disease. Nature (Lond.) 182, 535–536 (1958).Google Scholar
  150. Bryan, W. R.: Host virus relationship in tumor inducing viruses. Tex. Rep. Biol. Med. 15, 674–699 (1957).PubMedGoogle Scholar
  151. Bryan, W. R., D. Calnan and J. B. Moloney: Biological studies on Rous sarcoma virus; recovery of virus from experimental tumors in relation to initiating dose. J. nat. Cancer Inst. 16, 317–335 (1955).PubMedGoogle Scholar
  152. Buckley, S. M.: Visualization of poliomyelitis virus by fluorescent antibody. Arch. ges. Virusforsch. 6, 388 (1956).Google Scholar
  153. Buckley, S. M.: Cytopathology of poliomyelitis virus in tissue culture. Fluorescent antibody and tinctorial studies. Amer. J. Path. 33, 691–707 ( 1957 ). Pers. Mitteilungen 1960.Google Scholar
  154. Buck-Ley, S. M., E. Whitneyand F. Rapp: Identification by fluorescent antibody of developmental forms of psittacosis virus in tissue culture. Proc. Soc. exp. Biol. (N.Y.) 90, 226 (1955).Google Scholar
  155. Buffet, R. F., S. L. Commerford, J. Furth and M. J. Hunter: Agent in Ak leukemic tissues, not sedimented at 105000 g, causing neoplastic and non-neoplastic lesions. Proc. Soc. exp. Biol. (N.Y.) 99, 401–407 (1958).Google Scholar
  156. Buist, J. B.: Vaccinia and variola: A study of their life history. London: Churchill 1887.Google Scholar
  157. Burgdorfer, W., and D. Lackman: Identification of the virus of Colorado Tick Fever in mouse tissues by means of fluorescent antibodies. J. Bact. 80, 131–136 (1960).PubMedGoogle Scholar
  158. Burke, D. C., and A. Isaacs: Some factors affecting the production of interferon. Brit. J. exp. Path. 39, 452 (1958).PubMedGoogle Scholar
  159. Burmester, B. R.: Studies on fowl lymphomatosis. Ann. N.Y. Acad. Sci. 54, 992 (1952).PubMedGoogle Scholar
  160. Burmester, B. R.: Routes of natural infection in avian lymphomatosis. Ann. N.Y. Acad. Sci. 68, 487–495 (1957).PubMedGoogle Scholar
  161. Burmester, B. R., A. K. Fontes, N. F. Waters, W. R. Bryanand V. Groupé: The reponse of several inbred lines of White Leghorn to inoculation with the viruses of strain RPL 12 visceral lymphomatosis-erythroblastosis and of Rous sarcoma. Poultry Sci. 39, 199–215 (1960).Google Scholar
  162. Burmester, Friedrich: Das Speicheldrüsenvirus des Menschen (Cytomegalia infantum). Virchows Arch. path. Anat. 317, 165 (1949).Google Scholar
  163. Burnet, F. M.: Virus as organism. HarvardUniversity Press 1950.Google Scholar
  164. Burnet, F. M.: A genetic approach to variation in influenza viruses. 2. VariationGoogle Scholar
  165. Burnet, F. M.: in the strain NWS on allantoic passage. J. gen. Microbiol. 5, 54 (1951 b).Google Scholar
  166. Burnet, F. M.: In: Principles of animal virology. New York: Academic Press 1955.Google Scholar
  167. Burnet, F. M.: In: Ciba Found. Sympos. on Tumor Viruses of Murine Origin, p. 395. London: J. u. A. Churchill 1962.Google Scholar
  168. Burnet, F. M.: Animal viruses: A comparative survey. In: The viruses, vol. III, p. 2. New York and London: Acaedmic Pres1959.Google Scholar
  169. Burnet, F. M., and D. R. Bull: Changes in influenza virus associated with adaptation to passage in chick embryo. Aust. J. exp. Biol. med. Sci. 21, 55 (1943).Google Scholar
  170. Burnet, F. M., and F. Fenner: The production of antibodies, 2nd ed. Melbourne: Macmillan 1944.Google Scholar
  171. Burnet, F. M., and J. D. Stone: Further studies on the O—D change in influenza virus A. A.st. J. exp. Biol. med. Sci. 23, 151 (1945).Google Scholar
  172. Burnet, F. M., and S. W. Williams: Herpes simplex; a new point of view. Med. J. Aust. 1939I, 637.Google Scholar
  173. Burton, L., F. Friedman, R. Kassel, M. L. Kaplanand A. Rottino: The purification and action of tumor factor extracted from mouse and human neoplastic tissues. Trans. N.Y. Acad. Sci. 21, 700–707 (1959).PubMedGoogle Scholar
  174. Cajal, N., Y. Copelovici and R. Capraru: Manifest clinical infection by Coxsackie A2 virus in irradiated adult albino mice. Stud. Cercet. Inframicrobiol. 9, 463–470 (1959).Google Scholar
  175. Calkins, G. N.: Protozoology. Philadelphia: Lea und Febiger 1909.Google Scholar
  176. Cantell, K., and V. Tommila: Effect of interferon on experimental vaccinia and herpes-simplex virus infections in rabbits’ eyes. Lancet 1960 I1, 682–684.Google Scholar
  177. Carr, J. G.: Observations upon spontaneously recurring Rous no. 1 tumors. Brit. J. exp. Path. 23, 206–213 (1942).Google Scholar
  178. Carr, J. G.: Renal adenocarcinoma induced by fowl leukemia virus. Brit. J. Cancer 10, 379–383 (1956).PubMedGoogle Scholar
  179. Carski, T. R.: Fluorescent antibody study of simian foamy agent. Fed. Proc. 18, 561 (1959).Google Scholar
  180. Carski, T. R.: A fluorecent antibody study of the simian foamy agent. J. Immunol. 84, 426–433 (1960).PubMedGoogle Scholar
  181. Carvalho, S. De: Cytopathogenicity of RNA-rich particles from human leukemic and tumor cells for human amnion cultures. Canad. Cancer Conf. Proc. IIIrd Canad. Cancer Res. Conf. (R. W, Begg, ed.), pp. 329–336. New York: Academic Press 1959.Google Scholar
  182. Carvalho, S. De: Biologic properties of human leukemic and tumoral RNA. III. The effect of different media on the cytopathogenicity in tissue culture. J. Lab. clin. Med. 55, 694–705 (1960).Google Scholar
  183. Carvalho, S. De, and H. J. Rand: Comparative effects of liver and tumuor ribonucleic acids on the normal liver and the Novikoff hapatoma cells of the rat. Nature (Lond.) 189, 815–817 (1961).Google Scholar
  184. Carvalho, S. DE, H. T. Rand and D. P. Meyer: Biologic and tumoral RNA. IV. Leukemia and neoplasms induced in mice with human leukemic RNA carried in tissue culture. J. Lab. clin. Med. 55, 706–714 (1960).Google Scholar
  185. Casals, J., and W. Reeves: Arthropod-borne animal viruses. In: Viral and rickettsial infections of man. Philadelphia, Montreal: J. B. Lippincott Company 1959.Google Scholar
  186. Caspersson, T.: Cell growth and cell function. A cytochemical study. New York: W. W. Norton und Co. 1950.Google Scholar
  187. Caspersson, T., and H. Hyden: Högrevirusarters förökning. Nord. Med. 28, 2631 (1945).Google Scholar
  188. Caspersson, T., u. K. G. Thorsson: Virus und Zellstoffwechsel. Klin. Wschr. 31, 205–212 (1953).Google Scholar
  189. Chamorro, R., R. Latarjet, P. Vicier and F. Zajdela: New investigations on the friend disease. In: A Ciba Foundation Symposium on tumour viruses of murine origin. London: J. and A. Churchill 1962.Google Scholar
  190. Cheever, F. S.: Multiplication of Coxsackie virus in adult mice exposed to roentgen radiation. J. Immunol. 71, 431–435 (1953).Google Scholar
  191. Chiozotto, A., A. Coppo, P. Domini and F. Graziosi: The icosahedral form of a temperate phage of Bacillus megatherium. European Regional Conf. on Electron Microscopy 2nd, Delft, pp. 1012–1015 (1960).Google Scholar
  192. Chow, B.: Interrelationship between vitamin B12 steroids and protein metabolism. In: Symposium on protein metabolism, 1953 Toronto Canada, p. 14. New York: Nat. Vitamin Foundation.Google Scholar
  193. Chu, C. M.: The action of normal mouse serum on influenza virus. J. gen. Microbiol. 5, 739 (1951).PubMedGoogle Scholar
  194. Chu, T. H., F. S. Cheever, A. H. Coons and J. B. Daniels: Distribution of mumps virus in the experimentally infected monkey. Proc. Soc. exp. Biol. (N.Y.) 76, 571–574 (1951).Google Scholar
  195. Cieciuria, S. J., P. I. Marcus and T. T. Puck: The use of x-irradiated HeLa cell giants to detect latent virus in mammalian cells. Virology 3, 426 (1957).Google Scholar
  196. Coffin, D. L., A. H. Coons and V. J. Cabasso: A histological study of infectious canine hepatitis by means of fluorescent antibody. J. exp. Med. 98, 13–20 (1953).PubMedGoogle Scholar
  197. Cohen, P. P.: In: The enzymes, vol. 1, part 2, chap. 32 ( J. B. SUMNER und K. MYRBÄCK eds.). New York: Academic Press Inc. 1951.Google Scholar
  198. Cohen, S. M., I. Gordon, F. Rapp, J. C. Macaulayand S. M. Buckley: Fluorescent antibody and complement-fixation tests of agents isolated in tissue culture from measles patients. Proc. Soc. exp. Biol. (N. Y.) 90, 118–122 (1955).Google Scholar
  199. Cohen, S. S.: Cytoplasmatic particles of chorioallantoic membrane and their relations to purified preparations of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 57, 358–360 (1944).Google Scholar
  200. Cohen, S. S.: The synthesis of bacterial viruses in infected cells. Cold Spr. Harb. Symp. quant. Biol. 12, 35–49 (1947).Google Scholar
  201. Cohen, S. S.: Growth requirements of bacterial viruses. Bact. Rev. 13, 1–24 (1949).PubMedGoogle Scholar
  202. Cohen, S. S.: Studies on controlling mechanisms in the metabolism of virus-infected bacteria. Cold Spr. Harb. Symp. quant. Biol. 18, 221–235 (1953).Google Scholar
  203. Cohen, S. S.: The biosynthesis of nucleic acids in some microbial systems. In: The chemical basis of heredity (W. D. MCELROY and B. GLASS, eds.), pp. 651 685. Baltimore: Johns Hopkins Press 1957.Google Scholar
  204. Coiin, Z. A.: Quantitative distribution of phosphorus in chorioallantoic membrane as affected by infection with influenza virus. Proc. Soc. exp. Biol. (N. Y.) 79, 566–568 (1952).Google Scholar
  205. Cohrs, P., u. F. Schulte: Zur differentialdiagnostischen Bedeutung der Aluminiumhydroxydgranulome. Mh. Vet. Med. 6, 105 (1951).Google Scholar
  206. Colter, J. S., H. H. Bird, A. W. Moyerand R. A. Brown: Infectivity of ribonucleic acid isolated from virus-infected tissues. Virology 4, 522–532 (1957).PubMedGoogle Scholar
  207. Colter, J. S., and K. A. O. Ellem: Structure of viruses. Ann. Rev. Microbiol. 15, 219–244 (1961).Google Scholar
  208. Commoner, B., J. A. Lippincott, G. B. Shearer, E. E. Richman and J. H. Wu: Reconstitution of tobacco virus components. Nature (Lond.) 178, 767–771 (1956).Google Scholar
  209. Coons, A. H.: Labeled antigens and antibodies. Ann. Rev. Microbiol. 8, 333 (1954).Google Scholar
  210. Coons, A. H.: Histochemistry with labeled antibody. Int. Rev. Cytol. 5, 1 (1956).Google Scholar
  211. Coons, A. H.: Antibodies and antigens labeled with fluorescein. Schweiz. Z. Path. 22, 693–699 (1959).Google Scholar
  212. Coons, A., H. E. H. Leducand J. M. Connolly: Immunohistochemical studies of antibody response in the rabbit. Fed. Proc. 12, 439 (1953).Google Scholar
  213. Coons, A.H., J. C. Snyder, F. S. Cheeverand E. S. Murray: Localization of antigen in tissue cells. IV. Antigens of rickettsial and mumps virus. J. exp. Med. 91, 31–38 (1950).PubMedGoogle Scholar
  214. Cordy, D. R., and J. R. Gorham: The pathology and etiology of salmon disease in the dog and fox. Amer. J. Path. 26, 617 (1950).PubMedGoogle Scholar
  215. Cowdry, E. V.: Intracellular pathology in virus disease. In: TH. M. Rivers Filtrable Viruses. Baltimore: Williams und Wilkins Company 1928.Google Scholar
  216. Cowdry, E. V.: Comparison of intranuclear inclusions produced by herpetic virus and by virus III in rabbits. Arch. Path. 10, 23 (1930).Google Scholar
  217. Cowdry, E. V.: Identification of inclusions in virus diseases. Amer. J. clin. Path. 10, 133 (1940).Google Scholar
  218. Crawford, G. N. C., and F. K. Sanders: The multiplication of vaccinia virus in tissue cultures of adult rabbit skin. Quart. J. micr. Sci. 93, 119–132 (1952).Google Scholar
  219. Crick, F. H. C., and J. D. Watson: Structure of small viruses. Nature (Lond.) 177, 473–475 (1956).Google Scholar
  220. Crick, F. H. C., and J. D. Watson: Virus structure; general principles. In: The nature of viruses (G. E. W. WOLSTENHOLME and E. C. P. MILLAR eds.), pp. 5–18. London: Churchill; New York: Little Brown und Co. 1957.Google Scholar
  221. Crouse, H. V., L. L. Coriell, H. Blank and T. F. M. Scott: Cytochemical studies on the intranuclear inclusion of herpes simplex. J. exp. Med. 93, 119–128 (1950).Google Scholar
  222. Dalldorf, G., M. Douglassand H. E. Robinson: Sparing effect of dog distemper on experimental poliomyelitis. Science 85, 184 (1937).PubMedGoogle Scholar
  223. Dalldorf, G., G. M. Sickles, H. Plager and R. Gifford: A virus recovered from the feces of „poliomyelitis“ patient, pathogenic for suckling mice. J. exp. Med. 89, 567 (1949).PubMedGoogle Scholar
  224. Dalton, A. J., and M. Potter: Some of the features of the fine structure of a series of plasma cell tumors of mice. Proc. Amer. Ass. Cancer Res. 3, 14 (1959).Google Scholar
  225. Daniels, J. B., M. D. Eaton and M. E. Perry: Effect of glucose on the growth of influenza virus in deembryonated eggs and tissue cultures. J. Immunol. 69, 321–329 (1952).PubMedGoogle Scholar
  226. Darnelljr., J. E.: Early events in poliovirus infection. Cold Spr. Harb. Symp. quant. Biol. 27, 149–157 (1962).Google Scholar
  227. Darnelljr., J. E., and H. Eagle: Nutritional requirements for poliovirus synthesis in Hela cells. Fed. Proc. 17, 508 (1958).Google Scholar
  228. Dawson, A. M., and A. S. Mcfarlane: Structure of an animal virus. Nature (Lond.) 161, 464 (1948).Google Scholar
  229. Dean, D. J., and G. Dalldorf: The susceptibility of the hamster of mouse encephalomyelitis virus. J. exp. Med. 88, 645 (1948).PubMedGoogle Scholar
  230. Deibel, R., and J. E. Hotchin: Quantitative applications of fluorescent antibody technique to influenza-virus-infected cell cultures. Virology 8, 367–380 (1959).PubMedGoogle Scholar
  231. Deinhardt,F., V. V. Bergs, G. Henle and W. Henle: Studies on persistent infections of tissue cultures. III. Some quantitative aspects of host cell-virus interactions. J. exp. Med. 108, 573–589 (1958).Google Scholar
  232. Delbrück, M.: Interference between bacterial viruses. III. J. Bact. 50, 151–170 (1945).Google Scholar
  233. Delbrück, M., and W. T. Bailayjr.: Induced mutations in bacterial viruses. Cold Spr. Harb. Symp. quant. Biol. 11, 33–37 (1946).Google Scholar
  234. Delbrück, M., and S. E. Luria: Interference between bacterial viruses. I. Arch. Biochem. 1, 111–141 (1942).Google Scholar
  235. Demars, R. J., S. B. Luria, H. Fisher and C. Levinthal: The production of incomplete bacteriophage particles by the action of proflavine, and the properties of the incomplete particles. Ann. Inst. Pasteur 84, 113–128 (1953).Google Scholar
  236. Demonbreun, W. A., and E. W. Ggodpasture: Infectious oral papillomatosis of dogs. Amer. J. Path. 8, 43 (1932).PubMedGoogle Scholar
  237. Desomer, P., A. Prinzie, P. Denys jr. and E. Schonne: Mechanism of action of interferon. I. Relationship with viral ribonucleic acid. Virology 16, 63–70 (1962).Google Scholar
  238. Desomer, P., A. Prinzieand E. Schonne: Infectivity of poliovirus ribonucleic acid for embryonated eggs and unsusceptible cell lines. Nature (Lond.) 184, 652–653 (1959).Google Scholar
  239. Dimayorca, G. A., B. E. Eddy, S. E. Stewart, W. S. Hunter, C. Friend and A. Bendich: Isolation of infectious deoxyribonucleic acid from SE polyoma-infected tissue cultures. Proc. nat. Acad. Sci (Wash.) 45, 1805–1808 (1959).Google Scholar
  240. Dmochowski, L.: Milk factor problems in mice. British Empire Cancer Campaign, 13th Ann. Rept. p. 184 (1952).Google Scholar
  241. Dmochowski, L.: The milk agent in the origin of mammary tumors in mice. Advanc. Cancer Res. 1, 103–172 (1953a).Google Scholar
  242. Dmochowski, L.: Study of development of mammary tumours in hybrid mice. Brit. J. Cancer 7, 73–119 (1953b).PubMedGoogle Scholar
  243. Dmochowski, L.: In: Cancer (R. W. Raven, ed.), vol. 1, chap. 8. London:Viruses and tumors in the light of electron microscope studies. Cancer Res. 20, 977–1015 (1960).Google Scholar
  244. Dmochowski, L.: The viral etiology of leukemia. In: Progr. med. Virol. 3, 363494 (1961).Google Scholar
  245. Dmochowski, L., and C. E. Grey: Subcellular structures of possible viral origin in some mammalian tumors. Ann N Y Acad. Sci. 68, 559–615 (1957).PubMedGoogle Scholar
  246. Dmoohowski, L., C. E. Grey, B. E. Eddyand S. E. Stewart: An electron microscope study of tissues from animals infected with polyoma virus. Proc. XVIIIth Ann. Meeting Electron Microsc. Soc. Am. p. 13 (1960).Google Scholar
  247. Dmoclowski, L., C. E. Greyand L. Gross: The role of viruses in X-ray-induced leukemia. In: Radiation Biology and Cancer, pp. 382–399. Worth: Univ. Texas Publ. 1958.Google Scholar
  248. Dmochowski, L., C. E. Grey, J. A. Sykes, C. C. Shullenbergerand C. D. Howe: Studies on human leukemia. Proc. Soc. exp. Biol. (N.Y.) 101, 686–690 (1959 a).Google Scholar
  249. Dmochowski, L., and J. Orr: Chemically induced breast tumours and mammary tumours agent. Brit. J. Cancer 3, 520–525 (1949).PubMedGoogle Scholar
  250. Dmgchowski, L., J. G. Sinkovics, J. A. Sykes, C. C. Shullenbergerand C. D. Howe: Biological studies on human leukemia. Ann. Rep. Univ. Texas M. D. Anderson Hosp. Tumor Inst. Zit. Nach Dmochowski 1961.Google Scholar
  251. Dmochowski, L., J. A. Sykes, C. E. Grey, C. C. Shullenbergerand C. D. Howe: Studies on human leukemia. Proc. Amer. Ass. Cancer Res. 3, 17 (1959 b).Google Scholar
  252. Doerr, R.: Die Entwicklung der Virusforschung und ihre Problematik. In: Handbuch der Virusforschung, Bd. I, S. 42. Wien: Springer 1938 a.Google Scholar
  253. Doerr, R.: Die Entwicklung der Virusforschung und ihre Problematik. Art und Lokalisation der anatomischen Veränderungen. Organo-und Cytotropismen. In : Handbuch der Virusforschung, Bd. I, S. 81. Wien : Springer 1938 b.Google Scholar
  254. Doerr, R.: Allgemeine Beurteilung der Immunitätsverhältnisse bei Viruskrankheiten. „Natürliche Resistenz“ und erworbene Immunität. In: Handbuch der Virusforschung, Bd. I, S. 86.Wien : Springer 1938 c.Google Scholar
  255. Doerr, R.: Die Ausbreitung der Virusarten im Wirtsorganismus In : Hand-buch der Virusforschung, 2. Hälfte Wien : Springer 1939.Google Scholar
  256. Doerr, R.: Die Lehre von den Infektions-krankheiten in allgemeiner Darstellung. In: Lehrbuch der inneren Medizin, 5. Aufl., S. 110. Berlin: Springer 1942.Google Scholar
  257. Doerr, R.: Die Infektion als Gast-Wirt-Beziehung mit besonderer Berücksichtigung der tierpathogenen Virusarten. Arch. Virusforsch. 2, 87 (1944a).Google Scholar
  258. Doerr, R.: Mensch und Tier als Virusträger und Virusausscheider. In : Handbuch der Virusforschung, Erg.-Bd. I, S. 88. Wien : Springer 1944 b.Google Scholar
  259. Doerr, R.: Mensch und Tier als Virusträger und Virusausscheider. Herpes febrilis. In : Handbuch der Virusforschung, Erg.-Bd. I, S. 152. Wien : Springer 1944 c.Google Scholar
  260. Doerr, R., et K. VöcHTING: Sur le virus de l’herpès fébrile. Rev. gén. Ophtal. (Paris) 34, 409 (1920).Google Scholar
  261. Dohi, Seiichi: On the biology of inclusion bodies in virus diseases. (I.) On ectromelia viruses. Acta path. jap. 1, 87–96 (1951).Google Scholar
  262. Donaldson, P., D. E. Davis, J. R. Watkins and S. E. Sulkin: Tissue culture and fluorescent antibody techniques for rapid isolation and identification of agents of the IGV-psittacosis group. Bact. Proc. P 65 (1958 a).Google Scholar
  263. Donaldson, P., D. E. Davis, J. R. Watkins and S. E. Sulkin: The isolation and identification of ornithosis infection in turkeys by tissue culture and immunochemical staining. Amer. J. vet. Res. 19, 950–954 (1958b).PubMedGoogle Scholar
  264. Donaldson, P., and S. E. Sulkin: Identification of feline pneumonitis virus in tissue cultures by fluorescein-labeled antibody. Tex. Rep. Biol. Med. 15, 421 (1957).Google Scholar
  265. Dostal, V., R. Gadeke, H. Grunewald. R. Mauler, H. K. MittelstrassU. R. Sauthoff: Untersuchungen über den intracellulären Nachweis des Echo-Virus Typ 9 in Affennieren-Kulturzellen. Z. ges. Hyg. 146, 367–384 (1960).Google Scholar
  266. Doty, P.: The relation of the interaction of polynucleotides to the secondary structure of nucleic acids. In: The structure and biosynthesis of macromolecules, Biochemical Society Symposia No. 21. Cambridge: Cambridge University Press 1962.Google Scholar
  267. Dougherty, T. F., and A. White: Functional alterations in lymphoid tissue induced by adrenal cortical secretion. Amer. J. Anat. 77, 81 (1945).Google Scholar
  268. Dourmashkin, R. R., and G. Negroni: Identification with the electron microscope of particles associated with polyoma virus in induced parotid gland tumors of C3H mice. Exp. Cell. Res. 18, 573–576 (1959).PubMedGoogle Scholar
  269. Dourmashkin, R. R., and P. J. Simons: The ultrastructure of Rous sarcoma virus. J. Ultrastruct. Res. 5, 505–522 (1961).PubMedGoogle Scholar
  270. Drouhet, V.: Cellular lesions induced by reovirus (ECHO 10). Fluorescent antibody and cytochemical studies. Ann Inst. Pasteur 98, 618–621 (1960).Google Scholar
  271. Druckrey, H., u. K. Küpfmüller: Quantitative Analyse der Krebsentstehung. Z. Naturforsch. 3 b, 254–266 (1948).Google Scholar
  272. Dubes, G. R., and M. Chapin: Cold-adapted genetic variants of polio viruses. Science 124, 586–588 (1956).PubMedGoogle Scholar
  273. Dubes, G. R., and H. A. Wenner: Virulence of polioviruses in reaction to variant characteristics distinguishable on cells in vitro. Virology 4, 275–296 (1957).PubMedGoogle Scholar
  274. Dubin, I. N., G. J. Baylinand W. G. Gobbeljr.: Effect of roentgen therapy on experimental virus pneumonia, on pneumonia produced in white mice by swine influenza virus. Amer. J. Roentgenol. 55, 478–481 (1946).Google Scholar
  275. Dulbecco, R.: Production of plaques in monolayer tissue cultures by single particles of an animal virus.Proc. nat. Acad. Sci. (Wash.) 38, 747 (1952).Google Scholar
  276. Dulbecco, R.: Mutual exclusion between related phages. J. Bact. 63, 209–217 (1952).PubMedGoogle Scholar
  277. Dulbecco, R.: Quantitative aspects of virus growth in cultivated animal cells. Ciba Foundation Symposium. The nature of viruses, p. 147. London: J. and A. Churchill Ltd. 1957.Google Scholar
  278. Dulbecco, R.: In: Basic mechanisms in animal viruses. Cold Spr. Harb. Symp. quant. Biol. 27, 519–525 (1962).Google Scholar
  279. Dulbecco, R., and M. Vogt: Evidence for a ring structure of polyoma virus DNA. Proc. nat. Acad. Sci. (Wash.) 50, 236–243 (1963).Google Scholar
  280. Duran-Reynals, F.: A hemorrhagic disease occuring in chicks inoculated with the Rous and Fujinami viruses. Yale J. Biol. Med. 13, 77–98 (1940).Google Scholar
  281. Duran-Reynals, F.: In: The physiopathology of cancer (F. HOMBURGER and W. H. FISHMAN, eds.), vol. 1, chap. 13. New York: Hoeber 1953.Google Scholar
  282. Duran-Reynals, F., and R. M. Thomas: A hemorrhagic disease occurring in chicks inoculated with the Rous and Fujinami viruses (with section of histopathological findings). Yale J. Biol. Med. 13, 77–98 (1940).Google Scholar
  283. Eagle, H.: Specific amino acid requirements of mammalian cell (strain L) in tissue culture. J. biol. Chem. 214, 839 (1955a).PubMedGoogle Scholar
  284. Eagle, H.: The specific amino acid requirements of a human carcinoma cell (strain HeLa) in tissue culture. J. exp. Med. 102, 37 (1955b).PubMedGoogle Scholar
  285. Eagle, H.: The minimum vitamin requirements of the L and HeLa cells in tissue culture, the production of specific vitamin deficiencies and their cure. J. exp. Med. 102 595 (1955 c).Google Scholar
  286. Eagle, H., and K. Ha-Bel: The nutritional requirements for the propagation of poliomyelitis virus by the HeLa cell. J. exp. Med. 104, 271–287 (1956).PubMedGoogle Scholar
  287. Eaton, M. D.: Observations on growth of virus. Arch. ges. Virusforsch. 5, 53–72 (1952).Google Scholar
  288. Eddy, B. E.: The polyoma virus. Section B. In: Advanc. Virus Res. 7 91–102 (1960).Google Scholar
  289. Eddy, B. E., S. E. Stewartand W. Berkeley: Cytopathogenicity in tissue cultures by tumor virus from mice. Proc. Soc. exp. Biol. (N.Y.) 98, 848–851 (1958).Google Scholar
  290. Eddy, B. E., S. E. Stewart, R. L. Kirschstein and R. Young: Subcutaneous nodules in rabbits induced with SE polyoma-virus. Nature (Lond.) 183, 766–767 (1959).Google Scholar
  291. Eddy, B. E., S. E. S.ewart,R. Youngand G. H. Mider: Neoplasma in hamsters induced by mouse tumor agent passed in tissue culture. J. nat. Cancer Inst. 20, 747–761 (1958).Google Scholar
  292. Edwards, G. A.: In Symposium on Phenomena of Tumor Viruses. National Cancer Institute, Monograph No 4, 313 (1960).Google Scholar
  293. Eklund, C. M., E. J. Bell and W J Hadlow: Detection of live virus in certain lots of poliomyelitis vaccine by inoculation of monkeys. Amer. J. Hyg. 64, 85 (1956).PubMedGoogle Scholar
  294. Ellerman, V., u. O. Bang: Experimentelle Leukämie bei Hühnern. Zbl. Bakt., I. Abt. Orig. 46, 595 (1908).Google Scholar
  295. Enders, J. F.: Observations on certain viruses causing exanthematous diseases in man Amer. J. med. Sci. 231, 622–637 (1956).Google Scholar
  296. Enders, J. F.: Die Bedeutung der Gewebekultur für die moderne Virusforschung. Nova Acta Leopoldina 19, Nr 134, 76–94 (1957 a).Google Scholar
  297. Enders, J. F.: The future of virus studies in tissue culture. J. nat. Cancer Inst. (Bethesda) 19, 735–752 (1957b).Google Scholar
  298. Enders, J. F., and H. E. Pearson: Resistance of chicks to infection with influenza A virus. Proc. Soc. exp. Biol. (N.Y.) 48, 143–146 (1941).Google Scholar
  299. Enders-Ruckle, G.: Studien mit Masernvirus. Behringwerkmitt. H. 34 (1958).Google Scholar
  300. Engel, L. L., and R. Randall: Some relations between equine encephalomyelitis virus (Eastern type) and normal host cellular constituents. J. Immunol. 55, 331–336 (1947).PubMedGoogle Scholar
  301. Engelrreth-Holm, J.: In: Spontaneous and experimental leukemia in animals. Edinburgh: Oliver und Boyd 1942.Google Scholar
  302. Engler, R., and G. Schramm: Infectious ribonucleic acid as precursor of tobacco mosaic virus. Nature (Lond.) 183, 1277–1279 (1959).Google Scholar
  303. Espinoza, S., y J. Daneri, N.: Estudio anatomo-patologico de treinta y ocho casos des poliomielitis anterior aguda. Rev. chil. Pediat. 23, 409 (1952).Google Scholar
  304. Espinoza, S., y J. Daneri, N.: Ref. R. Gadekein: Die inapparente Virusinfektion und ihre Bedeutung für die Klinik. BerlinGöttingen-Heidelberg: Springer 1957.Google Scholar
  305. Etcuebarne, M., P. G. Bernaand G. R. Lepton: Purification of rabies antibodies in horse serum and diagnostic importance of the fluorescent antibody technique. J. Immunol. 84, 6–10 (1960).Google Scholar
  306. Evans, C. A., and V. C. Chambers: Growth of neurotropic viruses in extraneural tissues. I. MM virus in the feet of hamsters. Proc. Soc. exp. Biol. (N.Y.) 68, 436 (1948).Google Scholar
  307. Everett, S. F., and H. S. Ginsberg: A toxinlike material separable from type 5 adenovirus particles. Virology 6, 770–771 (1958).PubMedGoogle Scholar
  308. Faber, H. K., R. C. Mcnaught, R. J. Silverbergand L. Dong: Experimental production of post-tonsillectomy bulbar poliomyelitis. Proc. Soc. exp. Biol. (N.Y.) 77, 532 (1951).Google Scholar
  309. Faber, H. K., R. J. Silverbergand L. Dong: Studies on entry and egress of poliomyelitis infection. V. Entry after simple feeding: with notes on viraemia. J. exp. Med. 97, 69 (1953).Google Scholar
  310. Fairbrother, R. W.: The production of immunity to vaccinia virus by mixtures of immune serum and virus and the importance of phagocytosis in antivaccinial immunity. J. Path. Bact. 36, 55–64 (1933).Google Scholar
  311. FazekasDE ST. Groth, S.: Destruction of influenza virus receptors in mouse lung by enzyme from V. cholerae. Aust. J. exp. Biol. med. Sci. 26, 29–36 (1948).Google Scholar
  312. Fazekas, DE ST. Groth, S., and M. Donnelley: Studies in experimental immunology of influenza. III. The antibody response. Aust. J. exp. Biol. med. Sci. 28, 45 (1950).Google Scholar
  313. Fenner, F.: The epizootic behaviour of mouse-pox (infectious ectromelia). Brit. J. Path. 29 69 (1948 a).Google Scholar
  314. Fenner, F.: The clinical features and pathogenesis of mouse-pox. (Infectious ectromelia of mice.) J. Path. Bact. 60, 529 (1948b).Google Scholar
  315. Fenner, F.: The pathogenesis and pathology of viral diseases. New York: Columbia Univ. Press 1950.Google Scholar
  316. Fenner, F.: Myxomatosis in European rabbits. Evolutionary changes in an infectious disease. Aust. J. biol. Sci. 19, 117–122 (1957).Google Scholar
  317. Fenner, F., and E. L. French: Zit. nach Burnet 1955.Google Scholar
  318. Fenner, F., I. H. Olmes, W. K. Joklik and G. M. Woodroofe: Reactivation of heat-inactivated poxviruses: A general phenomenon which includes the fibroma-myxoma virus. Nature (Lond.) 183, 1340–1341 (1959).Google Scholar
  319. Fey, F., u. A. Graff’: Beeinflussung der myeloischen Filtratleukämien der Maus durch Splenektomie. Naturwissenschaften 45, 471–472 (1958).Google Scholar
  320. Feyrter, F.: Über das Wesen des Zoster. Virchows Arch. path. Anat. 325, 70 (1954).Google Scholar
  321. Field, E. J.: Pathogenesis of herpetic encephalitis following corneal and masseteric inoculation. J. Path. Bact. 64, 1 (1952). Google Scholar
  322. Fiers, W., and R. L. Sinsheimer: The structure of the DNA of bacteriophage X 174, I, II u. III. J. molec. Biol. 5, 408–434 (1962).PubMedGoogle Scholar
  323. Finberg, L., C. N. Luttrelland H. Redd: Pathogenesis of lesions in the nervous system in hypernatremic states. II. Experimental studies of gross anatomic changes and alterations of chemical composition of the tissue. Pediatrics 23, 46–53 (1959).PubMedGoogle Scholar
  324. Finch, J. T., and A. Klug: Structure of poliomyelitis virus. Nature (Lond.) 183, 1709–1714 (1959).Google Scholar
  325. Findlay, G. M., and E. M. Howard: The effect of cortisone and adrenocorticotropic hormone on poliomyelitis and on other virus infections. J. Pharm. Pharmacol. 4, 37 (1952).PubMedGoogle Scholar
  326. Findlay, G. M., and F. O. Maccallum: An interference phenomenon in relation to yellow fever and other viruses. J. Path. Bact. 44, 405–424 (1937).Google Scholar
  327. Findlay, G. M., and A. F. Mahaffy: Path of infection of central nervous system in yellow fever. Trans. roy. Soc. trop. Med. Hyg. 30, 355 (1936).Google Scholar
  328. Finkeldey, W.: Über Riesenzellbefunde an den Gaumenmandeln, zugleich ein Beitrag zur Histopathologie der Mandelveränderungen im Maserninkubationsstadium. Virchows Arch. path. Anat. 281, 323 (1931).Google Scholar
  329. Fisher, T. N., and H. S. Ginsberg: Accumulation of organic acids by HeLa cells infected with Type 4 adenovirus. Proc. Soc. exp. Biol. (N. Y.) 95, 47–51 (1957).Google Scholar
  330. Flaum, A.: Poliomyelitis anterior actua in graviditate. Nord. med. 18, 563–564 (1943).Google Scholar
  331. Fong, J., and R. LouIE: Interferebce in cortisone-treated hosts. Proc. Soc. exp. Biol. (N. Y.) 84, 269 (1953).Google Scholar
  332. Foulds, L.: Filtrable tumors of fowls. Imperial Cancer Res. Fund. 11th Rept. Suppl. 1934.Google Scholar
  333. Fraenkelconrat, H., and R. C. Williams: Reconstitution of active tobacco mosaic virus from its inactive protein and nucleic acid component. Proc. nat. Acad. Sci. (Wash.) 41, 690–698 (1955).Google Scholar
  334. Francis, T.: The inactivation of epidemic influenza virus by nasal secretions of human individuals. Science 91, 198 (1940).PubMedGoogle Scholar
  335. Francisjr., TH.: Dissociation of hemagglutinating and antibody-measuring capacities of influenza virus. J. exp. Med. 85, 1 (1947).PubMedGoogle Scholar
  336. Franklin, E. A., D. Duncan, W.Wood, and A. J. Rhodes: Cultivation of Lansing poliomyelitis virus in tissue culture. II. Utilization of glucose in synthetic medium. Proc. Soc. exp. Biol. (N. Y.) 79, 715–718 (1952).Google Scholar
  337. Franklin, R. M.: Growth of fowl plague virus in macrophages and giant cells. Nature (Loud.) 180, 510 (1957).Google Scholar
  338. Franklin, R. M. : Some observations on the formation of giant cells in tissue cultures of chicken macrophages. Z. Naturforsch. 13b, 213–214 (1958 a).Google Scholar
  339. Franklin, R. M. : The growth of fowl plague virus in tissue cultures of chicken macrophages and giant calls. Virology 6, 81–95 (1958 b)..Google Scholar
  340. Franklin, R. M.: The significance of lipids in animal viruses. An essay on virus multiplication. In: Progress in medical virology, vol. 4, p. 1–42 (E. Berger u. J. L. Melnick, eds.). Basel and New York: S. Karger 1962.Google Scholar
  341. Franklin, R. M., and D. Baltimore: Patterns of macromolecular synthesis in normal and virus infected mammalian cells. Cold Spr. Harb. Symp. quant. Biol. 27, 175–198 (1962).Google Scholar
  342. Franklin, R. M., and P. M. Breiten-Feld: The abortive infection of Earle’s L-Cells by fowl plague virus. Virology 8, 293–307 (1959).PubMedGoogle Scholar
  343. Franklin, R. M., and J. Rosner: Localization of ribonucleic acid synthesis in mengo virus-infected L-cells. Biochim. biophys. Acta (Amst.) 55, 240–241 (1962).Google Scholar
  344. Fraser, D., H. Mahler, A. SHuG and C. Thomasjr.: The infection of subcellular Escherichia coli strain B with free DNA from T2 bacteriophage. Proc. nat. A.ad. Sci. (Wash.) 43, 939–947 (1957).Google Scholar
  345. Fraser, K. B.: Immunological tracing: Viruses and rickittsiae. In: Fluorescent protein tracing. Edinburgh and London: E. and S. Livingstone Ltd. 1962.Google Scholar
  346. Freeman, V. J.: Studies on the virulence of bacteriophage-infected strains of corynebacterium diphtheriae. J. Bact. 61, 675–688 (1951).PubMedGoogle Scholar
  347. French, R. C.: The contribution of protein from parent to progeny in T2 coliphage. J. Bact. 67, 45–49 (1954).PubMedGoogle Scholar
  348. French, R. C., S. M. Lesley, A. F. Grahamand C. E. Van Rooyen: Studies on the relationship between virus and host cell. III. Canad. J. med. Sci. 29, 144–148 (1951).Google Scholar
  349. Fresco, J. R., B. M. Albertsand P. DOTY: Some molecular details of the secondary structure of ribonucleic acid. Nature (Lond.) 188, 98–101 (1960).Google Scholar
  350. Friedewald, W. F.: Cell state as affecting susceptibility to a virus, enhanced effectiveness of the rabbit papilloma virus on hyperplastic epidermis. J. exp. Med. 75, 197 (1942).PubMedGoogle Scholar
  351. Friedewald, W. F.: Qualitative differences in the antigenic composition of influenza A virus strains. J. exp. Med. 79, 633 (1944).PubMedGoogle Scholar
  352. Friedrich-Freska, H.: Die stammesgeschichtliche Stellung der Virusarten und das Problem der Urzeugung. Aus: Die Evolution der Organismen, 2. Aufl., S. 278–301. Stuttgart: Gustav Fischer 1954.Google Scholar
  353. Friend, C.: Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J. exp. Med. 105, 307–318 (1957).PubMedGoogle Scholar
  354. Friend, C., V. DarchunE. DE Harven and J Haddad: The incidence and classification of spontaneous malignant diseases of the haematopoietic system in swiss mice. In: A Ciba Foundation Symposium on Tumour Viruses of Murine Origin. London: J. and A. Churchill 1962.Google Scholar
  355. Frisch-Niggemeyer, W.: Absolute amount of ribonucleic acid in viruses. Nature (Lond.) 178, 307–308 (1956).Google Scholar
  356. Frommhagen, L. H., N. K. Freeman, and C. A. Knight: The lipid constituent of influenza virus, chick allantoic membrane and sedimentable allantoic protein. Virology 5, 173–175 (1958).PubMedGoogle Scholar
  357. Frost, J. W., R. L. Dryerand K. G. Kohlstaedt: Stress studies on auto race drivers. J. Lab. clin. Med. 38, 523–525 (1951).PubMedGoogle Scholar
  358. Furth, J., R. K. Cole and M. C. Boon: The effect of maternal influence upon spontaneous leukemia of mice. Cancer Res. 2, 280 (1942).Google Scholar
  359. Gadeke, R.: Kidney lesions in suckling mice following group A Coxsackie virus infection. Arch. Path. 54, 276 (1952 a).Google Scholar
  360. Gadeke, R.: Glomeruläre und tubuläre Nephrose der Säuglingsmaus nach experimenteller Infektion mit Viren der Coxsackie A-Gruppe. Naturwissenschaften 39, 71 (1952b).Google Scholar
  361. Gadeke, R.: Morphologische Grundlagen neuerer Anschauungen über das Krankheitsbild der Poliomyelitis. Virchows Arch. path. Anat. 322, 563 (1952 c).Google Scholar
  362. Gadeke, R.: Experimentelle Untersuchungen über Frühreaktionen der Ratte nach Infektion mit dem MM-Virus. Verhandl. Dtsch. Ges. f. Path. 38 Tagg, S. 128 (1955).Google Scholar
  363. Gadeke, R.: Analytische Studien über die Absterbeordnung weißer Mäuse nach experimenteller Infektion mit dem MM-Virus. Naturwissenschaften 42, 216 (1955).Google Scholar
  364. Gadeke, R.: Die inapparente Virusinfektion und ihre Bedeutung für die Klinik. Berlin-Göttingen-Heidelberg: Springer 1957.Google Scholar
  365. Gadeke, R.: Lokalisation eines ECHO 9-Virus in Geweben infizierter Säuglingsmäuse mittels fluoreszierender Antikörper. Schweiz. Z. Path. 22, 751–758 (1959).Google Scholar
  366. Gädeke, R., H. Bayer, B. Hammel, S Kanzler U. F. Schoenberg: Vergleichende experimentelle Untersuchungen über das Verhalten des Skeletmuskelgewebes der Albinomaus nach Infektion mit murinen Parapoliomyelitisviren, mausadaptierten und „klassischen“ Poliomyelitisviren. I. Mitteilung. Untersuchungen mit dem MM-Virus. Arch. Virusforsch. 5, 310 (1954).PubMedGoogle Scholar
  367. Gadeke, R., u. K. Betke: Die Wirkung von Viren der Para-Poliomyelitis-Gruppe auf die lymphatischen Organe der Maus. Z. Naturforsch. 7b, 401 (1952).Google Scholar
  368. Gädeke, R., H. Kanzler, S. Kanzler u F Schoenberg: Vergleichende experimentelle Untersuchungen über das Verhalten des Skeletmuskelgewebes der Albinomaus nach Infektion mit murinen Parapoliomyelitisviren, mausadaptierten und „klassischen“ Poliomyelitisviren. II. Mitteilung. Untersuchungen mit dem Lansing-und dem Leon-Virus. Arch. Virusforsch. 6, 302 (1955).PubMedGoogle Scholar
  369. Gädeke, R., u. H. Waltenberger: Histologische, histochemische und chemische Untersuchungen an der Skeletmuskulatur von Säuglingsmäusen und saugenden Meerschweinchen zur Frage der Pathogenität der Coxsackie A-Viren. Z. Naturforsch. 7b, 524 (1952).Google Scholar
  370. Ganasinskj, R.: Istota zmian histopatologicznych w mozgu i rdzeniu owiec zakazonych ustalonym zarazkiem wscieklizny. Ann. Univ. Mariae Curie Sklodowska Sect. D.D. Vet. Med. 7, 133 (1954).Google Scholar
  371. Ganasinskj, R.: Ref. von R. Gädeke, in: Die inapparente Virusinfektion und ihre Bedeutung für die Klinik. Berlin-Göttingen-Heidelberg: Springer 1957.Google Scholar
  372. Gara, P. F. DE, and J. Furth: The relative susceptibility of normal and X-rayed mice of different stocks to pneumotropic viruses. J. Immunol. 50, 255 (1945).Google Scholar
  373. Gardner, R. E., and R. R. Hyde: Transformation of rabbit fibroma virus (Shope) into infectious myxomatosis (Sanarelli). J. infect. Dis. 71, 47–49 (1942).Google Scholar
  374. Gaylord, W. H., J. L. Melnickand H. Bonting: Intracellular development of vaccinia virus. Proc. Soc. exp. Biol. (N.Y.) 80, 24–27 (1953).Google Scholar
  375. Gelfand, H. M., J. P. Foxand D. R. LE Blanc: Observations on natural poliomyelitis infection in immunized children. Publ. Health Assn. Mtg. Unpublished 1956.Google Scholar
  376. Gerlach, F.: Über Lyssa beim Menschen. Dtsch. med. Wschr. 51, 1681 (1925).Google Scholar
  377. Gerlach, F.: Virusstudien bei Tollwut. Z. Infekt.-Kr. Haustiere 53, 279 (1938).Google Scholar
  378. German, W. J., and J. D. Trask: Cutaneous infectivity in experimental poliomyelitis increased susceptibility after neurosurgical produces. J. exp. Med. 68, 125 (1938).PubMedGoogle Scholar
  379. Gerschberg, H., E. G. Fry, J. R. Brobeck and C. N. H. Long: Role of epinephrine in secretion of adrenal cortex. Yale J. Biol. Med. 23, 32–51 (1950).Google Scholar
  380. Gierer, A.: Structure and biological function of ribonucleic acid from tobacco mosaic virus. Nature (Lond.) 179, 1297–1299 (1957).Google Scholar
  381. Gierer, A.: Die Größe der biologisch aktiven Einheit der Ribosenucleinsäure des Tabakmosaikvirus. Z. Naturforsch. 13b, 485–488 (1958).Google Scholar
  382. Gierer, A.: Die Eigenschaften der infektiösen Einheit des Tabakmosaikvirus. In: Biochemistry of viruses (E. BRODA u. W. FRISCH-NIGGEMEYER, eds. ), S. 58–65.Google Scholar
  383. Gierer, A.: Proceedings of the IVth Internat. Congr. of Biochemistry, Vienna, 1958. London: Pergamon Press 1959.Google Scholar
  384. Gierer, A., and G. Schramm: Infectivity of ribonucleic acid from tobacco mosaic virus. Nature (Lond.) 177, 702–703 (1956).Google Scholar
  385. Giese, W.: Die Atmungsorgane. In : Lehrbuch der speziellen pathologischen Anatomie. Hrsg. v. Kaufmann, Bd. II, Teil 3. Berlin: W. de Gruyter Co. 1960.Google Scholar
  386. Gifford, G. E., H. E. Robertson, and J. T. Syverton: Propagation in vitro of polioviruses. VIII. Effect of pH on virus yield and cell metabolism. Proc. Soc. exp. Biol. (N. Y.) 93, 321–323 (1956).Google Scholar
  387. Gifford, G. E., and J. T. Syverton: Replication of polivirus in primate cells maintained under anaerobic conditions. Fed. Proc. 16, 414 (1957).Google Scholar
  388. Gimmy, J., A. Graffi u. L. Krause: Über die Wirkung des polyvalenten Sarkom-Virus beim Goldhamster. Acta biol. med. germ. 3, 509 (1959).PubMedGoogle Scholar
  389. Ginder, D. R.: Rabbit papillomas and the rabbit papilloma virus; a review. Ann. N.Y. Acad. Sci. 54, 1120 (1952).PubMedGoogle Scholar
  390. Ginder, D. R., and W. F. Friedewald: Effect of semliki forest virus on rabbit fibroma. Proc. Soc. exp. Biol. (N.Y.) 77, 272–276 (1951).Google Scholar
  391. Ginoza, W.: Kinetics of heat inactivation of ribonucleic acid of tobacco mosaic virus. Nature (Lond.) 181, 958–961 (1958).Google Scholar
  392. Ginoza, W., and A. Norman: Radiosensitive molecular weight of tobacco mosaic virus nucleic acid. Nature (Loud.) 179, 520 (1957).Google Scholar
  393. Ginsberg, H. S., and F. L. Horsfalljr.: Concurrent infection with influenza virus and mumps virus or pneumonia virus of mice (PVM) as bearing on the inhibition of virus multiplication by bacterial polysaccharides. J. exp. Med. 89, 37–52 (1949a).PubMedGoogle Scholar
  394. Ginsberg, H. S., and F. L. Horsfalljr.: A resistant variant of mumps virus. Multiplication of the variant in the presence of inhibitory quantities of Friedländer bacillus polysaccharide. J. exp. Med. 90, 393–407 (1949b).PubMedGoogle Scholar
  395. Ginsberg, H. S., and F. L. Horsfalljr.: A labile component of normal serum which combines with various viruses. Neutralization of infectivity and inhibition of hemagglutination by the component. J. exper. Med. 90, 475 (1949c).Google Scholar
  396. Ginsberg, H. S., and F. L. Horsfall jr.: Characteristics of the multiplication cycle of pneumonia virus of mice (PVM). J. exp. Med. 93, 151–160 (1951).PubMedGoogle Scholar
  397. Glaser, G. H.: On the relationship between adrenal cortical activity and the convulsive state. Epilepsia (Amsterdam) 2, 7 (1953 a).Google Scholar
  398. Glaser, G. H.: Pituitary gland in relation to cerebral metabolic disorders of the nervous system. Ass. Res. nerv. Dis. Proc. 32, 21 (1953b).Google Scholar
  399. Glaser, G. H., D. S. Kornfeldand R. P. Knight: Intravenous hydrocortisone, corticotropic and the electroencephalogram. Arch. Neurol. Psychiat. (Chic.) 73, 338 (1955).Google Scholar
  400. Glaser, G. H., and H. H. Merrit: Effects of corticotropin (ACTH) and cortisone on disorders of the nervous system. J. Amer. med. Ass. 148, 898 (1952).Google Scholar
  401. Goetz, O.: Einst und jetzt: Schutzimpfungen gegen Viruskrankheiten. Munch. med. Wschr. 1960, 2217–2220.Google Scholar
  402. Goldberg, S. A., M. Brodieand P. Stanley: Effect of X-ray on experimental encephalitis in mice inoculated with the St. Louis strain. Proc. Soc. exp. Biol. (N. Y.) 32, 587–590 (1935).Google Scholar
  403. Goldfine, H., R. Kopelman, and E. A. Evansjr.: Nucleoside incorporation into HeLa cells infected with poliomyelitis virus. J. biol. Chem. 232, 577–588 (1958).Google Scholar
  404. Goldwasser, R. A., and R. E.Kissling: Fluorescent antibody staining of street and fixed rabies virus antigens. Proc. Soc. exp. Med. (N.Y.) 98, 219–223 (1958).Google Scholar
  405. Goldwasser, R. A., R. E. Kissling, T. R. Carskiand T. S. Hosty: Fluorescent antibody staining of rabies virus antigens in the salivary glands of rabid animals. Bull. Wld H1th Org. 20, 579–588 (1959).Google Scholar
  406. Good, R. A., and B. Campbell: The precipitation of latent Herpes simplex encephalitis by anaphylactic shock. Proc. Soc. exp. Biol. (N.Y.) 68, 82 (1948).Google Scholar
  407. Goodpasture, E. W.: The axis-cylinders of peripheral nerves as portals of entry to the central nervous system for the virus of herpes simplex, etc. Amer. J. Path. 1, 11 (1925).PubMedGoogle Scholar
  408. Goodpasture, E. W., and F. B. Talbot: Concerning the nature of protozoan-like cells in certain lesions of infancy Amer. J. Dis. Child. 21, 415 (1921).Google Scholar
  409. Goodpasture, E.W., and O. Teague: The occurrence of intranuclear inclusion bodies in certain tissues of the rabbit inoculated directly with the virus of herpes labialis. Proc. Soc. exp. Biol. (N.Y.) 20, 400 (1922/23).Google Scholar
  410. Goodpasture, E.W., and O. Teague: Experimental herpes zoster. J.Amer. med. Ass. 81, 377 (1923).Google Scholar
  411. Goodpasture, E.W., and O. Teague: Transmission of the virus of herpes febrilis along nerves in experimentally infected rabbits. J. med. Res. 44, 139 (1923).PubMedGoogle Scholar
  412. Goodpasture, E.W., and O. Teague: Experimental production of herpetic lesions in organs and tissues of the rabbit. J. med. Res. 44, 121 (1923/24).Google Scholar
  413. Goodpasture, E. W., and C. E. Woodruff: A comparison of the inclusion bodies of fowl-pox and Molluscum contagiosum. Amer. J. Path. 7, 1 (1931).PubMedGoogle Scholar
  414. Gordon, M. P., and M. Staehlin: The incorporation of 5-fluoruracil into the nucleic acid of tobacco mosaic virus. J. Amer. them. Soc. 80, 2340 (1958).Google Scholar
  415. Gottschalk, A.: N-Substituted iso-glucosamine released from mucoprotein by the influenza virus-enzyme. Nature (Lond.) 167, 845 (1951).Google Scholar
  416. Gottschalk, A.: Structural relationship between sialic acid, neuraminic acid and 2-carboxypyrrol. Nature (Lond.) 176, 881 (1955).Google Scholar
  417. Gottschalk, A.: The linkage of sialic acid in mucoprotein. Biochim. biophys. Acta (Amst) 20, 560–561 (1956).Google Scholar
  418. Gottschalk, A.: Neuraminidase, the specific enzyme of influenza virus and vibrio cholerae. Biochim. biophys. Acta (Amst) 23, 645–646 (1957).Google Scholar
  419. Graffi, A.: Zur Virusätiologie verschiedener Mäuseleukämien. Acta haemat. (Basel) 20, 49 (1958).Google Scholar
  420. Graffi, A.: Untersuchungen zur Virusätiologie maligner Tumoren. Mber. dtsch. Akad. Wiss. Berlin 1, 628 (1959).Google Scholar
  421. Graffi, A., H. Bielkan F Fey: Leukämie-Erzeugung durch ein filtrierbares Agens aus malignen Tumoren. Acta haemat. (Basel) 15, 145–174 (1956).Google Scholar
  422. Graffi, A., H. Bielka, F. Fey, F. Scharsachu. R. Weiss: Gehäuftes Auftreten von Leukämien nach Injektion von Sarkomfiltraten. Naturwissenschaften 4, 503–504 (1954).Google Scholar
  423. Graffi, A., et D. Fritz: Essais de transmission de la souche BB-T2 du virus de la tumeur parotidienne-polyome a l’aide d’acides nucléiques isolés. Rev. franç. Étud. clin. biol. 5, 388 (1960).PubMedGoogle Scholar
  424. Graffi, A., u. J. Gimmy: Über die Wirkung des Virus der myeloischen Leukämie der Maus bei der Ratte. Z. ges. inn. Med. 13, 881 (1958).Google Scholar
  425. Graffi, A., J. Gimmy, L. BaiimbachR. F. Schneider: Zur Histologie der durch den BB/T2-Polyoma-Virusstamm bei Kaninchen und Meerschweinchen induzierten Geschwülste. Acta biol. med. germ. 9, 167–202 (1962).PubMedGoogle Scholar
  426. Graffi, A., J. Gimmy u. L. Krause: Über ein polyvalentes Sarkomvirus der Ratte. Naturwissenschaften 46, 330 (1959).Google Scholar
  427. Graffi, A., U. Heine, J. G. Helmcke, D. Bierwolfu. A. Randt: Über den elektronenmikroskopischen Nachweis von Viruspartikeln bei der myeloischen Leukämie der Maus nach Injektion zellfreier Tumorfiltrate. Klin. Wschr. 38, 254–262 (1960).PubMedGoogle Scholar
  428. Graffi, A., u. W. Krischke: Steigerung der leukämogenen Wirkung zellfreier Tumorfiltrate durch Kombination mit Röntgen-Ganzkörperbestrahlung. Naturwissenschaften 43, 333 (1956). Versuche zur Frage der zellfreien Übertragbarkeit chemisch induzierter Mäuseleukämien. Acta biol. med. germ. 5, 299 (1960).PubMedGoogle Scholar
  429. Graham, A. F., and L. Mcclelland: The uptake of radioactive phosphorus by influenza virus A (PR 8 strain). Canad. J. Res., E 28, 121–134 (1950).Google Scholar
  430. Graham, A. F., and L. Siminovitch: Conservation of RNA and DNA phosphorus in strain L (Earle) mouse cells. Biochim. biophys. Acta (Amst) 26, 427–428 (1957).Google Scholar
  431. Green, M.: Studies on the biosynthesis of viral DNA. Cold Spr. Harb. Symp. quant. Biol. 27, 219–244 (1962).Google Scholar
  432. Green, M., G. Henle and F. Deinhardt: Respiration and glycolysis of human cells grown in tissue culture. Virology 5, 206–219 (1958).PubMedGoogle Scholar
  433. Green, R. G.: On the nature of filtrable viruses. Science 82, 443–445 (1935).PubMedGoogle Scholar
  434. Greenwood, A. W., J. S. S. Blythand J. G. Carr: Indications of heritable nature of non-suscpetibility to Rous sarcoma in fowls. Brit. J. Cancer 2, 135–143 (1948).PubMedGoogle Scholar
  435. Groman, N. B., A. Lwoffand M. Lwoff: Recherches sur un variant dit „froid“ du virus de la poliomyélite. Ann. Inst. Pasteur 98, 351–359 (1960).Google Scholar
  436. Gross, L.: Susceptibility of suckling-infant and resistance of adult mice of C311 and of the C 57 lines to inoculation with AK leukemia. Cancer (Philad.) 3, 1073–1087 (1950a).Google Scholar
  437. Gross, L.: Susceptibility of newborn mice of an otherwise apparently „resistant“ strain to inoculation with leukemia. Proc. Soc. exp. Biol. (N.Y.) 73, 246–248 (1950b).Google Scholar
  438. Gross, L.: „Spontaneous“ leukemia developing in C3H mice following inoculation in infancy, with AK-leukemic extracts, or AK-embryos. Proc. Soc. exp. Biol. (N.Y.) 76 27 (1951 a).Google Scholar
  439. Gross, L.: Pathogenic properties and „vertical“ transmission of the mouse leukemia agent. Proc. Soc. exp. Biol. (N.Y.) 78 342–348 (1951 b).Google Scholar
  440. Gross, L.: Influence of ether on pathogenic properties of mouse leukemia extracts. Acta haemat. (Basel) 15, 273–277 (1956).Google Scholar
  441. Gross, L.: Effect of thymectomy on development of leukemia in C311 mice inoculated with leukemia passage virus. Proc. Soc. exp. Biol. (N.Y.) 100, 325 (1959b).Google Scholar
  442. Gross, L.:Development of myeloid (chloro) leukemia in thymektomized C3H mice following inoculation of lymphatic leukemia virus. Proc. Soc. exp. Biol. (N.Y.) 103, 509 (1960a).Google Scholar
  443. Gross, L.: Induction of leukemia in rats with mouse leukemia (passage A) virus. Proc. Soc. exp. Biol. (N.Y.) 106, 890 (1961 a).Google Scholar
  444. Gross, L.: „Vertical“ transmission of passage A leukemic virus from inoculated C3H mice to their untreated offspring. Proc. Soc. exp. Biol. (N.Y.) 107, 90 (1961 b).Google Scholar
  445. Oncogenic viruses. New York and London : Pergamon Press 1961 c.Google Scholar
  446. Grossberg, S. E., E. W. Hook and R. R. Wagner: Hemorrhagic encephalopathy in chicken embryos infected with influenza virus. III. Interference at a distant site induced by prior allantoic infection. J. Immunol. 88, 1–8 (1962).PubMedGoogle Scholar
  447. Groupé, V., and F. J. Rauscher: Nonviral tumors produced in turkeys by Rous sarcoma virus. Science 125, 694–695 (1957).Google Scholar
  448. Groupé, V., F. J. Rauscher and W. R. Bryan: Modification of tumor-response to Rous sarcoma virus (RSV) by hydrocortisone. Proc. Soc. exp. Biol. (N.Y.) 91, 113–117 (1956).Google Scholar
  449. Groupé, V., F. J. Rauscher and W. R. Bryan: Haemorrhagic disease and unusual hepatic lesions associated with intracerebral passage of Rous sarcoma virus in chicks. J. nat. Cancer Inst. 19, 37–47 (1957).Google Scholar
  450. Grubmüller, J., u. H. Holkup: Beitrag zum Problem der Entstehung einer Lokaldisposition bei der Poliomyelitiserkrankung. Mitt. öst. Sanit.-Verwalt. 56, H. 9 (1955).Google Scholar
  451. Grundmann, E.: Die Krebsentwicklung als intrazelluläres Problem, dargestellt am Diäthylnitrosmin-Krebs der Rattenleber. Mitteilungsdienst der Gesellschaft zur Bekämpfung der Krebskrankheiten Nordrhein-Westfalen 2, 589–633 (1962).Google Scholar
  452. Guthrie, G. R., and R. L. Sinsheimer• Infection of protoplasts of Escherichia coli by subviral particles of bacteriophage X 174. J. molec. Biol. 2, 297–305 (1960).Google Scholar
  453. Haas, V. H., G. M. Briggsand S. E. Stewart: Inapparent lymphocytic choriomeningitis infection in folic acid-deficient mice. Science 126, 405 (1957 a).Google Scholar
  454. Haas, V. H., S. E. Stewartand G. M. Briggs: Folic acid deficiency and the sparing of mice infected with the virus of lymphocytic choriomeningitis. Virology 3, 15–21 (1957b).PubMedGoogle Scholar
  455. Habel, K.: Resistance of polyoma virus animals to tranplanted polyoma tumours. Proc. Soc. exp. Biol. (N.Y.) 106, 722–727 (1961).Google Scholar
  456. Ham, A. W., E. A. Mcculloch, L. Siminovitch, A. F. Howatsonand A. A. Axelrad: The process of viral carcinogenesis in the hamster kidney with the polyoma virus. In: A Ciba Foundation Symposium on tumour viruses of murine origin. London: J. and A. Churchill 1962.Google Scholar
  457. Ham, A. W., and L. Siminovitch: Viral carcinogenesis with particular reference to in vivo and in vitro studies with the polyoma virus. Progr. exp. Tumor Res. (Basel) 2, 67–89 (1961).Google Scholar
  458. Hammon, W. McD., and E. H. Ludwig: Possible protective effect of previous type 2 infection against paralytic poliomyelitis due to type 1 virus. Amer. J. Hyg. 66, 274 (1957).PubMedGoogle Scholar
  459. Hanafusa, H.: Factors involved in the initiation of multiplication of vaccinia virus. Cold Spr. Harb. Symp. quant. Biol. 27, 209–215 (1962).Google Scholar
  460. Hanafusa, H., T. Hanafusa, and H. Rubin: The defectiveness of Rous sarcoma virus. Proc. nat. Acad.Sci. (Wash.) 49, 572 (1963).Google Scholar
  461. Hanafusa, H., T. Hanafusa, and H. Rubin: Analysis of the defectiveness of Rous sarcoma virus. II. Specification of RSV antigenicity by helper virus. Proc. nat. Acad. Sci. (Wash.) 51, 41 (1964).Google Scholar
  462. Hanafusa, T., H. Hanafusaand J. Kamahora: Transformation of ectromelia into vaccinia virus in tissue culture. Virology 8, 525–527 (1959 a).Google Scholar
  463. Hanafusa, T., H. Hanafusaand J. Kamahora: Transformation phenomena in the pox group viruses. I. Transformation of extromelia into vaccinia virus in tissue culture. Biken’s J. 2, 77–84 (1959b).Google Scholar
  464. Hanafusa, T., H. Hanafusa and J. Kamahora: Transformation phenomena in the pox group viruses. II. Transformation between several members of pox group. Biken’s J. 2 85–91 (1959 c).Google Scholar
  465. Hanig, M.: Electrokinetic change in human erythrocytes during adsorption and elution of PR 8 influenza virus. Proc. Soc. exp. Biol. (N.Y.) 68, 385 (1948).Google Scholar
  466. Hanson, R. J., J. E. Kempfand A. V. Boandjr.: Phagocytosis of influenza virus. II. Its occurrence in normal and immune mice. J. Immunol. 79 (5), 422–427 (1957).PubMedGoogle Scholar
  467. Harding, C. V., D Harding, W. F. Mclimans, and G. Rake: Cytological changes accompanying the growth of Poliomyelitis virus in cells of human origin (Strain HeLa) Virology 2, 109 (1956).PubMedGoogle Scholar
  468. Hare, J. D., and H. R. Morgan: Studies on the factors essential to the initiation and maintenance of multiplication of psittacosis virus (6 BC strain) in deficient cells in tissue culture. J. exp. Med. 99, 461 (1954).PubMedGoogle Scholar
  469. Hargreaves, E. R.: Poliomyelitis: Effect of exertion during the preparalytic stage. Brit. med. J. 1948 II, 1021.Google Scholar
  470. Harris, R. J. C.: Properties of the agent of Rous No. 1 sarcome. Advanc. Cancer Res. 1, 233–271 (1953).Google Scholar
  471. Harris, R. J. C., F. C. Chesterman and G. Negroni: Induction of tumours in newborn ferrets with Mill Hill polyoma virus. Lancet 1961I, 788–791.Google Scholar
  472. Hartenstein, H.: Masernvirus, Riesenzellpneumonie und Hundestaupe. Dtsch. med. Wschr. 85, 1769 (1960).Google Scholar
  473. Hatch, M. H., S. S. Kalter and Gloria W. Ajello: Identification of poliovirus isolates with fluorescent antibody. Proc. Soc. exp. Biol. (N.Y.) 107, 1–4 (1961).Google Scholar
  474. Havens, W. P., and R. E. Marck: The leukocytic response of patients with experimentally induced infectious hepatitis. Amer. J. med. Sci. 212, 129 (1946).PubMedGoogle Scholar
  475. Heine, U., G. S. Beaudreau, C. Becker, D. Beard and J. W. Beard: Virus of avian erythroblastosis. VII. Ultrastructure of erythroblasts from the chicken and from tissue culture. J. nat. Cancer Inst. 26, 359–377 (1961).PubMedGoogle Scholar
  476. Heine, U., A. Graffi, J. G. Helmckeu. A. Randt: Virusartige Partikel in zeltfrei übertragbaren Mäuseleukämien. Naturwissenschaften 44, 449–450 (1957).Google Scholar
  477. Heine, U., A. Krautwald, J. G. Helmckeu. A. Graffi: Zur Atiologie der Lym-phogranulomatose. Naturwissenschaften 45, 369–370 (1958).Google Scholar
  478. Heinlein, H.: Die allgemeine Pathologie der Viruskrankheiten beim Menschen. Verhandl. Dtsch. Path. Ges- 38. Tagg, S. 56 (1955).Google Scholar
  479. Henderson, J. R., and R. M. Taylor: Studies on mechanisms of arthropod-borne virus interference in tissue culture. Virology 13, 477–484 (1961).PubMedGoogle Scholar
  480. Henderson, W.: Notice of the molluscum contagiosum. Edinb. med. and Surg. J. 56, 213 (1841).Google Scholar
  481. Henle, G., F. Deinhardt, V. V. Bergsand W. Henle: Studies on persistent infections of tissue cultures. I. General aspects of the system. J. exp. Med. 108, 537–560 (1958).Google Scholar
  482. Henle, G., F. Deinhardt, and A. Girardi: Cytolytic effects of mumps virus in tissue cultures of epithelial cells. Proc. Soc. exp. Biol. (N.Y.) 87, 386 (1954).Google Scholar
  483. Henle, G., F. Deinhardtand J. Rodriguez: The development of polyoma virus in mouse embryo cells as revealed by fluorescent antibody staining. Virology 8, 388–391 (1959).PubMedGoogle Scholar
  484. Henle, G., A. Girardiand W. Henle: A non-transmissible cytopathogenic effect of influenza virus in tissue culture accompanied by formation of non-infectious hemagglutinins. J. exp. Med. 101, 25–41 (1955).PubMedGoogle Scholar
  485. Henle, G., and W. Henle: Studies on the toxicity of influenza viruses. I. The effect of intracerebral injection of influenza viruses. J. exp. Med. 84, 623–637 (1946 a).Google Scholar
  486. Henle, W.: Studies on host-virus interactions in the chick embryo-influenza virus system. I, II u. III. J. exp. Med. 90, 1–23 (1949).PubMedGoogle Scholar
  487. Henle, W.: Interference phenomena between animal viruses: A review. J. Immunol. 64, 203 (1950).PubMedGoogle Scholar
  488. Henle, W., and G. Henle: Interference of inactive virus with the propagation of virus of influenza. Science 98, 87 (1943).PubMedGoogle Scholar
  489. Henle, W., and G. Henle: Studies on the toxicity of influenza viruses. II. The effect of intra-abdominal and intravenous injection of influenza viruses. J. exp. Med. 84, 639–660 (1946 b).Google Scholar
  490. Henle, W., G. Henleand E. B. Rosenberg: The demonstration of one-step growth curves of influenza viruses through the blocking effect of irradiated virus on further infection. J. exp. Med. 86, 423–437 (1947).PubMedGoogle Scholar
  491. Henle, W., and K. Pauker: Interference between inactivated and active influenza viruses in chick embryo. I. A re-evaluation of factors of dosage and timing using infectivity titrations for assay. Virology 6, 181 (1958).PubMedGoogle Scholar
  492. Henneberg, G.: Zur Nomenklatur der menschenpathogenen Viren. Zbl. Bakt., I. Abt. Orig. 158, 308 (1952).Google Scholar
  493. Herrlich, A.: liber den Einfluß von ACTH und Cortison auf die Vaccine-Infektion des Kaninchens. Vorläufige Mitt. Verh. Dtsch. Ges. Inn. Med. 58. Kongr. S. 80–83. München: J. F. Bergmann 1952.Google Scholar
  494. Herrlich, A.: Probleme der Pocken und Pockenschutzimpfung. Munch. med. Wschr. 96, 529 (1954).Google Scholar
  495. Hershey, A. D.: Inheritance in bacteriophage. Ann. N.Y. Acad. Sci. 54, 960 (1952).PubMedGoogle Scholar
  496. Hershey, A. D.: An upper limit to the protein content of the germinal substance of bacteriophage T2. Virology 1, 108–127 (1955).PubMedGoogle Scholar
  497. Hershey, A. D., and M. Chase: Independent functions of viral protein and nucleic acid in growth of bacteriophage. J. gen. Physiol. 36, 39–56 (1952).PubMedGoogle Scholar
  498. Hershey, A. D., and N. E. Melechen: Some minor components of bacteriophage T2 particles. Virology 4, 237 (1957).PubMedGoogle Scholar
  499. Hershey, A. D., and R. Rotman: Linkage among genes controlling inhibition of lysis in a bacterial virus. Proc. nat. Acad. Sci. (Wash.) 34, 89–96 (1948).Google Scholar
  500. Hess, B.: Aldolase und Trioseisomerase im Hühnerei nach Infektion mit Influenza-Virus. In: Verh. dtsch. Ges. inn. Med. 31, 189 (1955).Google Scholar
  501. Heston, W. E., M. K. Deringer, T. B. Dunnand W. D. Levillain: Factors in development of spontaneous mammary gland tumors in agent free strain C3Hb mice. J. nat. Cancer Inst. 10, 1139— 1155 (1950).Google Scholar
  502. Higgins, G. K., and G. T. Pack: Virus therapy in the treatment of tumors. Bull. Hosp. JtDis. (N.Y.) 12, 379 (1951).Google Scholar
  503. Hill, A. B., and J. Knowelden: Inoculation and polio myelitis; a statistical investigation in England and Wales in 1949. Brit. med. J. 1950 11, 1.Google Scholar
  504. Hillis, W. D., A. J. Moffatand O. A. Holtermann: The development of soluble and viral antigens of influenza A virus in tissue culture as studied by the fluorescent antibody technique. 3. Studies on the abortive cycle of replication in HeLa cells. Acta path. microbiol. stand. 50, 419 (1960).Google Scholar
  505. Hirst, G. K.: The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science 94, 22–23 (1941).PubMedGoogle Scholar
  506. Hirst, G. K.: Adsorption of influenza hemagglutinin and virus by red blood cells. J. exp. Med. 76, 195 (1942).PubMedGoogle Scholar
  507. Hirst, G. K.: The quantitative determination of influenza virus and antibodies by means of red cell agglutination. J. exp. Med. 75, 49–53 (1942).PubMedGoogle Scholar
  508. Hirst, G. K.: Vgl. auch: Übersicht über spätere Arbeiten in A. BUZZEL and M. HANIG, Mechanism of hemagglutination by influenza virus. In: Advances in virus research, vol. V, p. 290–346 ( K. M. SMITH and M. A. LAUFFER eds. New York: Academic Press 1958 ).Google Scholar
  509. Hirst, G. K.: Virus-host cell relation. In: Viral and rickettsial infections of man. Edit. by RIVERS and HoRSFALL. Philadelphia: J. B. Lippincott Company 1959.Google Scholar
  510. Hitchcock, G., and A. Isaacs: Protection of mice against the lethal action of an encephalitis virus. Brit. med. J. 1960 II, 1268–1270.Google Scholar
  511. Hjärre, A.: Vergleichende Untersuchungen über Shopes Schweineinfluenza und eine in Schweden bei Ferkeln vorkommende enzootische Viruspneumonie. Arch. exp. Vet.-Med. 6, Beih. 82 (1952).Google Scholar
  512. Hjärre, A., Z. Dinteru. K. Bakos: Vergleichende Untersuchungen über eine influenzaähnliche Schweinekrankheit in Schweden und Shope-Schweineinfluenza. Nord. Vet.-Med. 4, 1025 (1952).Google Scholar
  513. Ho, M., and M. K. Breinig: Conditions for the production of an interferon appearing in chick cell cultures infected with sinbis virus. J. Immunol. 89, 177–186 (1962).PubMedGoogle Scholar
  514. Hofman, B.: A receptor-destroying enzyme in human saliva and its possible relation to poliomyelitis infection. J. Immunol. 73, 273 (1954).PubMedGoogle Scholar
  515. Hofschneider, P. H.: Plaque-forming ability of urea-or phenoltreated T2 coli-phage preparations. Nature (Lond.) 186, 330 (1960).Google Scholar
  516. Holland, J. J.: Receptor affinities as major determinants of enterovirus tissue tropismus in humans. Virology 15, 312–326 (1961).PubMedGoogle Scholar
  517. Holland, J. J.: In: Basic mechanisms in animal virology. Cold Spr. Harb. Symp. quant. Biol. 27 (1962).Google Scholar
  518. Holland, J. J., and B. H. Hoyer: Early stages of enterovirus infection. Cold Spr. Harb. Symp. quant. Biol. 27, 101–111 (1962).Google Scholar
  519. Holland, J. J., L. C. Molarenand J. T. Syverton: The mammalian cell-virus relationship. III. Poliovirus production by non-primate cells exposed to poliovirus ribonucleic acid. Proc. Soc. exp. Biol. (N.Y.) 100, 843–845 (1959a).Google Scholar
  520. Holland, J. J., L. C. Molarenand J. T. Syverton: The mammalian cell virus relationship. IV. Infection of naturally insusceptible cells with enterovirus ribonucleic acid. J. exp. Med. 110, 65–80 (1959b).PubMedGoogle Scholar
  521. Holle, G.: Hyalinisierung von Gefäßwänden bei Viruskrankheiten. In: Sitzungsberichte „Grundsubstanz, Zelle, Kapillare“ anläßlich des 100jährigen Bestehens des Lehrstuhls für pathologische Anatomie in Greifswald. Ref. Zbl. allg. Path. path. Anat. 96, 367–389 (1957).Google Scholar
  522. Holmes, F. O.: Filterable viruses. In: Bergey’s Manual of determinative bacteriology, 6th, ed. 2nd Suppl., p. 1127. Baltimore: Williams Wilkins Company 1948.Google Scholar
  523. Holtermann, O. A., W. D. Hillisand A. J. Moffat: The development of soluble and viral antigens of influenza A virus in tissue culture, as studied by the fluorescent antibody technique. I. Studies employing a low multiplicity of infection in beef embryo kidney cells. Acta path. microbiol. stand. 50, 398 (1960).Google Scholar
  524. Holzaepfel, J. H., and J. G. Boutselis: The use of APC3 Virus as a cancericidal agent. Cancer (Philad.) 10, 577 (1957).Google Scholar
  525. Horne, R. W.: The examination of small particles. In: Techniques in electron microscopy ( Dr. KAY, ed.). Oxford: Blackwell 1961.Google Scholar
  526. Horne, R. W., S. Brenner, A. P. Watersonand P. Wildy: The icosahedral form of an adenovirus. J. molec. Biol. 1, 84–86 (1959 a).Google Scholar
  527. Horne, R. W., and A. P. Waterson: A helical structure in mumps, Newcastle disease, and Sendai viruses. J. molec. Biol. 2, 76–77 (1960).Google Scholar
  528. Horne, R. W., A. P. Waterson, P. Wildyand A. E. Farnham: The structure and composition of the myxoviruses. I. Electron microscope studies of the structure of myxovirus particles by negative staining techniques. Virology 11, 79–98 (1960).PubMedGoogle Scholar
  529. Horne, R. W., and P. Wildy: Symmetry in virus architecture. Virology 15, 348–373 (1961).PubMedGoogle Scholar
  530. Horsfalljr., F. L.: On the reproduction of influenza virus. Quantitative studies with procedures which enumerate infective and hemagglutinating virus particles. J. exp. Med. 100, 135–161 (1954).PubMedGoogle Scholar
  531. Horster, H., u. L. Whitman: Die Methode der intraneuralen Injektion. Z. ges. Hyg. 113, 113 (1931).Google Scholar
  532. Horstmann, D. M.: Acute poliomyelitis. Relation of physical activity at the time of onset to the course of disease. J. Amer. med. Ass. 142, 236 (1950).Google Scholar
  533. Horstmann, D. M., R. W. Mccollumand A. D. Mascola: Viremia in human poliomyelitis. J. exp. Med. 99, 355 (1954).PubMedGoogle Scholar
  534. Hoskin, M.: A protective action of neurotropic against viscerotropic yellow fever virus in Macacus rhesus. Amer. J. trop. Med. 15, 675–680 (1935).Google Scholar
  535. Howatson, A. F., and J. D. Almeida: Observations on the fine structure of polyoma virus. J. biophys. biochem. Cytol. 8, 828–833 (1960a).PubMedGoogle Scholar
  536. Howe, H. A., and D. Bodian: Refractoriness of nerve cells to poliomyelitis virus after interruption of their axones. Bull. Johns Hopk. Hasp. 69, 92 (1941).Google Scholar
  537. Howe, H. A., and D. Bodian: Neural mechanisms in poliomyelitis, pp. 30, 99. New York: Commonwealth Fund 1942.Google Scholar
  538. Howe, H. A., and J. B. Flexner: Succinic dehydrogenase in regenerating neurons. J. biol. Chem. 167, 663 (1947).PubMedGoogle Scholar
  539. Howe, H. A., and R. C. Mellors: Cytochrome oxydase in normal and regenerating neurons. J. exp. Med. 81, 489 (1945).PubMedGoogle Scholar
  540. Howitt, B. F.: A nonspecific heat-labile factor in the serum neutralization test for Newcastle-disease virus. J. Immunol. 64, 73 (1950).Google Scholar
  541. Hoyle, L.: Structure of the influenza virus. The relation between biological activity and chemical structure of virus fraction. J. Hyg. (Loud.) 50, 229–245 (1952).Google Scholar
  542. Hoyle, L.: The fate of the infective particle. In: Ciba Foundation Symposium on the Nature of Viruses (G. E. W. Wolstenholme u. E. C. P. Millar, eds.). London: J. and A. Churchill Ltd. 1957.Google Scholar
  543. Hoyle, L.: The entry of myxoviruses into the cell. Cold Spr. Harb. Symp. quant. Biol. 27, 113–121 (1962).Google Scholar
  544. Hoyle, L., R. W. Horneand A. P. Waterson: The structure and composition of the myxoviruses. II. Components released from the influenza virus particle by ether. Virology 13, 448–459 (1961).PubMedGoogle Scholar
  545. Hoyle, L., R. Reed and W. T. Astbury: Electron microscope studies of the structure of the influenza virus. Nature (Lond.) 171, 256 (1953).Google Scholar
  546. Huang, C. H.: A visible method for titration and neutralization of viruses on the basis of pH changes in tissue cultures. Proc. Soc. exp. Biol. (N. Y.) 54, 160–161 (1943).Google Scholar
  547. Huebner, R. J.: In: A Ciba Foundation Symposium on tumour viruses of murine origin. London: J. and A. Churchill 1962.Google Scholar
  548. Hyden, H.: Protein metabolism in the nerve cell during growth and function. Acta physiol. scand. 6, Suppl., X VII (1943).Google Scholar
  549. Hyden, H.: Die Funktion des Kernkörperchens bei der Eiweißbildung in Nervenzellen. Z. mikr -anat. Forsch. 54, 96 (1944).Google Scholar
  550. Hyden, H.: Nucleoproteins in virus reproduction. Cold Spr. Harb. Symp. quant. Biol. 12, 104 (1947).Google Scholar
  551. Hyden, H.: Inman, D. R., D. A. Woods, and G. Negroni: Electron microscopy of virus particles in cell cultures inoculated with passage fluid from human leukaemic bone-marrow. Brit. med. J. 1964 I, 929–931.Google Scholar
  552. Isaacs, A.: Particle counts and infectivity titrations for animal viruses. In: Advanc. Virus Res. 4, 111–158 (1957).Google Scholar
  553. Isaacs, A.: Viral interference. In: Virus growth and variation. Cambridge : Cambridge University Press 1959 a).Google Scholar
  554. Isaacs, A.: Action of interferon on the growth of sublethally irradiated virus. Virology 9, 56–61 (1959 b)Google Scholar
  555. Isaacs, A.: Production and action of interferon. In: Basic mechanisms in animal virology. Cold Spr. Harb. Symp. quant. Biol. 27, 343–349 (1962).Google Scholar
  556. Isaacs, A.: Interferon. Advanc. Virus Res. 10. 1–38 (1963).Google Scholar
  557. Isaacs, A., D. C. Burkeand L. Fadeva: Effect of interferon on the growth of viruses on the chick chorion. Brit. J. exp. Path. 39, 447–451 (1958).PubMedGoogle Scholar
  558. Isaacs, A., and M. Edney: Interference between inactive and active influenza viruses in the chick embryo. I. Quantitative aspects of interference. Aust. J. exp. Biol. med. Sci. 28, 219 (1950).Google Scholar
  559. Isaacs, A., and G. Hitchcock: Role of interferon in recovery from virus infections. Lancet 1960 11, 69–71.Google Scholar
  560. Isaacs, A., and J. Lindenmann: Virus interference. I. The interferon. Proc. roy. Soc. B 147, 258–267 (1957).Google Scholar
  561. Ito, Y.: A tumor-producing factor extracted by phenol from papillomatous tissue (Shope) of cottontail rabbits. Virology 12, 596–601 (1960).PubMedGoogle Scholar
  562. Ivanovlcs, G., E. Abrahamand A. Koch: The culture of the virus of Aujeszky’s disease in chick embryo tissue cultures and its pathogenicity for fowl. Zbl. Bakt., I. Abt. Orig. 161 (3–10) (1954).Google Scholar
  563. Jacob, F., and E. L. Wollman: Genetic aspects of lysogeny. In : The chemical basis of heredity. Ed. by W. D. Mcelroy and B. Glass. Baltimore : Johns Hopkins Univ. Press 1957.Google Scholar
  564. Jailer, J. W., and A. J. Knowlton: Simulated adrenocortical activity during pregnancy in an Addisonian patient. J. clin. Invest. 29, 1430 (1950).PubMedGoogle Scholar
  565. Jamuni, A., and Margaret Holden: The role of leucocytes in immunity to herpes. J. Immunol. 26, 395–400 (1934).Google Scholar
  566. Jesioneku. Kiolemenoglou: Über einen Befund von protozoenartigen Gebilden in den Organen eines hereditär-luetischen Fötus. Munch. med. Wschr. 51 (1905).Google Scholar
  567. Johnson, H. N.: In : Viral and rickettsial diseases of man, edit. by T. M. RIVERS, pp. 267–299. Philadelphia: J. B. Lippincott Company 1952.Google Scholar
  568. Johnson, K. M., and H. R. Morgan: Latent viral infection of cells in tissue culture. II. Relationship of cell nutrition to initiation of growth of psittacosis virus. J. exp. Med. 103, 765 (1956).PubMedGoogle Scholar
  569. Joklik, W. K.: The multiplication of pox-virus DNA. Cold Spr. Harb. Symp. quant. Biol. 27, 199–208 (1962).Google Scholar
  570. Joklik, W. K., G. M. Woodroofe, I. H. Holmes, F. Fennerand M. J. Briggs: The reactivation of pox-viruses. I. Demonstration of the phenomenon and techniques of assay. II. The range of reactivating viruses. III. Properties of reactivable particles. Virology 11, 168–218 (1960).PubMedGoogle Scholar
  571. Jones, E. E.: Studies on the mammary glands of hybrid mice theoretically free of the milk agent. Acta Un. int. Cancr. 12, 638 (1956).Google Scholar
  572. Jones, J. H., C. Fosterand W. Henle: Effect of oxythiamine on infection of mice with the Lansing strain of poliomyelitis virus. Proc. Soc. exp. Biol. (N.Y.) 69, 454 (1948).Google Scholar
  573. Jungeblut, C. W., B. Horvathand A. W. Knox: Inhibition of Aol.-Sk-virus hemagglutination by human saliva. Arch. Pediatr. 69, 321 (1952).PubMedGoogle Scholar
  574. Kabat, E. A., and J. Furth: Chemical and immunological studies on the agent producing leukosis and sarcoma of fowls. J. exp. Med. 71, 55–70 (1940).PubMedGoogle Scholar
  575. Kalter, S. S., M. H. Hatchand G. W. Ajello: The laboratory diagnosis of poliomyelitis with fluorescent antibodies. Bact. Proc. (N. Y.) 1959, 89.Google Scholar
  576. Kamahora, J., S. Kato, E. Babaand K. Hagiwara: Studies on the inclusion bodies of fowlpox virus. Med. J. Osaka Univ. 6, 745–753 (1955).Google Scholar
  577. Kamahora, J., Y. Sato, S. KATO and K. Hagiwara: Inclusion body of vaccinia virus. Proc. Soc. exp. Biol. (N.Y.) 97, 43–47 (1958).Google Scholar
  578. Kamerbek, A. E. H. M.: Het Rubella-problem in het licht von Nederlandse ervaringen. Diss. Leiden 1949. Leiden: Stenvert Kroese 1949.Google Scholar
  579. Kameyama, S., M. Takahashi, K. Toyoshima, S. Kato and J. Kamahora: Studies on the inclusion bodies of ectromelia virus using the fluorescent antibody technique. Biken’s J. 2, 341–344 (1959).Google Scholar
  580. Kaplan, A. S.: The susceptibility of monkey kidney cells to poliovirus in vivo and in vitro. Virology 1, 377–392 (1955).PubMedGoogle Scholar
  581. Kaplan, A. S., and T. Ben-Porat: The action of 5-fluoruracil on the nucleic acid metabolism of pseudorabies virus infected and non-infected rabbit kidney cells. Virology 13, 78–92 (1961).PubMedGoogle Scholar
  582. Kaplan, M. M., Z. Forsekand H. Koprowski: Demonstration of rabies virus in tissue culture with fluorescent antibody technique. Bull.Wld Hlth Org. 22, 434–435 (1960).Google Scholar
  583. Karzon, D. T.: Non specific viral inactivating substance (VIS) in human and mammalian sera. Natural antagonists to the inactivator of Newcastle disease virus and observations on the nature of the union between the inactivator and virus. J. Immunol. 76, 454–463 (1956).PubMedGoogle Scholar
  584. Kates, M., A. C. AllisonD. A. J. Tyrrelland A. T. James: Origin of lipids in influenza virus. Cold Spr. Harb. Symp. quant. Biol. 27, 293–301 (1962).Google Scholar
  585. Kato, S., and W. Cutting: A study of the inclusion bodies of rabbit myxoma and fibroma virus and a consideration of the relationship between all pox vir is inclusion bodies. Stanf. med. Bull. 17, 31 45 (1959).Google Scholar
  586. Kato, S., K. Hagiwaraand J. Kamahora: The mechanism of the growth of ectromelia virus propagated in the ascites tumor cells. Med. J. Osaka Univ. 6, 39–50 (1955).Google Scholar
  587. Kato, S., M. Takahashi, S. Kameyamaand J. Kamahora: A study on new inclusion bodies of cowpox virus. Biken’s J. 2, 92–96 (1959b).Google Scholar
  588. Kausche, G. A., u. H. Hoffmann-Berling: Zur Morphologie des Achsenzylinders beim Warmblüter und seine Beziehungen zu neurotropen Viren. Arch. Virusforsch. (Wien) 4, 424 (1951).Google Scholar
  589. Kausche, G. A., CH. Landscbatzu. R. Sauthoff: Histochemischer Nachweis von alkalischer Phosphatase am Mäusemuskel nach Infektion mit dem Coxsackie-Virus. Z. Naturforsch. 66, 445–447 (1951).Google Scholar
  590. Kellenberger, E.: Vegetative bacteriophage and the maturation of the virus particles. In: Advanc. Virus Res. 8, 2–57 (1961).Google Scholar
  591. Kellenberger, E., u. W. Arber: Die Struktur des Schwanzes der Phagen T2 und T4 und der Mechanismus der irreversiblen Adsorption. Z. Naturforsch. 10b, 698–704 (1955).Google Scholar
  592. Kerr, I. M., E. M. Martin, M. G Hamiltonand T. S. Work: The initiation of virus protein synthesis in Krebs ascites tumor cells infected with EMC virus. Cold Spr. Harb. quant. Biol. 27, 259–269 (1962).Google Scholar
  593. Kersting, G., H. Lennartzu. H. Pette: Zur Pathogenese der experimentellen Poliomyelitis. I. Mitt. Der Virusgehalt des Liquors. Dtsch. Z. Nervenheilk. 175, 72–86 (1956).Google Scholar
  594. Kettler, L. H.: Hyalinisierung von Gefäßwänden bei Viruskrankheiten. In: Sitzungsber „Grundsubstanz, Zelle, Kapillare“ anläßlich des 100jährigen Bestehens des Lehrstuhls für pathologische Anatomie in Greifswald. Ref. Zbl. allg. Path. path. Anat. 96, 367–389 (1957).Google Scholar
  595. Kikuth, W., R. Gönnert U. M. Schweickert: Infektiöse Aleukozytose der Katzen Zbl. Bakt., I. Abt. Orig. 146, 1 (1940).Google Scholar
  596. Kilbourne, E. D.: Paradoxial effects of cortisone on influenza B virus infections of the chick embryo. J. clin. Invest. 31, 643 (1952).Google Scholar
  597. Kilbourne, E. D. : The influence of cortisone on experimental viral infection. I. Prolongation of survival time and suppression of inflammation in chick embryos infected with influenza B virus. J. Immunol. 74, 57 (1955 a).Google Scholar
  598. Kilbourne, E. D.: Influence of cortisone on experi- mental viral infection. II. Effects on antibody formation and acquired immunity. Proc. Soc. exp. Biol. (N.Y.) 90, 685 (1955b).Google Scholar
  599. Kilbourne, E. D.: Reactivation of non-infective virus in a cortisone-injected host. J. exp. Med. 101, 437 (1955c).PubMedGoogle Scholar
  600. Kilbourne, E. D., and L. M. Daves: Influence of cortisone on adaptation of influenza A virus to mouse lung. Fed. Proc. 12, 449 (1953).Google Scholar
  601. Kilbourne, E. D., and F. L. Horsfalljr.: Increased virus in eggs injected with cortisone. Proc. Soc. exp. Biol. (N.Y.) 76, 116 (1951).Google Scholar
  602. Kilbourne, E. D., and I. Tateno: In vitro effects of cortisone on multiplication of influenza B virus. Proc. Soc. exp. Biol. (N.Y.) 82, 274 (1953).Google Scholar
  603. Kilbourne, E. D., Cu. B. Wilsonand D. Perrier: The induction of gross myocardial lesions by a Coxsackie (Pleurodynia) virus and cortisone. J. clin. Invest. 35, 362 (1956).PubMedGoogle Scholar
  604. Kilham, L.: Transformation of fibroma into myxoma virus in tissue culture. Proc. Soc. exp. Biol. (N.Y.) 95, 59–62 (1957).Google Scholar
  605. Kilham, L.: Fibroma-myxoma virus transformations in different types of tissue culture. J. nat. Cancer Inst. 20, 729–738 (1958).PubMedGoogle Scholar
  606. Kilham, L.: The fibroma-myxoma virus transformation. In: Advances in virus research, 7, 103–130 New York and London: Academic Press 1960.Google Scholar
  607. Kind, C.: Generalisierte Cytomegalie bei eineiigen Zwillingen Schweiz. med. Wschr. 91, 15–20 (1961).Google Scholar
  608. King, L. S.: Studies on eastern equin encephalomyelitis. VI. Facilitation of infection in the mouse. J. exp. Med. 76, 325–334 (1942).PubMedGoogle Scholar
  609. Kirber, M. W., and W. Henle: A comparison of influenza complement fixation antigens derived from allantoic fluids and membranes, J. Immunol. 65, 229 (1950).PubMedGoogle Scholar
  610. Kit, S., D. R. Dubbs, and T. C. hsi-Lt: Biochemistry of Vaccinia infected mouse fibroblasts (strain L—M). Virology 19, 13–22 (1963).PubMedGoogle Scholar
  611. Klamerth, 0: Einbau von 32P in Chorioallantois-Zellen nach Infektion mit Influenza-Virus in vitro. Z. Naturforsch. 14b, 78–81 (1959).Google Scholar
  612. Klamerth, 0: Die Beeinflussung der Aktivitäten von Gewebsenzymen durch Virusinfektion. Arch. ges. Virusforsch. 10, 578–587 (1960).Google Scholar
  613. Klamerth, 0: Virus und enzymatische Eigenschaften. Z. Naturforsch. 16b, 781–785 (1961).Google Scholar
  614. Klamerth, 0: Unveröffentlicht (1962).Google Scholar
  615. Klein, G.: Antigenic properties of other experimental tumors. In: Basic mechanisms in animal virology. Cold Spr. Harb. Symp. quant. Biol. 27 (1962).Google Scholar
  616. Klemperer, P.: The pathogenesis of lupus erythematosus and allied conditions. Ann. intern. Med. 28, 1 (1948).PubMedGoogle Scholar
  617. Klemperer, P.: The concept of collagen diseases. Amer. J. Path. 26, 505 (1950).PubMedGoogle Scholar
  618. Klemperer, P.: Pathology of systemic lupus erythematosus. In: J. F. A. MCMANUS editor: Progress in Fundamental Medicine. Philadelphia: Lea und Febiger 1952.Google Scholar
  619. Klenk, E.: Chemie und Biochemie der Neuraminsäure. Z. angew. Chem. 68, 349–352 (1956).Google Scholar
  620. Kligler, I. J., and H. Bernkopf: Cultivation of rabies virus in allantois of developing chick embryo. Proc. Soc. exp. Biol. (N.Y.) 39, 212 (1938).Google Scholar
  621. Kligler, I. J., and H. Bernkopf: The path of dissemination of rabies virus in the body of normal and immunized mice. J. exp. Path. 24, 15 (1943).Google Scholar
  622. Klug, A., and D. L. D. Caspar: The structure of small viruses. In: Advanc. Virus Res. 7, 225–325 (1960).Google Scholar
  623. Klug, A., F. H. C. Crickand R. W. G. Wyckoff: Diffraction by helical structures. Acta tryst. 11, 199–213 (1958).Google Scholar
  624. Knight, C. A.: Precipitation reactions of highly purified influenza viruses and related materials. J. exp. Med. 83, 281–294 (1946).Google Scholar
  625. Knox, A. W.: Influence of pregnancy in mice on the course of infection with murine poliomyelitis virus. Proc. Soc. exp. Biol. (N.Y.) 73, 520 (1950).Google Scholar
  626. Köhler, H.: Über Einschlußkörperchen. Verhandl. Dtsch. Path. Ges. 38. Tag,S. 86, 1955.Google Scholar
  627. Köszegi, B., u. I. Piukovich: Cytomegalia infantum und Herzentwicklungsanomalie. Zbl. allg. Path. path. Anat. 94, 124 (1955/56).Google Scholar
  628. Kopelman, R., and E. A. Evansjr.: The metabolism of virus infected animal cells. In: Progress in medical virology (E. Berger and J. L. Melnick, eds.), vol. II, pp. 73105. Basel u. New York: S. Karger 1959.Google Scholar
  629. Korteweg, R.: 1934 (zit. nach ANDERVONT 1959 ).Google Scholar
  630. Kovacs, E.: Comparative biochemical studies on normal and on poliomyelitis infected tissue cultures. I. Observations on synthetic nutrient mixtures incubated with tissue cultures of normal kidney. Canad. J. Biochem. 34, 273 (1956 a).Google Scholar
  631. Kovacs, E.: Comparative bio-chemical studies on normal and on poliomyelitis infected tissue cultures. II. Investigation of various enzyme systems in homogenates of kidney tissue cultures of normal rhesus monkeys. Canad. J. Biochem. 34, 600 (1956b).PubMedGoogle Scholar
  632. Kovacs, E.: Comparative biochemical studies on normal and on poliomyelitis infected tissue cultures. IV. Enzyme changes in host cells. Proc. Soc. exp. Biol. (N.Y.) 92, 183–188 (1956 c).Google Scholar
  633. Kovacs, E.: Comparative biochemical studies on normal and on poliomyelitis virus infected tissue cultures. Z. Naturforsch. 13b, 34–41 (1958 a).Google Scholar
  634. Kovacs, E.: Vergleichende biochemische Untersuchungen an normalen und mit Poliomyelitisvirus infizierten Gewebekulturen. IX. Die nucleolytischen Enzymaktivitäten in Kulturen suspendierter Affennierenstückchen vor und nach der Beimpfung mit Poliomyelitis-Viren. Biochem. Z.330, 113–130 (1958 b).Google Scholar
  635. Kovkcs, E., G. Wagner, and V. Stürtz: Early enzyme-changes in cultivated cells as a preparative phase for the biosyntheis of poliovirus. Z. Naturforsch. 15b, 506–517 (1960).Google Scholar
  636. Kozloff, L. M.: Desoxyribonuclease inhibitor and bacteriophagesi infection. Fed. Proc. 12, 234 (1953).Google Scholar
  637. Kozloff, L. M. and K. Henderson: Action of complexes of the zinc group metals on the tail protein of bacteriophage Ter+. Nature (Lond.) 196, 1169–1171 (1955).Google Scholar
  638. Kozloff, L. M., and M. Lute: Viral invasion II. The role of zinc in bacteriophage invasion. J. biol. Chem. 228, 529–536 (1957).PubMedGoogle Scholar
  639. Kozloff, L. M., M. Luteand K. Henderson: Viral invasion. I. Rupture of thiol ester bonds in the bacteriophage tail. J. biol. Chem. 228, 511 (1957).Google Scholar
  640. Kraus, R., u. Y. Fukuhara: Ober das Lyssavirus „Fermi“, über Schutzimpfversuche mit normaler Nervensubstanz und über Wirkungen des rabiziden Serums. Z. Immun -Forsch. 3, 352 (1909).Google Scholar
  641. Kraus, R., F. Gerlachu. F. Schweinburg: Lyssa bei Mensch und Tier. Berlin u. Wien: Urban und Schwarzenberg 1926.Google Scholar
  642. Krause, W. W.: Neue Erkenntnisse in der Pathogenese der Tollwut und deren Folgen für die Impfstoffpriifung. Vortrag Österr. Ges. Mikrobiol. u. Hyg., Innsbruck, Sept. 1954.Google Scholar
  643. Krehh, U.: Intravenous infectivity of type 2 poliomyelitis virus in mice. Proc. Soc. exp. Biol. (N.Y.) 86, 488 (1954).Google Scholar
  644. Krehl, L.: Entstehung, Erkennung und Behandlung innerer Krankheiten, Bd. II, Die Erkennung innerer Krankheiten, 2. Aufl. Berlin: F. C. Vogel 1932.Google Scholar
  645. Krischke, W., u. A. Graffi: Über das Vorkommen des Virus der myeloischen Leukämie der Maus in verschiedenen Organen und zu verschiedenen Zeitpunkten nach künstlicher Infektion. Acta biol. med. germ. 5, 409 (1960).PubMedGoogle Scholar
  646. Kudo, M., SH. Mutaiand K. Uraguchi: The effects of cortisone, cortate, parotin and adrenalectomy on Japanese encephalitis virus infection in mice. Yokohama med. Bull. 5, 337 (1954).Google Scholar
  647. Küntzel, J.: Viruskrankheiten, insbesondere Röteln während der Schwangerschaft, als Ursache angeborener, erworbener Taubstummheit und anderer angeborener Defekte. HNO (Berl.) 3, 225 (1952).Google Scholar
  648. Kuin, R., u. R. Brossmer: Über 0-Acetyl-lactaminsäure-lactose aus Kuh-Colostrum und ihre Spaltbarkeit durch Influenza-Virus. Chem. Ber. 89, 2013–2025 (1956 a).Google Scholar
  649. Kuin, R., u. R. Brossmer: Isolierung einer niedermolekularen durch Influenza-Virus spaltbaren Substanz aus Milch. Angew. Chem. 68, 211–212 (1956b).Google Scholar
  650. Kuin, R., u. R. Brossmer: Über das durch Viren der Influenzagruppe spaltbare Trisaccharid der Milch. Chem. Ber. 92, 1667–1674 (1959).Google Scholar
  651. Kun, E., D. W. Fanshier, J. E. Aylingand B. V. Siegel: Kinetic characterigation of lactate dehydrogenase of normal and virus-infected chorioallantoic membrane of the chick embryo. Biochim. biophys. Acta (Amst) 64, 177–179 (1962).Google Scholar
  652. Kuw, E., and M. H. D. Smith: Effect of infectious myxoma virus on glycolysis of chorioallantoic membrane of chick embryo (17768). Proc. Soc. exp. Biol. (N.Y.) 73, 628–631 (1950).Google Scholar
  653. Laidlaw, P. P.: Virus diseases and viruses. Cambridge: Cambridge University Press 1938.Google Scholar
  654. Lattes, R., W. Blunt, M. H. Rose, R. A. Jessar, G. DE Vaillancourtand CH. Ragan: Lack of cortisone effect in the early stages of inflammation and repair. Amer. J. Path. 29, 1 (1953).PubMedGoogle Scholar
  655. Law L. W., T. B. Dunnand P. J. Boyle: Neoplasms in the C3H strain and in F1 hybrid mice of two crosses following introductions of extracts and filtrates of leukemia tissues. J. nat. Cancer Inst. 16, 495 (1955).PubMedGoogle Scholar
  656. Lebrun, J.: Cellular localization of herpes simplex virus by means of fluorescent antibody. Virology 2, 496–510 (1956 a).Google Scholar
  657. Lebrun, J.: Etude de la localisation cellulaire du virus de l’herpes simplex par la méthode des anticorps fluorescents. Bull. Mier. app. 6, 94 (1956b)Google Scholar
  658. Lebrun, J.: L’antigène poliomyélitique au cours du développement intracellulaire du virus. Ann Inst. Pasteur 93, 225–229 (1957).Google Scholar
  659. Ledingham, J. C. G.: Studies on the serological inter-relationship of the rabbit viruses, myxomatosis (Sanarelli, 1898) and fibroma (Shope, 1932). Brit. J. exp. Path. 18, 436 (1937).Google Scholar
  660. Lelong, M., FR. Lepage, LE Tan Vinh, P. Tournieret CH. Chany: Le virus de la maladie des inclusions cytomégaliques. Arch. franç. Pédiat. 17, 437–450 (1960).Google Scholar
  661. Lennartz, H., H. Pet-TE, G. Kerstingu. K. Mannweiler: Zur Pathogenese der experimentellen Poliomyelitis. II. Mitteilung: Untersuchungen über den Einfluß des Cortisons auf Empfänglichkeit und Infektionsablauf. Zbl. Bakt., I. Abt. Orig. 167, 9 (1956).Google Scholar
  662. Lennette, E. H., and H. Koprowski: Interference between viruses in tissue culture. J. exp. Med. 83, 195 (1946).Google Scholar
  663. Levaditi, C., P. Lépine et J. Verge: Les ultravirus des maladies animales. Paris: Maloine 1943.Google Scholar
  664. Levaditi, C., et R. Schoen: Les corps de Negri dans le cytoplasme des épitheliums de la cornée. Ann. Inst. Pasteur 55, Suppl. 69 (1935).Google Scholar
  665. Levaditi, C., R. Schoenet L. Reinié: Virus rabique des rues et papillome de Shope. C. R. Soc. Biol. (Paris) 124, 793Google Scholar
  666. Levaditi, C., R. Schoenet L. Reinié: G. POETSCHKE und O. KLAMERTH: Virus und Virusinfektionen. (1937a).Google Scholar
  667. Levaditi, C., R. Schoen et L. Reinié: Virus rabique et cellules néoplasiques. Ann Inst. Pasteur 58, 353 (1937b).Google Scholar
  668. Levine, A. S., P. H. Bond and H. C. Rouse: Modification of viral synthesis in tissue culture by substituting pyruvate for glucose in the medium. Proc. Soc. exp. Biol. (N. Y.) 93, 233–235 (1956).Google Scholar
  669. Levine, S., and B. P. Sagik: The interactions of Newcastle disease virus (NDV) with chick embryo tissue culture cells: attachment and growth. Virology 2, 57 (1956).PubMedGoogle Scholar
  670. Levinson, S. O., A. Milzer and P. Lewin: Effect of fatigue, chilling and mechanical trauma on resistance to experimental poliomyelitis. Amer. J. Hyg. 42, 204–213 (1945).Google Scholar
  671. Levinthal, C., and H. Fisher: The structural development of a bacterial virus. Biochim. biophys. Acta (Amst.) 9, 419–429 (1952).Google Scholar
  672. Levy, H. B., and S. Baron: The effect of animal viruses on host cell metabolism. II. Effect of poliomyelitis virus on glycolysis and uptake of glycine by monkey kidney tissue cultures. J. infect. Dis. 100, 109–118 (1957).PubMedGoogle Scholar
  673. Levy, H. B., W. P. Rowe, L. F. Snellbakerand J. W. Hartley: Biochemical changes in HeLa cells associated with infection by type 2 adenovirus. Proc. Soc. exp. Biol. (N.Y.) 96, 733–738 (1957).Google Scholar
  674. Lichstein, H. C., K. B. Mccall, E. B. Kearney, C. A. Elvehjemand P. F. Clark: Effect of minerals on susceptibility of Swiss mice to Theiler’s virus. Proc. Soc. exp. Biol. (N.Y.) 62, 279 (1946).Google Scholar
  675. Lieberman, M., and H. S. Kaplan: Induction of lymphoid tumors by cell-free filtrates from radiation-induced thymic lymphomas of isologous mice. Proc. Amer. Ass. Cancer Res. 3, 38 (1959).Google Scholar
  676. Lindenmann, J., D. C. Burkeand A. Isaacs: Studies on the production, mode of action and properties of interferon. Brit. J. exp. Path. 38, 551 (1957).PubMedGoogle Scholar
  677. Linzenmeier, G.: Die Bedeutung des Speicheldrüsenvirus für den Menschen unter dem morphologischen Bild der Cytomegalie (Versuch einer Abgrenzung von Erythroblastose und Toxoplasmose). Z. Kinderheilk. 71, 162–182 (1952).PubMedGoogle Scholar
  678. Lippincott, J. A., and B. Commoner: Reactivation of tobacco mosaic virus infectivity in mixtures with protein. Biochim. biophys. Acta (Amst) 19, 198 (1956).Google Scholar
  679. Liu, C.: Studies on influenza infections in ferrets by means of fluorescein-labelled antibody.The pathogenesis and diagnosis of the disease. J. exp. Med. 101, 665–676 (1955 a).Google Scholar
  680. Liu, C.: Studies on influenza infection in ferrets by means of fluorescein-labelled antibody. The role of soluble antigen in nuclear fluorescence and cross reactions. J. exp. Med. 101, 677–686 (1955b).PubMedGoogle Scholar
  681. Liu, C.: Rapid diagnoses of human influenza infections from nasal smears by means of fluorescein-labelled antibody. Proc. Soc. exp. Biol. (N.Y.) 92, 883–887 (1956).Google Scholar
  682. Liu, C.: The use of fluorescent antibody in the diagnosis and study of viral and rickettsial infections. Ergebn. Mikrobiol. 33, 242–258 (1960).Google Scholar
  683. Liu, C., J. E. Carterand B. Hampil: Serotherapy of poliomyelitis in rhesus monkeys. Fed. Proc. 16, 423 (1957).Google Scholar
  684. Liu, C., and D. L. Coffin: Studies on the canine distemper infection by means of fluorescein-labelled antibody. I. The pathogenesis, pathology and diagnosis of the disease in experimentally infected ferrets. Virology 3, 115–131 (1957).PubMedGoogle Scholar
  685. Liu, O. C., H. Blank, J. Spizizenand W. Henle: Incorporation of radioactive phosphorus into influenza virus. J. Immunol. 73, 415–425 (1954).PubMedGoogle Scholar
  686. Lo, W. Y., G. O. Geyand P. Shapras: The cytopathogenic effect of the Rous sarcoma virus on chicken fibroblasts in tissue cultures. Bull. Johns Hopk. Hosp. 97, 248 (1955).Google Scholar
  687. Löffler, H.: Der inkomplette Infektionszyklus von Influenza-Virus in HeLa-Zellen. Fluoreszenzmikroskopische Untersuchungen. Path. Microbiol. 24, 988 (1961).Google Scholar
  688. Löffler, H.: Die Gruppe der Myxoviren. Ihre Untersuchung mittels fluorescierender Antikörper. Ergebn. Mikrobiol. 35, 240–264 (1962).Google Scholar
  689. Löffler, H., G. Henleand W. Henle: Attempts to influence the. incomplete reproductive cycle of influenza virus in HeLa cells by antibodies. J. Immunol. 88, 763–776 (1962).Google Scholar
  690. Loh, P. C., F. E. Payneand W. W.Ackermann: Synthesis of ribonucleic acid in HeLa cells infected with poliovirus. Fed. Proc. 17, 524 (1958).Google Scholar
  691. Long, C. N. H.: Regulation of ACTH secretions. Recent Progr. Hormone Res. 7, 75–105 (1952).Google Scholar
  692. Luria, S. E.: General virology, pp. 427. New York: John Wiley Sons, Inc. 1953 a. An analysis of bacteriophage multiplication. In: The nature of virus multiplication. Cambridge: Cambridge University Press 1953 b.Google Scholar
  693. Luria, S. E.: The multiplication of viruses. In: Protoplasmatologia, Bd. I V: Virus. Wien: Springer 1958.Google Scholar
  694. Luzyanina, T., and R. J. Polyak1958/1960 (zit. nach A. A. Smorodintsev 1960 ).Google Scholar
  695. Lwoff, A.: Lysogeny. Bact. Rev. 17, 269–337 (1953 a).Google Scholar
  696. Lwoff, A.: L’induction. Ann. Inst. Pasteur 84, 225 (1953b).Google Scholar
  697. Lwoff, A.: The concept of virus. J. gen. Microbiol. 17, 239–253 (1957).PubMedGoogle Scholar
  698. Lwoff, A.: Factors influencing the evolution of viral diseases at the cellular level and in the organism. Bact. Rev. 23, 109–124 (1959).PubMedGoogle Scholar
  699. Lwoff, A.: Bacteriophage as a model of host-virus relationship. In: The viruses, vol.2, pp. 187201. New York and London: Academic Press 1959.Google Scholar
  700. Lwoff, A.: Report presented at Fifth Internat. Poliomyelitis Conference, Copenhagen 1960.Google Scholar
  701. Lwoff, A., et M. Lwoff: L’inhibition du développement du virus poliomyélitique à 39° et le problème du rôle de l’hyperthermie dans l’évolution des infections virales. C. R. Acad, Sci. (Paris) 246, 190–192 (1958).Google Scholar
  702. Lwoff, A., et M. Lwoff: Remarques sur les facteurs aspécifiques gouvernant l’évolution des infection virales. La notion d’état critique. C. R. Acad. Sci. (Paris) 248, 154–156 (1959).Google Scholar
  703. Lwoff, A., et M. Lwoff: Remarques sur quelques caractères du développement du virus de la poliomyélite. C.R. Acad. Sci. (Paris) 248, 1725–1727 (1959).Google Scholar
  704. Lwoff, A., T. F. Andersonet F. Jacob: Remarques sur les caractéristiques de la particule virale infectieuse. Ann. Inst. Pasteur 97, 281–289 (1959).Google Scholar
  705. Lwoff, A., P. Tournier et J. P. Carteaud: Influence de l’hyperthermie expérimentale sur la poliomyélite de la souris.C.R. Acad. Sci. (Paris) 248, 1876–1878 (1959).Google Scholar
  706. Lwoff, A., P. Toirrnier, M. Lwoffet F. Cathala: Influence de l’hypothermie sur l’évolution de la poliomyélite de la souris. Relation entre neurovirulence et thermorésistance du développement viral. C. R. Acad. Sci. (Paris) 250, 2644 (1960).Google Scholar
  707. Maassab, H. F.: An infectious ribonucleic acid derived from influenza infected cells. Proc. nat. Acad. Sci. (Wash.) 45, 877–881 (1959).Google Scholar
  708. Maassab, H. F., P. C. Lox and W.W. Ackermann: Growth characteristics of poliovirus in HeLa cells in nucleic acid metabolism. J. exp. Med. 106, 641–648 (1957).PubMedGoogle Scholar
  709. Macleod, C. M.: Relation of the incubation period and the secondary immune response to lasting immunity to the infectious diseases. J. Immunol. 70, 421–425 (1953).PubMedGoogle Scholar
  710. Magnus, H. y., and J. Melnick: Tonsillectomy in experimental poliomyelitis. Amer. J. Hyg. 48, 113 (1948).Google Scholar
  711. Magnus, P. v.: Propagation of the PR 8 strain of influenza A virus in chick embryo. II. Acta path. microb. scand. 28, 278–293 (1951).Google Scholar
  712. Magrassi, F.: Studii sull’infezione e sull’immunità da virus erpetico. II. Z. Hyg. Infekt.-Kr. 117, 501–528 (1935).Google Scholar
  713. Mahnke, P. F.: Cytomegalie und plötzlicher Tod im Kindesalter. Frankfurt. Z. Path. 70, 621–629 (1960).PubMedGoogle Scholar
  714. Malkova, D.: The role of the lymphatic system in experimental infection with tick-borne encephalitis. I. The tick-borne encephalitis virus in the lymph and blood of experimentally infected sheep. Acta virol. 3, 233–240 (1960).Google Scholar
  715. Malkova, D., and V. Frankova: The lymphatic system in the development of experimental tick-borne encephalitis in mice. Acta virol. 3, 210–214 (1959).PubMedGoogle Scholar
  716. Manaker, R. A., and V. GroupÉ: Discrete foci of altered chicken embryo cells associated with Rous sarcoma virus in tissue culture. Virology 2, 838–840 (1956).Google Scholar
  717. Mandel, B.: Early stages of virus-cell interaction as studied by using antibody. Cold Spr. Harb. Symp. quant. Biol. 27, 123–136 (1962).Google Scholar
  718. Mandel, B., and E. Racker: Inhibition of Theiler’s encephalomyelitis virus (GD VII strain) of mice by an intestinal mucopolysaccharide. I. Biological properties and mechanism of action. J. exp. Med. 98, 399 (1953).Google Scholar
  719. Marinesco, G., et S. Draganesco: Recherches sur le neurotropisme du virus herpétique. Ann. Inst. Pasteur 37, 753 (1923).Google Scholar
  720. Marshall, I. D.: The influence of ambient temperature on the course of myxomatosis in rabbits. J. Hyg. (Lond.) 57, 484 497 (1959).Google Scholar
  721. Martin, C. M., C. M. Kunin, L. S. Gottlieb, M. W. Barnes, C. Liu and M. Finland: Asian influenza A in Boston 1957–1958.Google Scholar
  722. Martin, C. M., C. M. Kunin, L. S. Gottlieb, M. W. Barnes, C. Liu and M. Finland: I. Observations in thirty-two influenza associated fatal cases. Arch. intern. Med. 103, 515–531 (1959).Google Scholar
  723. Martin, J. K.: Local paralysis in children after injections. Arch. Dis. Childh. 25, 1 (1950).PubMedGoogle Scholar
  724. Mattia, DE R., G. C. Angelaet F. DI Nola: Considerations sur la „Fatigue“ comme facteur d’aggravation dans la Poliomyélite. Europ. Assoc. against Poliomyel., 3. Symposium, Zürich, 29. und 30. Sept. 1955.Google Scholar
  725. Matzelt, D., u. J. Homann: Das Verhalten glykolytischer Enzymaktivitäten in Gewebekulturen vor und nach Beimpfung mit Virus. I. Mitt. Biochem. Z. 330, 245–259 (1958).Google Scholar
  726. Matzelt, D., J. Homann u. H. Lennartz: Das Verhalten glykolytischer Enzymaktivitäten in Gewebekulturen vor und nach Beimpfung mit Virus. II. Mitt. Biochem. Z. 330, 260–268 (1958).Google Scholar
  727. Mayers-Bach, H: Immunhistologische Methoden in der Histochemie. In: GRAUMANN und NEUMANN, Handbuch der Histochemie, Bd. I, S. 599–639.Google Scholar
  728. Mayers-Bach, H: Stuttgart: Gustav Fischer 1958 a. Immunhistologische Methoden. II. Ein weiterer Markierungsfarbstoff: Dimethyl-1-Naphthylaminsulfonsäure-5. Acta histochem. (Jena) 5, 351–368 (1958b).Google Scholar
  729. Mayyasi, S. A., D. M. Schuurmansand A. Brown: The agglutination of cells by vaccinia virus. The agglutination and agglutination-inhibition titrations for virus and antibody. J. Immunol. 83, 411–417 (1959).Google Scholar
  730. Mcclellan, R. H., and E. W. Goodpasture: A method of demonstrating experimental gross lesions of the central nervous system. J. med. Res. 44, 201 (1924).Google Scholar
  731. Mccloskey, B. P.: Report of an investigation into an outbreak of poliomyelitis in a small town remote from Melbourne. Med. J. Aust. 1, 612 (1951).PubMedGoogle Scholar
  732. Mccullocx, E. A., A. F. Howatson, L. Siminovitci, A. A. Axelradand A. W. Ham: A cytopathogenic agent from a mammary tumour in a C3H mouse that produces tumours in Swiss mice and hamsters. Nature (Lond.) 183, 1535–1536 (1959).Google Scholar
  733. Mcdermott, W. (Ed.): Conference on airborne infection. Bact. Rev. 25 (1961).Google Scholar
  734. Mclaren, A.: Protective effect of aged vaccines on a neurotropic virus infection in mice. Nature (Lond.) 172, 38 (1953).Google Scholar
  735. Medawar, P. B.: Cellular inheritance and transformation. Biol. Rev. 22, 360 (1947).PubMedGoogle Scholar
  736. Melczer, M.: Primulinpositive und primulinnegative Virusarten. Die Möglichkeit von Differenzierung der Virusarten im Fluoreszenzlicht. Acta med. (Budapest) 2, 205–212 (1951).Google Scholar
  737. Melnick, J. L.: Antigenic crossings within poliovirus types. Proc. Soc. exp. Biol. (N.Y.) 89, 131–133 (1955).Google Scholar
  738. Meyer, K. F.: Phagocytosis and immunity in Psittacosis. Schweiz. med. Wschr. 71, 436–438 (1941).Google Scholar
  739. Mider, G. B., and J. J. Morton: Effect of methylcholanthrene on latent period of breast tumors in dilute brown mice. Proc. Soc. exp. Biol. (N.Y.) 42, 583–584 (1939).Google Scholar
  740. Miller, G. L., and W. M. Stanley: Derivates of tobacco mosaic virus. I. Acetyl and phenylureido virus. J. biol. Chem. 141, 905 (1941).Google Scholar
  741. Miller, G. L., and W. M. Stanley: Derivates of tobacco mosaic virus. II. Carbobenzoxy, p-chlorobenzoic, and benzenesulfonyl virus. J. biol. Chem. 146, 331 (1942).Google Scholar
  742. Miller, J. A., and E. C. Miller: The carcinogenic aminoazo dyes. Advanc. Cancer Res. 1, 340–396 (1953).Google Scholar
  743. Miller, J. F. A. P.: Role of the thymus in virus-induced leukaemia. In: A Ciba Foundation Symposium on tumor viruses of murine origin. London: J. and A. Churchill 1962.Google Scholar
  744. Mills, R. F. N.: The effect of infecting the cell. J. gen. Microbiol. 19, 473–481 (1958).PubMedGoogle Scholar
  745. Miller, A., M. A. Weissand K. Vanderboom: Effect of pertussis, diphtheria toxoid and Salmonella immunization on experimental poliomyelitis. Proc. Soc. exp. Biol. (N.Y.) 77, 485–488 (1951).Google Scholar
  746. Mims, C A: Intracerebral injections and the growth of viruses in the mouse brain. Brit. J. exper. Path. 41, 52–59 (1960).Google Scholar
  747. Minder, W. H.: Die Atiologie der Cytomegalia infantium. Schweiz. med. Wschr. 83, 1180 (1953).Google Scholar
  748. Miroff, G., W. E. Cornatzerand R. G. Fischer: The effects of poliomyelitis virus Type 1 (Mahoney strain) on the phosphorus metabolism of the HeLa cell. J. biol. Chem. 228, 255–262 (1957).PubMedGoogle Scholar
  749. Moffat, M. A., O. A. Holtermannand W. D. Hillis: The development of soluble and viral antigens of influenza A virus in tissue culture as studied by the fluorescent antibody technique. 2. Studies employing a high multiplicity of infection in beef embryo kidney cells. Acta path. microbiol. stand. 50, 409 (1960).Google Scholar
  750. Mooabgab, W. J., and F. L. Horsfall: Effect of sodium monofluoroacetate on the multiplication of influenza viruses, mumps virus„ and pneumonia virus of mice (PVM). J. exp. Med. 96, 531–548 (1952).Google Scholar
  751. Moldave, K.: The effect of Theiler’s GD VII virus on the intracellular distribution of radiophosphorus in mouse brain in vitro. J. biol. Chem. 210, 343–345 (1954).PubMedGoogle Scholar
  752. Moloney, J. B.: Preliminary studies on a mouse lymphoid leukemia virus extracted from sarcoma 37. Proc. Amer. Ass. Cancer. Res. 3, 44 (1959).Google Scholar
  753. Moloney, J. B.: Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. Origin and introducory investigattions. J. nat. Cancer Inst. 24, 933–951 (1960).PubMedGoogle Scholar
  754. Moloney, J. B.: Diskussionsbemerkung. In: A Ciba Foundation Symposium on tumor viruses of murine origin, S. 171. London: J. and A. Churchill 1962.Google Scholar
  755. Montemagno, F.: Contributo allo studio dell’eziologia virale della leucosi linfatica dei bovini. Acta med. vet. 4, 301–310 (1958).Google Scholar
  756. Montemagno, F., V. Papparella et G. Catellani: Contributo allo studio dell’etiologia della leucosi linfatica dei bovini. Acta med. vet. 3, 185–191 (1957).Google Scholar
  757. Moore, A. E.: The destructive effect of the virus of Russian far east encephalitis on the transplantable mouse sarcoma 180. Cancer (Philad.) 2, 525 (1949).Google Scholar
  758. Moore, A. E.: Inhibition of growth of five transplantable mouse tumors by the virus of Russian far east encephalitis. Cancer (Philad.) 4, 375 (1951 a).Google Scholar
  759. Moore, A. E.: Enhancement of oncolytic effect of Russian encephalitis virus. Proc. Soc. exp. Biol. (N.Y.) 76, 749 (1951 b).Google Scholar
  760. Moore, A. E.: Induction of tumors in newborn mice by inoculation of preparations of human tissues. Proc. Amer. Ass. Cancer Res. 3, 135 (1960).Google Scholar
  761. Moore, A. E., and S. O’connor: Further studies on the destructive effect of the virus of Russian far east encephalitis on the transplantable mouse sarcoma 180. Cancer (Philad.) 3, 886 (1950).Google Scholar
  762. Moore, A. E., and C. Friend: Attempts at growing the mouse leukemia virus in tissue culture. Proc. Amer. Cancer Res. 2, 328 (1958).Google Scholar
  763. Morgan, C.: The use of ferretin-conjugated antibody in electron-microscopic studies of animal viruses. In: Basic mechanisms in animal virology. Cold Spr. Harb. Symp. quant. Biol. 27 (1962).Google Scholar
  764. Morgan, C., S. A. Ellison, H. M. Roseand D. H. Moore: Electron microscopic examination of inclusion bodies of herpes simplex virus. Proc. Soc. exp. Biol. (N.Y.) 82, 454 (1953).Google Scholar
  765. Morgan, C., S. A. Ellison, H. M. Roseand D. H. Moore: Structure and development of viruses as observed in the electron microscope. I. Herpes simplex virus. J. exp. Med. 100, 195–202 (1954).Google Scholar
  766. Morgan, C., S. A. Ellison, H. M. Roseand D. H. Moore: Herpes simplex virus observed in the electron microscope in sectioned cells. Trans. N.Y. Acad. Sci. 16, 251 (1954).PubMedGoogle Scholar
  767. Morgan, C., S. A. Ellison, H. M. Roseand D. H. Moore: Internal structure in virus particles. Natur (Lond.) 173, 208 (1954).Google Scholar
  768. Morgan, C., E. P. Jones, M. Holzdenand H. M. Rose: Intranuclear crystals of herpes simplex virus observed with the electron microscope. Virology 5, 568 (1958).PubMedGoogle Scholar
  769. Morgan, C., H. M. Rose, M. Holdenand E. P. Jones: Electron microscopic observations on the development of herpes simplex virus. J. exp. Med. 110, 643 (1956).Google Scholar
  770. Morgan, C., H. M. Roseand D. H. Moore: Structure and development of viruses observed in the electron microscope. III. Influenza virus. J. exp. Med. 104, 171–182 (1956).PubMedGoogle Scholar
  771. Morgan, H. R.: Latent viral infection of cells in tissue culture. I. Studies on latent infection of chick embryo tissues with psittacosis virus. J. exp. Med. 103, 37 (1956).Google Scholar
  772. Morgan, H. R., and J. P. Bader: Latent viral infection of cells in tissue culture. IV. Latent infection of L cells with psittacosis virus. J. exp. Med. 106, 39–40 (1957).PubMedGoogle Scholar
  773. Morgan, J. F., H. J. Mortonand R. C. Parker: Nutrition of animal cells in tissue culture. I. Initial studies on a synthetic medium. Proc. Soc. exp. Biol. (N.Y.) 73, 1 (1950).Google Scholar
  774. Moulton, J. E.: Fluorescent antibody studies of demyelination in canine distemper. Proc. Soc. exp. Biol. (N.Y.) 91, 460–464 (1956).Google Scholar
  775. Moulton, J. E., and C. H. Brown: Antigenicity of canine distemper. Inclusion bodies as demonstrated by fluorescent antibody technic. Proc. Soc. exp. Biol. (N.Y.) 86, 99 (1954).Google Scholar
  776. Muench, H.: Infection and immunity in poliomyelitis. (Passive immunization.) The influence of passive immunization on the incidence of poliomyelitis. Third. Internat. Poliomyelitis Conf., Rom 6. bis 10. Sept. 1954.Google Scholar
  777. Mussgay, M.: Der Nachweis von Teschenvirus-Antigen in Gewebskulturzellen mit Hilfe von fluoreszierenden Antikörpern. Zbl. Bakt., I. Abt. Orig. 171, 231–247 (1958).Google Scholar
  778. Mussgay, M.: Untersuchungen mit fluoreszierenden Antikörpern über die Bildung von spezifischem Antigen des Virus der Maul-und Klauenseuche in Gewebekulturen. Zbl. Bakt., I. Abt. Orig. 171, 413–417 (1958).Google Scholar
  779. Nairn, R. C.: Fluorescent protein tracing. Edinburgh and London: E. and S. Livingstone Ltd. 1962.Google Scholar
  780. Nasemann, Th.: Zur Diagnostik der durch das Herpes simplex-Virus hervorgerufenen Hautkrankheiten des Menschen. Z. Tropenmed. Parasit. 8, 319 (1957).Google Scholar
  781. Nasemann, Th.: Die Viruskrankheiten der Haut und die Hautsymptome bei Rickettsiosen und Abtronellosen. In: Handbuch der Haut-und Geschlechtskrankheiten, Bd. IV/2. Berlin-Göttingen-Heidelberg: Springer 1961.Google Scholar
  782. Nauck, E. G.: Die Pathologie der Viruskrankheiten. Zbl. Bakt.,I. Abt. Orig. 160, 139–146 (1953/54).Google Scholar
  783. Negroni, G.: The properties of Mill Hill Polyoma virus. In : A Ciba Foundation Symposium on tumour viruses of murine origin. London:Google Scholar
  784. Negroni, G.: J. and A. Churchill 1962.Google Scholar
  785. Negroni, G.: Isolation of viruses from leukaemic patients. Brit. med. J. 1964 I, 927–929.Google Scholar
  786. Negroni, G., R. R. Dourmasiikinand F. C. Chesterman: A „polyoma“ virus derived from a mouse leukemia. Brit. med. J. 1959 I I, 1359 /60.Google Scholar
  787. Neidhardt, F. C., and F. Gros: Metabolic instability of the ribonucleic acid synthesized by Escherichia coli in the presence of chloromycetin. Biochim. biophys. Acta (Amst.) 25, 513–520 (1957).Google Scholar
  788. Nettleship, A., and D. E. Fletcher: The altered pathology of poliomyelitis in a local area. J. Neuropath. exp. Neurol. 1, 250 (1951).Google Scholar
  789. Newton, A., and M. G. P. Stoker: Changes in nucleic acid content of HeLa cells infected with herpes virus. Virology 5, 549–560 (1958).PubMedGoogle Scholar
  790. Nicolau, S.: La vitesse de dispersion du virus rabique des rues dans les nerfs périphériques des lapins infectés par voie sous-dur-emérienne. C. R. Soc. Biol. (Paris) 99, 677 (1928).Google Scholar
  791. Nicolle, Ch.: Naissance, vie et mort des maladies infectieuses. Paris: F. Alcan 1930.Google Scholar
  792. Nicolle, Ch.: Destin des maladies infectieuses. Paris: F. Alcan 1933.Google Scholar
  793. Nicolle, CH., et E. Conseil: Pouvoir préventif du sérum d’un malade convalescent de rougeole. Bull. Soc. méd. Hôp. Paris 42, 336 (1918).Google Scholar
  794. Nikolitsch, M.: Zweiter Beitrag zur Frage des Infektionsmechanismus bei neurotropen Virusarten. Arch. Hyg. (Berl.) 137, 11–19 (1953).Google Scholar
  795. Nikolitsch, M.: Die Tollwut. Stuttgart: Gustav Fischer 1961.Google Scholar
  796. Nikolitsch, M., H. Z. Jelesitsch: Phänomen der Eklipse bei dem Tollwut-virus und der Einfluß des Immunserums auf extraneurale Viren. Arch. Hyg. (Berl.) 141, 532–537 (1957 a).Google Scholar
  797. Nikolitsch, M., H. Z. Jelesitsch: Bestehen streng nsutrope Viren ? Arch. Hyg. (Berl.) 141, 104–109 (1957b).Google Scholar
  798. Nirenberg, M. W., and J. H. Matthaei: The dependence of cell free protein synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides. Proc. nat. Acad. Sci. (Wash.) 47, 1588–1602 (1961).Google Scholar
  799. Nisiiizawa, Y., and K. Okano: The significance of viremia in the pathway of infection of poliomyelitis. Arch. Pediat. 70, 71 (1953).Google Scholar
  800. Nisnmi, M., and H. Bernkopf: The toxic effect of vaccinia virus on leucocytes in vitro. J. Immunol. 81, 460–466 (1958).Google Scholar
  801. Niven, J. S. F.: Induced fluorescence microscopy of virus infected cells. In: Poliomyelitis. Papers and discussions presented at the Fifth International Poliomyelitis Conference. Copenhagen 1960. Philadelphia, Pa.: J. B. Lippincott Company.Google Scholar
  802. Nomura, M., K. Okamoto and K. Asano: RNA-metabolism in Escherichia coli infected with bacteriophage T4: Inhibition of host ribosomal and soluble RNA-synthesis by phage and effect of chloromycitin. J. molec. biol. 4, 376–388 (1962).PubMedGoogle Scholar
  803. Nossal, G. J. V., and P. M. DE Burgh: Growth cycle of ectromelia virus in mouse-liver. Nature (Lond.) 172, 671 (1953).Google Scholar
  804. Noyes, W. F.: Visualization of Egypt-101-virus in the mouse’s brain and in cultured human carcinoma cells by means of fluorescent antibody. J. exp. Med. 102, 243–248 (1955).PubMedGoogle Scholar
  805. Noyes, W. F.: Studies on the Shope rabbit papilloma virus. II. The localization of infective virus in papillomas of the cottontail rabbit. J. exp. Med. 109, 423–428 (1959).PubMedGoogle Scholar
  806. Noyes, W. F., and R. C. Mellors: Fluorescent antibody detection of the antigens of the Shope papilloma virus in papillomas of the wild and domestic rabbit. J. exp. Med. 106, 555–562 (1957).PubMedGoogle Scholar
  807. Noyes, W. F., and B. K. Watson: Studies on the increase of vaccine virus in cultured human cells by means of the fluorescent antibody technique. J. exp. Med. 102, 237–242 (1955).PubMedGoogle Scholar
  808. Oberling, C., et M. Guérin: Nouvelle recherches sur la production des tumeurs malignes avec le virus de la leucémie transmissible des poules. Bull. Ass. franç. Cancer 22, 326–361 (1933).Google Scholar
  809. Oberling, C., et M. Guérin: The role of viruses in the production of cancer. Advanc. Cancer Res. 2, 353–423 (1954).Google Scholar
  810. Oehme, Johannes: Klinik und Bedeutung der Cytomegalie. Munch. med. Wschr. 1961, 143–147.Google Scholar
  811. Oerskov, J., u. S. Schmidt: Infektionsmechanische Untersuchungen über die Geflügelpestinfektion der Maus. Zbl. Bakt., I. Abt. Orig. 137, 1 (1936).Google Scholar
  812. Page, N. G. DE: Sur la disparition d’un énorme cancer végétant du col de l’utérus. Ginecologia (Basel) 9, 82 (1912).Google Scholar
  813. Panov, A. G., and P. I. Remezov: 1960 (zit. nach F. B. Bang D. C. N. Luttrell. In: Advances in virus research. New York and London: Academic Press 1961.Google Scholar
  814. Panum, P. L.: Beobachtungen über das Masernkontagium. Virchows Arch. path. Anat. 1, 492 (1847).Google Scholar
  815. Paraf, A., R. E. Billinghamand H. Koprowski: Zit. nach Bang and Luttrell 1961. Fed. Proc. 91, 405 (1960).Google Scholar
  816. Parfentjev, I. A.: Bacterial allergy increases susceptibility to influenza virus in mice. Proc. Soc. exp. Biol. (N.Y.) 90, 373 (1955).Google Scholar
  817. Parnes, V.A., and V. V. Suntzova: Production of leukemia in mice by inoculation of blood from leukemic patients. 35th Meet. Scientific Board Inst. Hematology and Blood Transfusion. Path. Fiziol. éksp. Ter. 2, 14–20 (1959).Google Scholar
  818. Parodi, A. S.: Acid-soluble phosphorus content of embryos infected with influenza A virus. Arch. Biochem. 22, 324–327 (1949).PubMedGoogle Scholar
  819. Parson, R. J., and J. G.Kidd: Oral papillomatosis of rabbits; a virus disease. J. exp. Med. 77, 233 (1943).Google Scholar
  820. Paschen, E.: Technik zur Darstellung der Elementarkörperchen (Paschensche Körperchen)in der Variolapustel. Dtsch. med. Wschr. 43, 1036 (1917).Google Scholar
  821. Pasternak, G., u. A. Graffi: Versuche zum Nachweis gemeinsamer Antigenkomponenten beim Virus der myeloischen und der lymphatischen Leukämie der Maus. Z. Naturforsch. 16b, 73 (1961).Google Scholar
  822. Patterson, R.: Cases and observations on the molluscum contagiosum of Bateman with an account of the minute structure of the tumours. Edinb. med. and Surg. J. 56, 279 (1941).Google Scholar
  823. Pauker, K., and W. Henle: Studies on host virus interactions in the chick embryo-influenza virus system. XII. Further analyses of yields derived from heat-inactivated standard seeds. J. exp. Med. 101, 493–506 (1955).Google Scholar
  824. Pauker, K., and W. Henle:Interference between inactivated and active influenza viruses in the chick embryo. II. Interference by incomplete forms of influenza virus. Virology 6, 198 (1958).Google Scholar
  825. Payne, F. E., H. Kurtzand W. W. Ackermann: Initial stages of the interaction of HeLa cells with poliovirus. Arch. Ges. Virusforsch. 8, 1–15 (1958).PubMedGoogle Scholar
  826. Pearse, A. G. E.: Histochemistry, theoretical and applied, 2nd ed. London: Churchill 1959.Google Scholar
  827. Pearson, H. E., and R. J. Winzler: Oxidative and glycolytic metabolism of minced day-old mouse brain in relation to propagation of Theiler’s GD VII virus. J. biol. Chem. 181, 577–582 (1949).PubMedGoogle Scholar
  828. Pereira, H. G.: A protein factor responsible for the early cytopathic effect of adenovirus. Virology 6, 601–611 (1958).PubMedGoogle Scholar
  829. Pereira, H. G.: The cytopathic effect of animal viruses. Advanc. Virus Res. 8, 245–285 (1961).Google Scholar
  830. Pereira, H. G. : Cellular responses to non-infectious virus factors. In : Poliomyelitis. Papers and Discussions presented at the Fifth Internat. Poliomyelitis Conference. Copenhagen 1960. Philadelphia, Pa. : J. B. Lippincott.Google Scholar
  831. Pereira, H. G., A. C. Allisonand B. Balfour: Multiplication of adenovirus type 5 studied by infectivity titrations and by the fluorescent antibody technique. Virology 7, 300–314 (1959).PubMedGoogle Scholar
  832. Pereira, H. G., and B. Kelly: Dose-response curves of toxic and infective actions of adenovirus in HeLa cell cultures. J. gen. Microbiol. 17, 517–524 (1957).PubMedGoogle Scholar
  833. Peters, D., u. TH. Nassmann: Untersuchungen am Virus der Variolavaccine. I. Mitt. Über den Wert der Tupfpräparation für die elektronenoptische Abbildung und Ausmessung von Elementarkörpern. Z. Tropenmed. Parasit. 4, 11 (1952a).Google Scholar
  834. Peters, D., u. TH. Nassmann: Enzymatisch-morphologische Untersuchungen am Vacciniavirus. Naturwissenschaften 39, 306 (1952b).Google Scholar
  835. Peters, D., u. TH. Nassmann: Untersuchungen am Virus der Variolavaccine. II. Mitt. Nachweis von Elementarkörperstadien mittels enzymatisch-elektronenoptischer Analyse. Z. Naturforsch. 813, 547 (1953).Google Scholar
  836. Pette, H.: Wandlung epidemiologischer und pathologischer Gedankengänge bei der Poliomyelitis. Klin. Wschr. 27, 321 (1949).Google Scholar
  837. Pette, H., H. Demmeu ST. Környey: Studien über experimentelle Poliomyelitis. Dtsch. Z. Nervenheilk. 128, 125 (1932).Google Scholar
  838. Philibert, A.: Virus cytotropes (virus filtrants; virus filtrables). Ann Med. 16, 283 (1924).Google Scholar
  839. Pikovski, M. A.: The survival of mammary tumor agent in cultures of heterologous cells. J. nat. Cancer Inst. 13, 1275 (1953).PubMedGoogle Scholar
  840. Plowright, W.: Observations on the behaviour of rinderpest virus in indigenous African sheep. Brit. vet. J. 108, 450 (1952).Google Scholar
  841. Poetschke, G.: Zur Theorie provozierender und disponierender Faktoren bei der Poliomyelitis. Klin. Wschr. 34, 284 (1956 a).Google Scholar
  842. Poetschke, G.: Unveröffentlichte Untersuchungen1956 b.Google Scholar
  843. Poetschke, G.: Zum Wirkungsmechanismus fördernder oder hemmender Faktoren bei Virus-infekten, insbesondere der Poliomyelitis. Acta neuroveg. (Wien) 15, 486 (1957).Google Scholar
  844. Poetschke, G.: Der Nach-weis von Viren und Virusantigenen mit Hilfe fluoreszenz-markierter Antikörper. Progr. med. Virol. 3, 79–157 (1961).Google Scholar
  845. Poetschke, G., u. L. Killisen: Unveröffentlichte Ergebnisse 1960.Google Scholar
  846. Poetschke, G., H. Uehleke u L Killiscx: Untersuchungen mit fluoreszierenden Antikörpern. I. Allgemeines und Methodisches. Z. Immun -Forsch. 114, 393–415 (1957).Google Scholar
  847. Pollax, J. K.: Amino acids metabolism of growing tissues; alanine-glutamic acid transaminase activity of regenerating rat liver. Exp. Cell Res. 19, 156–163 (1960).Google Scholar
  848. Polyak, R. J.: 1960 (zit. nach Smorodintsev 1960 ).Google Scholar
  849. Polyak, R. J.: 1959 (zit. nach A. A. Smorodintsev 1960 ).Google Scholar
  850. Polyak, R. J., T. J. Luzyanina and A. A. Smorodintsev: Biochemical investigations of influenza virus neutralizing protein fractions of sera from animals. Acta Virol. 3, Suppl, 61–70 (1959).Google Scholar
  851. Portocala, Radii, M. M., Vera Bokru et Iosif Samuel: Sur la biosynthèse du virus grippal, à partir d’un acide ribonucléique extrait du virus. C.R. Acad. Sci. (Paris) 249, 201–202 (1959a).Google Scholar
  852. Portocala, Radii, M. M., Vera Bokru et Iosif Samuel: Sur la biosynthèse du virus grippal it partir d’un acide ribonucléique extrait du virus. Propriétés des souches récemment isolées et die l’acide ribonucléique. C. R. Acad. Sci. (Paris) 249, 848–849 (1959b).Google Scholar
  853. Portocala, Radii, M. M., Vera Bokruet Iosif Samuel: Biosynthesis of influenza virus starting from an ether phenol virus extract. Acta virol. 3, 172–174 (1959 d).Google Scholar
  854. Potel, K.: Hyalinisierung von Gefäßwänden bei Viruskrankheiten. In: Sitzungsber. „Grundsubstanz, Zelle, Kapillare“ anläßlich des 100 jährigen Bestehens des Lehrstuhls für pathologische Anatomie in Greifswald. Ref. Zbl. allg. Path. path. Anat. 96, 367 (1957).Google Scholar
  855. Potter, R.v., W. C. SchneidsrandG. J. Liebl: Enzyme changes during growth and differentiation in the tissues of the newborn rat. Cancer Res. 5, 21–24 (1950).Google Scholar
  856. Powell, RobinD., Nancy E. Warner, RobertS. Levineand JosephB. Kirsner:Cytomegalic inclusion disease and ulcerative colitis. Report of a case in a young adult. Amer. J. Med. 30, 334 (1961).PubMedGoogle Scholar
  857. Powell, W. F., and R. B. Setlow: The effect of monochromatic ultraviolet radiation on the interfering property of influenza virus. Virology 2, 337 (1956).PubMedGoogle Scholar
  858. Prince, A. M., and H. S. Ginsberg: Immunohistochemical studies on the interaction between Ehrlich ascites tumor cells and Newcastle disease virus. J. exp. Med. 105, 177–188 (1957).PubMedGoogle Scholar
  859. Putnam, F. W., and L. M. Kozloff: Biochemical studies of virus reproduction. IV. The fate of the infecting virus particle. J. biol. chem. 182, 243–250 (1950).Google Scholar
  860. Rafelsonjr., M. E., H. E. Pearsonand R. J. Winzler: Oxygen consumption and radiophosphate uptake by minced brain from mice of different ages in relation to propagation of mouse encephalomyelitis virus. Science 112, 231–232 (1950).Google Scholar
  861. Rafelson, jr. M. E., R. J. Winzlerand H. E. Pearson: The effects of Theiler’s GD VII virus on the incorporation of radioactive carbon from glucose into minced one day-old mouse brains. J. biol. Chem. 181, 595–600 (1949).PubMedGoogle Scholar
  862. Ramachandran, L. K.: The amino acid sequence of a pentadecapeptide obtained from a tryptic digest of the protein of tobacco mosaic virus. Biochim. biophys. Acta (Amst) 35, 557–559 (1959).Google Scholar
  863. Randall, C. C., and D. J. Moore: Chemical changes induced in HeLa cells by virus infection. Fed. Proc. 17, 454 (1958).Google Scholar
  864. Rapp, F., and I. Gordon: Development and spread of measles virus infectionin human cells. Bact. Proc. p., 58 (1958).Google Scholar
  865. Rapp, F., I. Gordonand R. F. Baker: Observations of measles virus infection of cultured human cells. I. A study of development and spread of virus antigen by means of immunofluorescence. J. biophys. biochem. Cytol. 7, 43–48 (1960).Google Scholar
  866. Rapp, F., S. J. Seligmanand I. Gordon: A method for estimating infectious virus units by counts of immunofluorescent foci. Bact. Proc. 1959, 79.Google Scholar
  867. Rappaport, Irving: Recovery of infectious nucleic acid from tobacco mosaic virus inactivated by antibody. Nature (Lond.) 184, 1732–1733 (1959).Google Scholar
  868. Rasmussen, A. F., J. T. Marshand N. Q. Brill: Increased susceptibility to herpes simplex in mice subjected to avoidance-learning stress or restraint. Proc. Soc. exp. Biol. (N.Y.) 95, 183–189 (1957).Google Scholar
  869. Rasmussen, A. F., H. A. Waismann, C. A. Elvehjemand P. F. Clark: Role of nutrition in response of host to poliomyelitis virus infection. Influence of thiamin and riboflavin deficiencies on resistance to Theiler’s virus and to Lansing strain poliomyelitis in mice. J. Bact. 45, 85 (1943).Google Scholar
  870. Reagan, R. L., and A. L. Brueckner: Early appearance of rabies virus in the blood and in the brain of hamsters exposed by rectal instillation (preliminary report). Cornell Vet. 43, 496 (1953).PubMedGoogle Scholar
  871. Reich, E., and R. M. Franklin: Effect of mitomycin C on the growth of some animal viruses. Proc. nat. Acad. Sci. (Wash.) 47, 1212–1217 (1961).Google Scholar
  872. Reid, E., and B. M. Stevens: Hormones and liver cytoplasm. 4. Ribonucleotides, ribonucleic acid synthesis and protein synthesis after adrenalectomy. Biochem. J. 67, 262–274 (1957).PubMedGoogle Scholar
  873. Reissig, M., D. W. Howesand J. L. Melnick: Sequence of morphological changes in epithelial cell cultures infected with poliovirus. J. exp. Med. 104, 289–304 (1956).PubMedGoogle Scholar
  874. Rhodes, A. J., F. T. Shimada, Etna M. Clark, W. Woodand R. C. Ritchie: Passive immunity in poliomyelitis. IV. Protection of rhesus monkey against cerebral challenge. Proc. Soc. exp. Biol. (N.Y.) 79, 421 (1952).Google Scholar
  875. Ribbert, H.: Über kompensatorische Hypertrophie der Nieren. Virchows Arch. path. Anat. 88, 11 (1882). Über protozoenartige Zellen in der Niere eines syphilitischen Neugeborenen und in der Parotis von Kindern. Zbl. allg. Path. path. Anat. 15, 945 (1904).Google Scholar
  876. Richter, H.: Weiterer Beitrag zur Ätiologie der Lymphogranulomatose. Dtsch. med. J. 4, 145–149 (1953).Google Scholar
  877. Riman, J., and B. Thorell: A nucleotide enzyme complex associated with fowl leukemia virus. Biochim. biophys. Acta (Amst.) 40, 565–567 (1960).Google Scholar
  878. Robbins, F. C., J. F. Enders and T. H. Weller: Cytopathogenic effect of poliomyelitis viruses in vitro on human embryonic tissues. Proc. Soc. exp. Biol. (N.Y.) 75, 370 (1950).Google Scholar
  879. Robbins, F. C., J. F. Enders, TWellerand G. L. Florentino: Studies on cultivation of poliomyelitis viruses in tissue culture, direct isolation and serologic identification of virus strains in tissue culture from patients with nonparalytic and paralytic poliomyelitis. Amer. J. Hyg. 54, 286 (1951).PubMedGoogle Scholar
  880. Robertis, E. DE, and C. M. Franchi: The submicroscopic organization of axon material isolated from myelin nerve fibers. J. exp. Med. 98, 269 (1953).Google Scholar
  881. Robertis, E. DE., and F. O. Schmitt: An electron microscope study of nerves infected with human poliomyelitis virus. J. exp. Med. 90, 283 (1949).Google Scholar
  882. Robertis, E. DE., Da Rocha Lima, H Zur pathologischen Anatomie des Gelbfiebers. Verh. dtsch. path. Ges. 15, 163 (1912).Google Scholar
  883. Röhrer, H.: Histologische Untersuchungen bei Schweinepest. I. Mitt.Lymphknotenveränderungen in akuten Fällen. Arch. Tierheilk. 62, 345(1930 a).Google Scholar
  884. Röhrer, H.: Histologische Untersuchungen bei Schweinepest. II. Mitt. Veränderungen des Zentralsystems in akuten Fällen. Arch. Tierheilk. 62, 439 (1930b).Google Scholar
  885. Röhrer, H.: Histologische Unter-suchungen bei Schweinepest. III. Mitt. Veränderungen der Milz in akuten Fällen unter besonderer Berücksichtigung der Milzinfarkte. Arch. Tierheilk. 64, 125 (1931).Google Scholar
  886. Röhrer, H.: Pathologisch-anatomische und histologische Studien bei akuter Schweinepest, insbesondere an Leber und Niere. Virchows Arch. path. Anat. 284, 203 (1932).Google Scholar
  887. Röhrer, H.: Die allgemeine morphologische Pathologie der Viruserkrankungen bei Tieren. Verh. dtsch. Ges. f. Path. 38. Tagg, S. 38 (1955).Google Scholar
  888. Röhrer, H.: Viruskrankheiten der Tiere und ihre Bekämpfung. Nova Acta Leopoldina 19, Nr 134, 120–132 (1957).Google Scholar
  889. Roizman, B., and Ann E. Scbiuederberg: Virus infection of cells in mitosis. II. Measles infection of mitotic HEp-2 cells. Proc. Soc. exp. Biol. (N.Y.) 106, 320–323 (1961).Google Scholar
  890. Roizman, B., and Ann E. Scbiuederberg: Virus infection of cells in mitosis. III. Cytology of mitotic and amitotic HEp-2 cells infected with measles virus. J. nat. Cancer Inst. 28, No 1, 35–52 (1962).Google Scholar
  891. Rosenbaum, H. E., and C. G. Harford: Effect of fatigue on susceptibility of mice to poliomyelitis. Proc. Soc. exp. Biol. (N.Y.) 83, 678 (1953).Google Scholar
  892. Ross, R. W., and E. Orlans: The redistribution of nucleic acid and the appearance of specific antigen in HeLa cells infected with Herpes virus. J. Path. Bact. 76, 393–402 (1958).PubMedGoogle Scholar
  893. Rous, P.: A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J. exp. Med. 13, 397 (1911).PubMedGoogle Scholar
  894. Rous, P.: Virus tumors and tumor problem. Amer. J. Cancer 28, 233–272 (1936).Google Scholar
  895. Rowe, W. P.: Propagation of group A Coxsackie viruses in denervated adult mouse muscle. Science 117, 3052 (1953).Google Scholar
  896. Rowe, W. P.: Protective effect of pre-irradiation on lymphocytic choriomeningitis infection in mice. Proc. Soc. exp. Biol. (N.Y.) 92, 194–198 (1956).Google Scholar
  897. Rowe, W. P., J. W. Hartley, B. Roizman and H. B. Levy: Characterization of a factor formed in the course of adenovirus infection of tissue cultures causing detachment of cells from glass. J. exp. Med. 108, 713–729 (1958).PubMedGoogle Scholar
  898. Rowe, W. P., J. W. Hartley, S. Waterman, H. C. Turnerand R. J. Huebner: Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc. Soc. exp. Biol. (N.Y.) 92, 418 (1956).Google Scholar
  899. Rubin, H.: Host cell reaction to the altered antigenicity of Rous sarcoma cells. In: Basic mechanisms in animal virology. Cold Spr. Harb. Symp. quant. Biol. 27 (1962).Google Scholar
  900. Rudder, B. DE, u. G. A. Petersen: Steigert körperliche Anstrengung die Disposition zu epidemischer Kinderlähme ? Eine epidemiologische Beobachtung. Klin. Wschr. 1938, 699.Google Scholar
  901. Rusra, H.: Über Grenzfragen aus dem Gebiet der Strukturforschung und Mikrobiologie. Dtsch. med. Wschr. 1941, 281.Google Scholar
  902. Russel, P. K., and H. R. Morgan: Mumps viral cytolysin. I. Action on human epithelial cells in tissue culture. J. infect. Dis. 104, 38–40 (1959).Google Scholar
  903. Russel, W. R.: Poliomyelitis: The pre-paralytic stage, and the effect of physical activity on the severity of paralysis. Brit. med. J. 1947, 1023.Google Scholar
  904. Russel, W. R.: Paralytic poliomyelitis: The early symptoms and the effect of physical activity on the course of the disease. Brit. med. J. 1949, 465.Google Scholar
  905. Sabin, A. B.: The mechanism of immunity to filterable viruses. Brit. J. exp. Path. 16, 70–84 (1935).Google Scholar
  906. Sabin, A. B.: Experimental poliomyelitis by the tonsillo-pharyngeal route. J. Amer.med. Ass. 111, 605 (1938).Google Scholar
  907. Sabin, A. B.: Genetic, hormonal and age factors in natural resistence to certain viruses. Ann. N.Y. Acad. Sci. 54, 936 (1952a).PubMedGoogle Scholar
  908. Sabin, A. B.: Transitory appearance of type 2 neutralizing antibody in patients infected with type 1 poliomyelitis virus. J. exp. Med. 96, 99–106 (1952b).PubMedGoogle Scholar
  909. Sabin, A. B.: Nature of inherited resistance to viruses affecting the nervous system. Proc. nat. Acad. Sci. 38, 540–546 (1952).Google Scholar
  910. Sabin, A. B.: Properties of attenuated polioviruses and their behavior in human beings. In: Cellular biology, nucleic acids and viruses (special publication), vol. 5, pp. 113–127. New York: Academy of Sciences 1957.Google Scholar
  911. Sabin, A. B., and A. Lwoff: Relation between reproductive capacity of polio viruses at different temperatures in tissue culture and neurovirulence. Science 129, 1287–1288 (1959).Google Scholar
  912. Sabin, A. B., and R. Ward: Nature of non-paralytic and transitory paralytic poliomyelitis in rhesus monkeys inoculated with human virus. J. exp. Med. 73, 757–770 (1941).PubMedGoogle Scholar
  913. Sadron, C. L.: Deoxyribonucleic acids as macromolecules. In: The nucleic acids, vol. III, p. 16 (E. CHAR-GAFF u. J. M., DAVIDSON, eds.). New York: Academic Press 1960.Google Scholar
  914. Sagik, B., T. Puckand S. Levine: Quantitative aspects of the spontaneous elution of influenza virus from red cells. J. exp. Med. 99, 251–260 (1954).PubMedGoogle Scholar
  915. Salaman, M. H.: The combining properties of vaccinia virus with the antibodies demonstrable in anti-vaccinial serum. Brit. J. exp. Path. 18, 245 (1937).Google Scholar
  916. Salk, J. E.: A concept of the mechanism of immunity for preventing paralysis in poliomyelitis. Ann. N.Y. Acad. Sci. 61, 1023–1038 (1955).PubMedGoogle Scholar
  917. Salk, J. E.: Requirements for persistent immunity to poliomyelitis. Amer. J. med. Sci. 232, 369–377 (1956).PubMedGoogle Scholar
  918. Salzman, N. P., A. J. Shatkin, E. D. Sebringand W. Munyon: On the replication of vaccinia virus. Cold Spr. Harb. Symp. quant. Biol. 27, 237–244 (1962).Google Scholar
  919. Sanders, F. K.: Multiplication cycles in neurotropic viruses. In: The nature of virus multiplication. Cambridge: Cambridge University Press 1953.Google Scholar
  920. Sanders, F. K.: Role of infective nucleic acid in the production of encephalomyocarditis. Nature (Lond.) 185, 802–804 (1960).Google Scholar
  921. Sanders, M., B A Akinand M. G. Soret: The role of Naja flava toxoid and toxin in experimental poliomyelitis. Acta neuroveg. (Wien) 8, 362 (1954).Google Scholar
  922. Sanders, M., M. G. Soretand B. A. Akin: Neurotoxoid interference with two human strains of poliomyelitis in rhesus monkeys. Ann. N.Y. Acad. Sci. 58, 1–12 (1953).PubMedGoogle Scholar
  923. Sandritter, W., U. M. Berg: Quantitative histochemische Untersuchungen an der Chorion-Allantoismembran nach Virusinfektionen und unspezifischen Reizen. Z. Naturforsch. 14b, 379–382 (1959).Google Scholar
  924. Sandritter, W., D. Müller u. O. Mantz: Zur Histochemie der Cytomegalie. Frankfurt. Z. Path. 70, 589–597 (1960).PubMedGoogle Scholar
  925. Schad, N.: Zur Problematik: Trauma und Poliomyelitis. Munch. med. Wschr. 1954, 966.Google Scholar
  926. Schäfer, W.: Units isolated after splitting fowl plague virus. In: CibaFoundation Symposium on the Nature of Viruses. London: J. and A. Churchill 1957.Google Scholar
  927. Schäfer, W.: Some aspects of animal virus multiplication. In: Perspectives in virology, edit. by MORRIS POLLARD New York and London: John Wiley und Sons 1959a.Google Scholar
  928. Schäfer, W.: Some observations concerning the reproduction of RNA-containing animal viruses. In: Virus growth and variation. Cambridge: Cambridge University Press 1959b.Google Scholar
  929. Schäfer, W.: The comparative chemistry of infectine virus particles and of other virus-specific products: Animal viruses. In: The viruses (F. M. BURNET u. W. M. STANLEY, eds.), vol. I, p. 475. New York: Academic Press 1959 c.Google Scholar
  930. Schäfer, W., u. K. Munk: Eigenschaften tierischer Virusarten, untersucht an den Geflügelpestviren als Modell. Z. Naturforsch. 7 b, 608–619 (1952).Google Scholar
  931. Schäfer, W., u. W. Zillig: Über den Aufbau des Virus-Elementarteilchens der klassischen Geflügelpest. I. Gewinnung, physikalisch-chemische und biologische Eigenschaften einiger Spaltprodukte. Z. Naturforsch. 9b, 779–788 (1954).Google Scholar
  932. Scräfer,W., W. Zilligu. K. Munk: Isolierung und Charakterisierung hämagglutinierender, nicht infektiöser Einheiten bei klassischer Geflügelpest. Ein Beitrag zur Kenntnis der „inkompletten Virusformen“. Z. Naturforsch. 9b, 329–340 (1954).Google Scholar
  933. Schaffer, C.: Nouvelle contribution à la pathologie et à l’histopathologie de la rage humaine. Ann Inst. Pasteur 3, 644 (1889).Google Scholar
  934. Schaffer, C.: Sur un cas atypique de rage humaine Ann. Inst. Pasteur 4, 513 (1890).Google Scholar
  935. Schell, K.: 1960a (zit. nach BANG und LUTTRELL 1961).1960b (zit. nach BANG und LUTTRELL 1961 ).Google Scholar
  936. Scherer, W. F.: Agglutination of a pure strain of mammalian cells (L strain, Earle) by suspensions of vaccinia virus. Proc. Soc. exp. Biol. (N.Y.) 80, 598–602 (1952).Google Scholar
  937. Scherer, W. F., J. T. Syvertonand G. O. Gey: Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J. exp. Med. 97, 695–710 (1953).PubMedGoogle Scholar
  938. Schindler, R.: Studies on the pathogenesis of rabies. Bull. Org. mond. Santé 25, 119–126 (1961).Google Scholar
  939. Schlesinger, R. W.: Interference between animal viruses. In: The viruses, vol. 3. New York and London: Academic Press 1959.Google Scholar
  940. Schmidt, F.: Über die Entstehung von lymphoiden Tumoren bei Experimenten auf der Basis der Induktionstheorie der Krebsentstehung. Naturwissenschaften 41, 504 (1954).Google Scholar
  941. Schmidt, F.: Über zellfreie Tumorübertragung. Abh. dtsch. Akad. Wiss. Berlin, Kl. Med. 1955, 112–123 (1957).Google Scholar
  942. Schmidt, H.: Fortschritte der Serologie. Darmstadt: Dr. Dietrich Steinkopff 1955.Google Scholar
  943. Scholtissek, CH., u. R. Rott: Zusammenhänge zwischen der Synthese von Ribonucleinsäure und Protein bei der Vermehrung eines Virus der Influenza-Gruppe (Virus der klassischen Geflügelpest). Z. Naturforsch. 16b, 663–673 (1961).Google Scholar
  944. Schramm, G.: Methoden der Fermentforschung. Naturwissenschaften 31, 94 (1943).Google Scholar
  945. Schramm, G.: Über die Spaltung des Tabakmosaikvirus und die Wiedervereinigung der Spaltstücke zu Höhermolekularen Molekülen. Z. Naturforsch. 2b, 112–121, 249–257 (1947).Google Scholar
  946. Schramm, G.: Die Biochemie der Viren. Berlin-Göttingen-Heidelberg: Springer 1954.Google Scholar
  947. Schramm, G.: Biosynthese des Tabakmosaikvirus. Symp. Nr. VII. IV. Int. Kongr. f. Biochemie, Wien, 1.-6. 9. 1958.Google Scholar
  948. Schramm, G., and R. Engler: The latent period after infection with tobacco mosaic virus and virus nucleic acid. Nature (Lond.) 181, 916 (1958).Google Scholar
  949. Schramm, G., and A. Gierer: Investigations on the ribonucleic acid of tobacco mosaic virus. Cellular Biology, Nucleic Acids and Viruses. New York. Acad. Sci. Special. Publ. 5, 229–235 (1957).Google Scholar
  950. Schramm, G., u. H. Miller: Zur Chemie des Tabakmosaikvirus über die Einwirkung von Keten und Phenylisocyanat auf das Virusprotein. Hoppe-Seylers Z. physiol. Chem. 266, 43 (1940).Google Scholar
  951. Schramm, G., u. H. Miller: Über die Bedeutung der Aminogruppen für die Vermehrungsfähigkeit des Tabakmosaikvirus. Hoppe-Seylers Z. physiol. Chem. 274, 267 (1942).Google Scholar
  952. Schramm, G., u. B. Röttger: Untersuchungen über das Tabakmosaikvirus mit fluoreszierenden Antikörpern. Z. Naturforsch. 14b, 510–515 (1959).Google Scholar
  953. Schramm, G., G. Schumacher and W. Zillig: An infectious nucleoprotein from tobacco mosaic virus. Nature (Lond.) 175, 549 (1955).Google Scholar
  954. Schramm, G., u. W. Zillig: Über die Struktur des Tabakmosaikvirus. IV. Die Reaggregation des nukleinsäure-freien Proteins. Z. Naturforsch. 10b, 493 (1955).Google Scholar
  955. Schikri-Aksel, I.: Die histopathologischen Veränderungen des Gehirnes bei der Lyssa.Arch. Psychiat. Nervenkr. 102, 645 (1934).Google Scholar
  956. Schikri-Aksel, I.: Weitere Untersuchungen zur Histopathologie des Gehirnes bei der Lyssa. Arch. Psychiat. Nervenkr. 104, 469 (1935).Google Scholar
  957. Schikri-Aksel, I.: Über die Patho-genese der Lyssa. Arch. Psychiat. Nervenkr. 107, 339 (1937).Google Scholar
  958. Schikri-Aksel, I., u. H. Spatz: Über die anatomischen Veränderungen bei der menschlichen Lyssa und ihre Beziehungen zu denen der Encephalitis epidemica. Z. ges. Neurol. Psychiat. 97, 627 (1925).Google Scholar
  959. Schulte, F., u. R. Akün: Der Nachweis der Kerneinschlußkörperchen, ihre morphologische Struktur und einige Gedanken über ihre Entstehung und chemische Zusammensetzung. Dtsch. tierärztl. Wschr. 60, 478 (1953).Google Scholar
  960. Schuster, H.: The ribonucleic acids of viruses. In: The nucleic acids, vol. III, p. 264 (E. Cjargaff u. J. M. Davidson, eds.). New York: Academic Press 1960.Google Scholar
  961. Schuster, H., u. G. Schramm: Bestimmung der biologisch wirksamen Einheit in der Ribonucleinsäure des Tabakmosaikvirus auf chemischem Wege. Z. Naturforsch. 13b, 697–704 (1958).Google Scholar
  962. Schwartz, S. O.: Diskussionsbemerkung in: A Ciba Foundation Symposium on tumour viruses of murine origin. London: J. and A. Churchill 1962.Google Scholar
  963. Schweinburg, F.: Über den Nachweis des Lyssavirus in verschiedenen Organen. Zbl. Bakt., I. Abt. Orig. 123, 434 (1932).Google Scholar
  964. Scott, T. F. M., C. F. Burgoon, L. L. Corielland H. Blank: The growth curve of the virus of herpes simplex in rabbit corneal cells grown in tissue culture with parallel observations on the development of the intranuclear inclusion body. J. Immunol. 71, 385–396 (1953).PubMedGoogle Scholar
  965. Seifert, G.: Zur Pathologie der Cytomegalie. (EinschluBkörperchenkrankheit, Speicheldrüsenviruserkrankung). Virchows Arch. path. Anat. 325, 596 (1954).Google Scholar
  966. Seifert, G.: Die Zytomegalie. Verhandl. Dtsch. Path. Ges. 40. Tagg, S. 123 (1956).Google Scholar
  967. Seifert, G.:Die morphologische Diagnose der Zytomegalie. Munch. med.Wschr. 1961, 139–143.Google Scholar
  968. Seifried, O. : Histopathology of infectious laryngotracheitis in chickens. J. exp. Med. 54, 817 (1931 a).Google Scholar
  969. Seifried, O. : Histological studies on hog cholera; lesions in central nervous system. J. exp. Med. 53, 277 (1931 b).Google Scholar
  970. Seifried, O.: Einfluß von Virusvirulenz und Infektionsart auf den anatomischen Charakter der sog. Laryngotracheitis der Hühner. Z. Infekt.-Kr. Haustiere 52, 108 (1938).Google Scholar
  971. Seifried, O., and C. B. Cain: Histological studies on hog cholera. II. Lesions of the vascular system. J. exp. Med. 56, 345 (1932).PubMedGoogle Scholar
  972. Seifried, O., and C. B. Cain: Histological studies on hog cholera. III. Lesions in the various organs. J. exp. Med. 56, 351 (1932).PubMedGoogle Scholar
  973. Sekiguchi, M., A. Taketoand Y. Takagi: An infective deoxyribonucleic acid from bacteriophage o x 174. Biochim. biophys. Acta (Amst.) 45, 199–200 (1960).Google Scholar
  974. Sellers, M. I.: Further studies of interrelationships between xanthine oxydase and influenzal pneumonia in mice. Proc. Soc. exp. Biol. (N. Y.) 91, 457–460 (1956).Google Scholar
  975. Sellers, M. I.: A study of the nucleic acid content of mouse lung infected with the virus of influenza. Arch. Biochem. Biophys. 75, 368–375 (1958).PubMedGoogle Scholar
  976. Sellers, M. I., and G. G. Jan: Biochemical changes in mouse lung concomitant with influenza virus infection. Proc. Soc. exp. Biol. (N. Y.) 86, 205–212 (1954).Google Scholar
  977. Shack, J., and L. Ku.Ham: Relation of myxoma deoxyribonucleic acid to fibromamyxoma virus transformation. Proc. Soc. exp. Biol. (N.Y.) 100, 726–729 (1959).Google Scholar
  978. Sharpless, G. R., M. C. Davies and H. R. Cox: Antagonistic action of certain neurotropic viruses toward a lymphoid tumor in chickens, with resulting immunity. Proc. Soc. exp. Biol. (N.Y.) 73, 270 (1950).Google Scholar
  979. Shope, R. E. A filtrable virus causing a tumor-like condition in rabbits and its relationship to virus myxomatosum. J. exp. Med. 56, 803 (1932).Google Scholar
  980. Shope, R. E. The swine lungworm as a reservoir and intermediate host for swine influenza virus. II. The transmission of swine influenza virus by the swine lungworm. J. exp. Med. 74, 49 (1941).PubMedGoogle Scholar
  981. Shope, R. E. Swine influenza. In: Virus diseases, pp. 85–109. Ithaca: Cornell Univ. Press 1943.Google Scholar
  982. Shope, R. E., and E. W. Hurst: Infectious papillomatosis of rabbit. J. exp. Med. 58, 607 (1933).PubMedGoogle Scholar
  983. Shwartzman, G.: Enhancing effect of cortisone upon poliomyelitis infection (strain MEF 1) in hamsters and mice. Proc. Soc. exp. Biol. (N.Y.) 75, 835 (1950).Google Scholar
  984. Shwartzman, G.: The effect of ACTH and cortisone upon infection and resistance. Sympos. N.Y. Acad. Med. Press New York: Columbia Univ. 1953.Google Scholar
  985. Shwartzman, G., S. M. Aronson, C. V. Teodoru, M. Adlerand R. Jahiel: Endocrinological aspects of pathogenesis of experimental poliomyelitis. Ann. N.Y. Acad. Sci. 61, 369 (1955).Google Scholar
  986. Shwartzman, G., S. M. Aronson, C. V. Teodoru, M. Adlerand R. Jahiel:Endocrinological aspects of pathogenesis of experimental poliomyelitis. Ann. N.Y. Acad. Sci. 61, 869–876 (1955).PubMedGoogle Scholar
  987. Shwartzman, G., and A. Fisher: Alteration of experimental poliomyelitis infection in the Syrian hamster with the aid of cortisone. J. exp. Med. 95, 347–362 (1952).PubMedGoogle Scholar
  988. Siede, Werner: Das Blutbild bei Viruserkrankungen. Dtsch. med. J. 4, 218–221 (1953).Google Scholar
  989. Siegert, R., E. Betzu. G. Schmidt: ZurProblematik desPyrogenbegriffs, dargestellt am Beispiel derViruspyrogene. Sonderdruck aus : S.-B. Ges. Beförderung ges. Naturw. Marburg 83/84, 255–276 (1961/62).Google Scholar
  990. Sigel, M. M., and A. R. Beasley: Demonstration of two effects of cortisone on virus-cell interaction. Proc. Soc. exp. Biol. (N.Y.) 88, 86 (1955).Google Scholar
  991. Sigel, M. M., A. J. Girardiand E. G. Allen: Studies on the psittacosis-lymphogranuloma group. J. exp. Med. 94, 401–413 (1951).PubMedGoogle Scholar
  992. Signer, E.: Cytomegalie bei einem Erwachsenen. Path. et Microbiol. (Basel) 25, 359 (1962).Google Scholar
  993. Silber, R. H., and C. C. Porter: Nitrogen balance, liver protein repletion and body composition of cortisone treated rats. Endocrinology 52, 518 (1953).PubMedGoogle Scholar
  994. Sinrovics, J.: Die Grundlagen der Virusforschung. Budapest: Ungarische Akademie der Wissenschaften 1956.Google Scholar
  995. Sinsheimer, R. L.: A single-stranded deoxyribonucleic acid from bacteriophage x 174. J. molec. Biol. 1, 43–53 (1959).Google Scholar
  996. Sivertseva, V. N.: The effect of preliminary X-ray irradiation of the organism on the course of infectious processes. Autoref. of thesis, Leningrad 1955 [in Russian].Google Scholar
  997. Sjögren, H O, I Hellström and G. Klein: Resistance of polyoma virus immunized mice to transplantation of established polyoma tumors. Exp. Cell Res. 23, 204–208 (1961).Google Scholar
  998. Smith, L. W., and F. S. Cheever: Relation of viral proliferation and antibody formation in mice exposed to Roentgen radiation. Proc. Soc. exp. Biol. (N.Y.) 100, 817–820 (1959).Google Scholar
  999. Smith, M. G.: Propagation in tissue cultures of cytopathogenic virus from human salivary gland virus disease. Proc. Soc. exp. Biol. (N. Y.) 92, 424 (1956).Google Scholar
  1000. Smith, M. H. D.: Zit. nach GROUPÉ, RAUSCHER und BRYAN 1956.Google Scholar
  1001. Smith, M. H. D., and E. KuN: Morphological and biochemical studies on the chorioallantois of the chick embryo following infection with certain viruses. Brit. J. exp. Path. 35 1–10 (1954).PubMedGoogle Scholar
  1002. Smith, R. R., R. J. Huebner, W. P. Rowe, W. E. Schattenand L. B. Thomas: Studies on the use of viruses in the treatment of carcinoma of the cervix. Cancer (Philad.) 9, 1211 (1956). Google Scholar
  1003. Smorodintsev, A. A.: Problems of pathogenesis and immunology of virus infections. Medgiz, Leningrad 1955 [in Russian]. 1957 (zit. nach SMORODINTSEV 1960 ).Google Scholar
  1004. Smorodintsev, A. A.: Basic mechanisms of nonspecific resistance to viruses in animal and man. Advanc. Virus Res. 7, 327–376 (1960).Google Scholar
  1005. Smorodintsev, A. A., and T. Luzyanina: 1958 (zit. nach SMoRODINTSEV 1960 ).Google Scholar
  1006. Smorodintsev, A. A., and O. I. Shishesna: 1940 (zit. nach SMORODINTSEV 1960). 1942 (zit. nach SMORODINTSEV 1960 ).Google Scholar
  1007. Smorodintsev, A. A., and H. Z. Zhumatov: 1949 (zit. nach Smorodintsev1960 ).Google Scholar
  1008. Smorodintsev, AL. A.: 1956 (zit. nach A. A. SMORODINTSEV 1960). 1957 (zit. nach A. A. SMORODINTSEV 1960 ).Google Scholar
  1009. Sokol, F.,H. Libikovaand J. Zemla: Infectious ribonucleic acid from mouse brains infected with tick-borne encephalitis virus. Nature (Lond.) 184, 1581 (1959).Google Scholar
  1010. Soxol, F., and J. Szurman: Isolation of ribonucleic acid from purified influenza virus preparation by phenol exstraction. Acta virol. (Engl. ed.) 3, 175–180 (1959).Google Scholar
  1011. Somer, DE s. unter DE Somer.Soule, D. W., G. V. Marinetti and H. R. Morgan: Studies of the hemolysis of red blood cells by mumps virus. J. exp. Med. 110, 93–102 (1959).Google Scholar
  1012. Southam, C. M., and V. I. Babcock: Effect of cortisone, related hormones and adrenalectomy on susceptibility of mice to virus infections. Proc. Soc. exp. Biol. (N.Y.) 78, 105 (1951).Google Scholar
  1013. Southam, C. M., and A. E. Moore: West Nile, Ilheus, and Bunyamwera virus infections in man. Amer. J. trop. Med. 31, 724 (1951).PubMedGoogle Scholar
  1014. Southam, C. M., and A. E. Moore: Clinical studies of viruses as antineoplastic agents, with particular reference to Egypt 101 virus. Cancer (Philad.) 5, 1025–1034 (1952).Google Scholar
  1015. Southam, C. M., W. F. Noyesand R. Mellors: Virus in human cancer cells in vivo. Virology 5, 395–398 (1958).PubMedGoogle Scholar
  1016. Speransky, A.: Faits nouveaux sur la pathogénie et la prophylaxie de la rage. Ann. Inst. Pasteur 41, 166 (1927).Google Scholar
  1017. Spizizen, J.: Infection of protoplasts by disrupted T2 virus. Proc. nat. Acad. Sci. (Wash.) 43, 694–701 (1957).Google Scholar
  1018. Sprunt, D. H., and S. Mcdearman: Studies on the relationship of sex hormones to infection. III. A quantitative study on the increased resistance to vaccinial infection produced by the estrogenic hormone and pseudopregnancy J. Immunol 38, 81–95 (1940).Google Scholar
  1019. Stanley, W. M.: Isolation of a crystalline protein possessing the properties of tobacco-mosaic virus. Science 81, 644–645 (1935).PubMedGoogle Scholar
  1020. Stanley, W. M.: Viruses as chemical agents. In: Poliomyelitis, pp. 6–8. Second Int. Poliomyelitis Conf. Philadelphia and Montreal J. B. Lippincott Company 1952.Google Scholar
  1021. Steigman, A. J., U. P. Koxxoand J. Silverberg: Mack virus-serum and gamma globulin neutralization of unidentified agent isolated from suspected non paralytic poliomyelitis. Proc. Soc. exp. Biol. (N.Y.) 83, 200 (1953a).Google Scholar
  1022. Steigman, A. J., U. P. Koxxoand J. Silverberg: Unusual virus from poliomyelitis spinal cord. J. Amer. med. Ass. 152, 1066 (1953b).Google Scholar
  1023. Steinhardt, E., C. Israeliand R. A. Lambert: Studies on the cultivation of the virus of vaccinia. J. infect. Dis. 13, 294 (1913).Google Scholar
  1024. Stewart, R. B., and H. R. Morgan: Studies on cytotropism in animal viruses. II. A comparison of the growth of four influenza virus strains in vivo and in vitro in hatched chick and chick embryo lung tissue. J. Immunol. 85, 465–468 (1960).Google Scholar
  1025. Stewart, S. E.: Leukemia in mice produced by a filterable agent present in AKR leukemic tissue with notes on sarcoma produced by the same agent. Anat. Rec. 117, 532 (1953).Google Scholar
  1026. Stewart, S. E.: Neoplasms in mice inoculated with cellfree extracts or filtrates of leukemic mouse tissues. I. Neoplasms of the parotid and adrenal glands. J. nat. Cancer Inst. 15, 1391–1415 (1955a).Google Scholar
  1027. Stewart, S. E.: Neoplasms in mice inoculated with cell-free extracts or filtrates of leukemic mouse tissues. II. Leukemia in hybrid mice produced by cell-free filtrates. J. nat. Cancer Inst. 16, 41–53 (1955b).PubMedGoogle Scholar
  1028. Stewart, S. E.: The polyoma virus. Sect. A. In: Advanc. Virus Res. 7, 61–90 (1960).Google Scholar
  1029. Stewart, S. E.: Tumours in polyomavirus-immunized mice. In: A Ciba Foundation Symposium on tumour viruses of murine origin. London: J. and A. Churchill 1962.Google Scholar
  1030. Stewart, S. E., and B. E. Eddy: In : Proc. VII World Congr. Hematol., Intern., Soc. Hematology, pp. 596–601.Roma: Il Pensiero Scientifico 1958 b.Google Scholar
  1031. Stewart, S. E., and B. E. Eddy: In: In: Perspectives in, virology, p. 245 (ed. M. Pollard). New York: Wiley 1959.Google Scholar
  1032. StewartS. E., B. E. Eddyand N. Borgese: Neoplasms in mice inoculated with a tumor agent carried in tissue culture. J. nat. Cancer Inst. 20, 1223–1243 (1958).PubMedGoogle Scholar
  1033. Stewart, S. E., B. E. Eddy, A. M. Gochenour, N. G. Borgeseand G. E. Grubbs: The induction of neoplasms with a substance released from mouse tumors by tissue culture. Virology 3, 380–400 (1957a).PubMedGoogle Scholar
  1034. Stewart, S. E., B. E. Eddy, V. H. Haasand N. G. Borgese: Lymphocytic choriomeningitis virus as related to chemotherapy studies and to tumor induction in mice. Ann N Y Acad. Sci. 68, 419–429 (1957 b).Google Scholar
  1035. Stewart, S. E., and M. L. Irwin: Cellular proliferation in primary tissue cultures induced with a substance derived from cell-free concentrates from human neoplastic material. Cancer Res. 20, 766–767 (1960).PubMedGoogle Scholar
  1036. Stewart, S. E., and M. L. Irwin: Proc. IV nat. Cancer Conf., p. 346. Philadelphia: J. B. Lippincott Company 1961.Google Scholar
  1037. Stoker, M.: Studies on the oncogenic activity of the Toronto strain of polyoma virus. Brit. J. Cancer 14, 679–689 (1960).PubMedGoogle Scholar
  1038. Stoker, M.: Conditions affecting transformation by polyoma virus. In: Basic mechanisms in animal virology. Cold Spr. Harb. Symp. quant. Biol. 27, 375–386 (1962).Google Scholar
  1039. Stoker, M. G. P.: Growth studies with herpes virus. In: Virus growth and variation. Cambridge: Cambridge University Press 1959.Google Scholar
  1040. Stone, I. D.: Prevention of virus infection with enzyme of V. cholerae, studies with influenza virus in mice. Aust. J. exp. Biol. med. Sci. 26, 287–298 (1948).Google Scholar
  1041. Strauss, M. J., E. W. Shaw, H. Buntingand J. L. Melnick: „Crystalline“ virus-like particles form skin papillomas characterized by intranuclear inclusion bodies. Proc. Soc. exp. Biol. (N.Y.) 72, 46 (1949).Google Scholar
  1042. Streisinger, G.: The genetic control of host range and serological specificity in bacteriophages T2 and T4. Virology 2, 377–387 (1956a).PubMedGoogle Scholar
  1043. Streisinger, G.: Phenotypic mixing of host range and serological specificities in bacteriophages T2 and T4. Virology 2, 388–398 (1956b).PubMedGoogle Scholar
  1044. Sugg, J. Y.: An influenza virus pneumonia of mice that is nontransferable by serial passage. J. Bact. 57, 399–403 (1949).PubMedGoogle Scholar
  1045. Sulkin, S E, R. A. Finkelsteinand E. D. Rosenbaum: Effect of zymosan on bacteriophage clearance. Science 125, 742 (1957).PubMedGoogle Scholar
  1046. Sulkin, S. E., R. Allen, R. Sims, P. H. Krutzscitand C. Kim: Studies on the pathogenesis of rabies in insectivorous bats. II. Influence of an environmental temperature. J. exp. Med. 112, 595–617 (1960).PubMedGoogle Scholar
  1047. Svec, F., E. Hlavay, V. Thurzo u. P. Kossey: Erythroleukämie der Ratte, hervorgerufen durch zellfreie Karzinomfiltrate. Acta haemat. (Basel) 17, 34–41 (1957).Google Scholar
  1048. Sykes, J. A., J. G. Sinkovics, L. Dmochowski, C. C. Schullenbergerand C. D. Howe: Tissue culture studies of human leukemia. Ann. Rep. Univ. Texas M. D. Anderson Hosp. Tumor Inst. 1960.Google Scholar
  1049. Syverton, J. T.: The pathogenesis of the rabbit papilloma-to-carcinoma sequence. Ann. N.Y. Acad. Sci. 54, 1126 (1952).PubMedGoogle Scholar
  1050. Syverton, J. T.: Cells in continuous culture for study of viruses. (Symposium on newer knowledge of viral and rickettsial diseases). Amer J trop. Med. Hyg. 5, 430–439 (1956).Google Scholar
  1051. Syverton, J. T., K. T. Brunner, J. O. H. Tobixand M. M. Cohen: Recovery of viable virus from poliomyelitis vaccine by use of monkeys pretreated with cortisone and X-radiation. Amer. J. Hyg. 64, 74 (1956).PubMedGoogle Scholar
  1052. Syverton, J. T., A. A. Werder, J. Friedman, A. B. Graham, F. J. Rothand O. J. Mira: Cortisone and roentgen radiation in combination as synergistic agents for production of lethal infection. Proc. Soc. exp. Biol. (N.Y.) 80, 123–128 (1952).Google Scholar
  1053. Takahashi, M., S. Kameyama, S Kato and J. Kamahora: A study of myxoma virus inclusion with fluorescein-labeled antibody. Biken’s J. 1, 198–200 (1958).Google Scholar
  1054. Takahashi, M., S. Kameyama, S Kato and J. Kamahora: The immunological relationship of the pox virus group. Bikens’ J. 2, 27–29 (1959).Google Scholar
  1055. Tamm, I.: Discussion in: Cold Spr. Harb. Symp. quant. Biol. 27, 196–198 (1962);Google Scholar
  1056. Tamm, I.: s. auch H. J. Eggers and I. Tamm, Spectrum and characteristics of the virus inhibitory action of 2-(a-hydroxybenzyl)-benzimidazole. J. exp. Med. 113, 657–682 (1961).Google Scholar
  1057. Tamm, I., K. Folkers, C. H. Skunkand F. L. Horsfalljr.: Inhibition of influenza virus multiplication by N-glycosides of benzimidazoles. J. exp. Med. 99, 227 (1954).PubMedGoogle Scholar
  1058. Taniguchi, T., T. Fujino, S. Inoki and Y. Okuno: Studies on experimental inoculation of dengue fever. Med. J. Osaka Univ. 2, 1 (1951).Google Scholar
  1059. Tarantino, C.: Sulla presenza di ACTH nella placenta. Folia en doer. (Roma) 4, 197–201 (1951).Google Scholar
  1060. Taubeneck, U., u. H. Böhme: Der Einfluß von Bakteriophagen auf die L-Phase von Proteus mirabilis. Z. Naturforsch. 13b, 471–472 (1 58).Google Scholar
  1061. Taylor, E. S., and J. M. Simmons: Acute anterior poliomyelitis in pregnm.ncy. Amer. J. Obstet. Gynec. 56, 143 (1948).PubMedGoogle Scholar
  1062. Taylor, J., and A. F. Graham: Purification of poliovirus labeled with radiophosphorus. Virology 6, 488–498 (1958).PubMedGoogle Scholar
  1063. Teilum, G., and H. E. Poulsen: Disseminated lupus erythematosus. Arch. Path. 64, 414 (1957).Google Scholar
  1064. Teissier, P., P. Gastinel et J. Reilly: L’herpès expérimental humain.L’inoculabilité du virus herpétique. J. phys. path. gener. 24, 271 (1926).Google Scholar
  1065. Teodoru, C. V., and G. Shwartzman: Endocrine factors in pathogenesis of experimental poliomyelitis in hamsters. Role of inoculatory and environmental stress. Proc. Soc. exp. Biol. (N.Y.) 91, 181 (1956).Google Scholar
  1066. Theiler, M: Studies on the action of yellow fever virus in mice. Ann trop. Med. Parasit. 24, 249 (1930).Google Scholar
  1067. Theiler, M:A yellow fever protection test in mice by intracerebral injection. Ann. trop. Med. Parasit. 27, 57 (1933).Google Scholar
  1068. Theiler, M:Spontaneous encephalomyelitis of mice, a new virus disease. J. exp. Med. 65, 705 (1937).PubMedGoogle Scholar
  1069. Theiler, M., u. J.Casals:Durch Arthropoden übertragene Viruserkrankungen des Menschen. Klin. Wschr. 37, 59 (1959).PubMedGoogle Scholar
  1070. Theiler, M., and S. Gard: Encephalomyelitis in mice. III. Epidemiology. J. exp. Med.